id	sid	tid	token	lemma	pos
ct-10123	1	1	2013	2013	NUM
ct-10123	1	2	:	:	PUNCT
ct-10123	1	3	update	update	NOUN
ct-10123	1	4	on	on	ADP
ct-10123	1	5	antimicrobial	antimicrobial	ADJ
ct-10123	1	6	therapy	therapy	NOUN
ct-10123	1	7	in	in	ADP
ct-10123	1	8	mare	mare	NOUN
ct-10123	1	9	reproduction	reproduction	NOUN
ct-10123	1	10	update	update	NOUN
ct-10123	1	11	on	on	ADP
ct-10123	1	12	antimicrobial	antimicrobial	ADJ
ct-10123	1	13	therapy	therapy	NOUN
ct-10123	1	14	in	in	ADP
ct-10123	1	15	mare	mare	PROPN
ct-10123	1	16	reproduction	reproduction	NOUN
ct-10123	1	17	kristina	kristina	PROPN
ct-10123	1	18	g.	g.	PROPN
ct-10123	1	19	lu	lu	PROPN
ct-10123	2	1	hagyard	hagyard	PROPN
ct-10123	2	2	equine	equine	PROPN
ct-10123	2	3	medical	medical	PROPN
ct-10123	2	4	institute	institute	PROPN
ct-10123	2	5	,	,	PUNCT
ct-10123	2	6	lexington	lexington	PROPN
ct-10123	2	7	,	,	PUNCT
ct-10123	2	8	ky	ky	PROPN
ct-10123	2	9	bacterial	bacterial	ADJ
ct-10123	2	10	uterine	uterine	ADJ
ct-10123	2	11	infections	infection	NOUN
ct-10123	2	12	are	be	AUX
ct-10123	2	13	associated	associate	VERB
ct-10123	2	14	with	with	ADP
ct-10123	2	15	significant	significant	ADJ
ct-10123	2	16	time	time	NOUN
ct-10123	2	17	and	and	CCONJ
ct-10123	2	18	monetary	monetary	ADJ
ct-10123	2	19	loss	loss	NOUN
ct-10123	2	20	in	in	ADP
ct-10123	2	21	the	the	DET
ct-10123	2	22	equine	equine	NOUN
ct-10123	2	23	breeding	breeding	NOUN
ct-10123	2	24	industry	industry	NOUN
ct-10123	2	25	.	.	PUNCT
ct-10123	3	1	the	the	DET
ct-10123	3	2	incidence	incidence	NOUN
ct-10123	3	3	of	of	ADP
ct-10123	3	4	identified	identify	VERB
ct-10123	3	5	bacterial	bacterial	ADJ
ct-10123	3	6	uterine	uterine	ADJ
ct-10123	3	7	infection	infection	NOUN
ct-10123	3	8	is	be	AUX
ct-10123	3	9	estimated	estimate	VERB
ct-10123	3	10	at	at	ADP
ct-10123	3	11	25	25	NUM
ct-10123	3	12	to	to	PART
ct-10123	3	13	60	60	NUM
ct-10123	3	14	%	%	NOUN
ct-10123	3	15	of	of	ADP
ct-10123	3	16	barren	barren	ADJ
ct-10123	3	17	mares.1	mares.1	NOUN
ct-10123	3	18	treatment	treatment	NOUN
ct-10123	3	19	and	and	CCONJ
ct-10123	3	20	resolution	resolution	NOUN
ct-10123	3	21	of	of	ADP
ct-10123	3	22	mare	mare	NOUN
ct-10123	3	23	urogenital	urogenital	ADJ
ct-10123	3	24	infection	infection	NOUN
ct-10123	3	25	involves	involve	VERB
ct-10123	3	26	a	a	DET
ct-10123	3	27	holistic	holistic	ADJ
ct-10123	3	28	approach	approach	NOUN
ct-10123	3	29	which	which	PRON
ct-10123	3	30	must	must	AUX
ct-10123	3	31	include	include	VERB
ct-10123	3	32	consideration	consideration	NOUN
ct-10123	3	33	of	of	ADP
ct-10123	3	34	the	the	DET
ct-10123	3	35	systemic	systemic	ADJ
ct-10123	3	36	health	health	NOUN
ct-10123	3	37	of	of	ADP
ct-10123	3	38	the	the	DET
ct-10123	3	39	mare	mare	NOUN
ct-10123	3	40	,	,	PUNCT
ct-10123	3	41	correction	correction	NOUN
ct-10123	3	42	of	of	ADP
ct-10123	3	43	urogenital	urogenital	ADJ
ct-10123	3	44	anatomic	anatomic	ADJ
ct-10123	3	45	defects	defect	NOUN
ct-10123	3	46	,	,	PUNCT
ct-10123	3	47	enhancement	enhancement	NOUN
ct-10123	3	48	of	of	ADP
ct-10123	3	49	uterine	uterine	ADJ
ct-10123	3	50	clearance	clearance	NOUN
ct-10123	3	51	in	in	ADP
ct-10123	3	52	non	non	ADJ
ct-10123	3	53	-	-	ADJ
ct-10123	3	54	pregnant	pregnant	ADJ
ct-10123	3	55	mares	mare	NOUN
ct-10123	3	56	,	,	PUNCT
ct-10123	3	57	identification	identification	NOUN
ct-10123	3	58	of	of	ADP
ct-10123	3	59	specific	specific	ADJ
ct-10123	3	60	infections	infection	NOUN
ct-10123	3	61	,	,	PUNCT
ct-10123	3	62	and	and	CCONJ
ct-10123	3	63	appropriate	appropriate	ADJ
ct-10123	3	64	antimicrobial	antimicrobial	ADJ
ct-10123	3	65	selection	selection	NOUN
ct-10123	3	66	and	and	CCONJ
ct-10123	3	67	administration	administration	NOUN
ct-10123	3	68	.	.	PUNCT
ct-10123	4	1	the	the	DET
ct-10123	4	2	following	follow	VERB
ct-10123	4	3	is	be	AUX
ct-10123	4	4	a	a	DET
ct-10123	4	5	brief	brief	ADJ
ct-10123	4	6	review	review	NOUN
ct-10123	4	7	of	of	ADP
ct-10123	4	8	antimicrobial	antimicrobial	ADJ
ct-10123	4	9	properties	property	NOUN
ct-10123	4	10	and	and	CCONJ
ct-10123	4	11	classes	class	NOUN
ct-10123	4	12	,	,	PUNCT
ct-10123	4	13	and	and	CCONJ
ct-10123	4	14	discussion	discussion	NOUN
ct-10123	4	15	regarding	regard	VERB
ct-10123	4	16	antimicrobial	antimicrobial	ADJ
ct-10123	4	17	selection	selection	NOUN
ct-10123	4	18	for	for	ADP
ct-10123	4	19	use	use	NOUN
ct-10123	4	20	in	in	ADP
ct-10123	4	21	specific	specific	ADJ
ct-10123	4	22	mare	mare	NOUN
ct-10123	4	23	reproductive	reproductive	ADJ
ct-10123	4	24	disease	disease	NOUN
ct-10123	4	25	states	state	NOUN
ct-10123	4	26	.	.	PUNCT
ct-10123	5	1	excellent	excellent	ADJ
ct-10123	5	2	additional	additional	ADJ
ct-10123	5	3	resources	resource	NOUN
ct-10123	5	4	are	be	AUX
ct-10123	5	5	available.2	available.2	PROPN
ct-10123	5	6	in	in	ADP
ct-10123	5	7	this	this	DET
ct-10123	5	8	age	age	NOUN
ct-10123	5	9	of	of	ADP
ct-10123	5	10	increasing	increase	VERB
ct-10123	5	11	bacterial	bacterial	ADJ
ct-10123	5	12	and	and	CCONJ
ct-10123	5	13	fungal	fungal	ADJ
ct-10123	5	14	antimicrobial	antimicrobial	ADJ
ct-10123	5	15	resistance	resistance	NOUN
ct-10123	5	16	and	and	CCONJ
ct-10123	5	17	heightened	heighten	VERB
ct-10123	5	18	awareness	awareness	NOUN
ct-10123	5	19	of	of	ADP
ct-10123	5	20	antimicrobial	antimicrobial	ADJ
ct-10123	5	21	use	use	NOUN
ct-10123	5	22	in	in	ADP
ct-10123	5	23	animals	animal	NOUN
ct-10123	5	24	,	,	PUNCT
ct-10123	5	25	judicious	judicious	ADJ
ct-10123	5	26	and	and	CCONJ
ct-10123	5	27	wise	wise	ADJ
ct-10123	5	28	employment	employment	NOUN
ct-10123	5	29	of	of	ADP
ct-10123	5	30	antimicrobials	antimicrobial	NOUN
ct-10123	5	31	should	should	AUX
ct-10123	5	32	be	be	AUX
ct-10123	5	33	emphasized	emphasize	VERB
ct-10123	5	34	.	.	PUNCT
ct-10123	6	1	keywords	keyword	NOUN
ct-10123	6	2	:	:	PUNCT
ct-10123	6	3	antibiotics	antibiotic	NOUN
ct-10123	6	4	,	,	PUNCT
ct-10123	6	5	antifungals	antifungal	NOUN
ct-10123	6	6	,	,	PUNCT
ct-10123	6	7	chelators	chelator	NOUN
ct-10123	6	8	,	,	PUNCT
ct-10123	6	9	endometritis	endometritis	PROPN
ct-10123	6	10	,	,	PUNCT
ct-10123	6	11	placentitis	placentitis	PROPN
ct-10123	6	12	general	general	ADJ
ct-10123	6	13	antimicrobial	antimicrobial	ADJ
ct-10123	6	14	properties	property	NOUN
ct-10123	6	15	bactericidal	bactericidal	ADJ
ct-10123	6	16	antimicrobials	antimicrobial	NOUN
ct-10123	6	17	a	a	DET
ct-10123	6	18	)	)	PUNCT
ct-10123	6	19	time	time	NOUN
ct-10123	6	20	dependent	dependent	ADJ
ct-10123	6	21	(	(	PUNCT
ct-10123	6	22	there	there	PRON
ct-10123	6	23	is	be	VERB
ct-10123	6	24	no	no	DET
ct-10123	6	25	benefit	benefit	NOUN
ct-10123	6	26	in	in	ADP
ct-10123	6	27	increasing	increase	VERB
ct-10123	6	28	the	the	DET
ct-10123	6	29	drug	drug	NOUN
ct-10123	6	30	concentration	concentration	NOUN
ct-10123	6	31	above	above	ADP
ct-10123	6	32	the	the	DET
ct-10123	6	33	minimum	minimum	ADJ
ct-10123	6	34	inhibitory	inhibitory	ADJ
ct-10123	6	35	concentration	concentration	NOUN
ct-10123	6	36	(	(	PUNCT
ct-10123	6	37	mic	mic	NOUN
ct-10123	6	38	)	)	PUNCT
ct-10123	6	39	;	;	PUNCT
ct-10123	6	40	instead	instead	ADV
ct-10123	6	41	the	the	DET
ct-10123	6	42	time	time	NOUN
ct-10123	6	43	the	the	DET
ct-10123	6	44	drug	drug	NOUN
ct-10123	6	45	concentration	concentration	NOUN
ct-10123	6	46	is	be	AUX
ct-10123	6	47	above	above	ADP
ct-10123	6	48	mic	mic	NOUN
ct-10123	6	49	is	be	AUX
ct-10123	6	50	most	most	ADV
ct-10123	6	51	important	important	ADJ
ct-10123	6	52	)	)	PUNCT
ct-10123	6	53	;	;	PUNCT
ct-10123	6	54	examples	example	NOUN
ct-10123	6	55	are	be	AUX
ct-10123	6	56	beta	beta	NOUN
ct-10123	6	57	-	-	PUNCT
ct-10123	6	58	lactams	lactam	NOUN
ct-10123	6	59	and	and	CCONJ
ct-10123	6	60	trimethoprim	trimethoprim	ADJ
ct-10123	6	61	-	-	PUNCT
ct-10123	6	62	sulfonamide	sulfonamide	NOUN
ct-10123	6	63	b	b	NOUN
ct-10123	6	64	)	)	PUNCT
ct-10123	6	65	concentration	concentration	NOUN
ct-10123	6	66	dependent	dependent	ADJ
ct-10123	6	67	(	(	PUNCT
ct-10123	6	68	rate	rate	NOUN
ct-10123	6	69	of	of	ADP
ct-10123	6	70	bacterial	bacterial	ADJ
ct-10123	6	71	killing	killing	NOUN
ct-10123	6	72	increases	increase	NOUN
ct-10123	6	73	as	as	ADP
ct-10123	6	74	the	the	DET
ct-10123	6	75	peak	peak	NOUN
ct-10123	6	76	concentration	concentration	NOUN
ct-10123	6	77	increases	increase	NOUN
ct-10123	6	78	above	above	ADP
ct-10123	6	79	the	the	DET
ct-10123	6	80	pathogen	pathogen	NOUN
ct-10123	6	81	’s	’s	PART
ct-10123	6	82	mic	mic	NOUN
ct-10123	6	83	rather	rather	ADV
ct-10123	6	84	than	than	ADP
ct-10123	6	85	the	the	DET
ct-10123	6	86	duration	duration	NOUN
ct-10123	6	87	of	of	ADP
ct-10123	6	88	the	the	DET
ct-10123	6	89	drug	drug	NOUN
ct-10123	6	90	’s	’s	PART
ct-10123	6	91	concentration	concentration	NOUN
ct-10123	6	92	)	)	PUNCT
ct-10123	6	93	;	;	PUNCT
ct-10123	6	94	examples	example	NOUN
ct-10123	6	95	are	be	AUX
ct-10123	6	96	aminoglycosides	aminoglycoside	NOUN
ct-10123	6	97	,	,	PUNCT
ct-10123	6	98	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	6	99	,	,	PUNCT
ct-10123	6	100	metronidazole	metronidazole	NOUN
ct-10123	6	101	,	,	PUNCT
ct-10123	6	102	and	and	CCONJ
ct-10123	6	103	peptides	peptide	VERB
ct-10123	6	104	bacteriostatic	bacteriostatic	ADJ
ct-10123	6	105	antimicrobials	antimicrobial	NOUN
ct-10123	6	106	concentration	concentration	NOUN
ct-10123	6	107	dependent	dependent	ADV
ct-10123	6	108	;	;	PUNCT
ct-10123	6	109	examples	example	NOUN
ct-10123	6	110	are	be	AUX
ct-10123	6	111	macrolides	macrolide	NOUN
ct-10123	6	112	,	,	PUNCT
ct-10123	6	113	tetracyclines	tetracycline	NOUN
ct-10123	6	114	,	,	PUNCT
ct-10123	6	115	and	and	CCONJ
ct-10123	6	116	chloramphenicol	chloramphenicol	NOUN
ct-10123	6	117	antimicrobial	antimicrobial	ADJ
ct-10123	6	118	classes	class	NOUN
ct-10123	6	119	beta	beta	NOUN
ct-10123	6	120	-	-	PUNCT
ct-10123	6	121	lactam	lactam	NOUN
ct-10123	6	122	:	:	PUNCT
ct-10123	6	123	penicillin	penicillin	NOUN
ct-10123	6	124	commonly	commonly	ADV
ct-10123	6	125	used	use	VERB
ct-10123	6	126	formulations	formulation	NOUN
ct-10123	6	127	are	be	AUX
ct-10123	6	128	procaine	procaine	NOUN
ct-10123	6	129	penicillin	penicillin	NOUN
ct-10123	6	130	,	,	PUNCT
ct-10123	6	131	aqueous	aqueous	ADJ
ct-10123	6	132	penicillin	penicillin	NOUN
ct-10123	6	133	salts	salt	NOUN
ct-10123	6	134	,	,	PUNCT
ct-10123	6	135	ampicillin	ampicillin	PROPN
ct-10123	6	136	,	,	PUNCT
ct-10123	6	137	ticarcillin	ticarcillin	PROPN
ct-10123	6	138	;	;	PUNCT
ct-10123	6	139	those	those	PRON
ct-10123	6	140	less	less	ADV
ct-10123	6	141	commonly	commonly	ADV
ct-10123	6	142	used	use	VERB
ct-10123	6	143	in	in	ADP
ct-10123	6	144	equine	equine	NOUN
ct-10123	6	145	reproduction	reproduction	NOUN
ct-10123	6	146	include	include	VERB
ct-10123	6	147	carbapenems	carbapenem	NOUN
ct-10123	6	148	(	(	PUNCT
ct-10123	6	149	imipenem	imipenem	PROPN
ct-10123	6	150	,	,	PUNCT
ct-10123	6	151	meropenem	meropenem	ADJ
ct-10123	6	152	)	)	PUNCT
ct-10123	6	153	mechanism	mechanism	NOUN
ct-10123	6	154	of	of	ADP
ct-10123	6	155	action	action	NOUN
ct-10123	6	156	.	.	PUNCT
ct-10123	7	1	beta	beta	NOUN
ct-10123	7	2	-	-	PUNCT
ct-10123	7	3	lactams	lactam	NOUN
ct-10123	7	4	are	be	AUX
ct-10123	7	5	time	time	NOUN
ct-10123	7	6	-	-	PUNCT
ct-10123	7	7	dependent	dependent	ADJ
ct-10123	7	8	antimicrobials	antimicrobial	NOUN
ct-10123	7	9	that	that	PRON
ct-10123	7	10	interfere	interfere	VERB
ct-10123	7	11	with	with	ADP
ct-10123	7	12	cell	cell	NOUN
ct-10123	7	13	wall	wall	NOUN
ct-10123	7	14	formation	formation	NOUN
ct-10123	7	15	by	by	ADP
ct-10123	7	16	inhibiting	inhibit	VERB
ct-10123	7	17	the	the	DET
ct-10123	7	18	penicillin	penicillin	NOUN
ct-10123	7	19	-	-	PUNCT
ct-10123	7	20	binding	bind	VERB
ct-10123	7	21	proteins	protein	NOUN
ct-10123	7	22	that	that	PRON
ct-10123	7	23	catalyze	catalyze	NOUN
ct-10123	7	24	polymer	polymer	NOUN
ct-10123	7	25	cross	cross	ADJ
ct-10123	7	26	-	-	ADJ
ct-10123	7	27	linking	link	VERB
ct-10123	7	28	necessary	necessary	ADJ
ct-10123	7	29	for	for	ADP
ct-10123	7	30	cell	cell	NOUN
ct-10123	7	31	wall	wall	NOUN
ct-10123	7	32	formation	formation	NOUN
ct-10123	7	33	.	.	PUNCT
ct-10123	8	1	beta	beta	NOUN
ct-10123	8	2	-	-	PUNCT
ct-10123	8	3	lactams	lactam	NOUN
ct-10123	8	4	are	be	AUX
ct-10123	8	5	bactericidal	bactericidal	ADJ
ct-10123	8	6	for	for	ADP
ct-10123	8	7	replicating	replicate	VERB
ct-10123	8	8	cells	cell	NOUN
ct-10123	8	9	,	,	PUNCT
ct-10123	8	10	thus	thus	ADV
ct-10123	8	11	clinical	clinical	ADJ
ct-10123	8	12	benefit	benefit	NOUN
ct-10123	8	13	is	be	AUX
ct-10123	8	14	reduced	reduce	VERB
ct-10123	8	15	when	when	SCONJ
ct-10123	8	16	used	use	VERB
ct-10123	8	17	concurrently	concurrently	ADV
ct-10123	8	18	with	with	ADP
ct-10123	8	19	a	a	DET
ct-10123	8	20	bacteriostatic	bacteriostatic	ADJ
ct-10123	8	21	drug	drug	NOUN
ct-10123	8	22	.	.	PUNCT
ct-10123	9	1	penicillins	penicillin	NOUN
ct-10123	9	2	are	be	AUX
ct-10123	9	3	generally	generally	ADV
ct-10123	9	4	most	most	ADV
ct-10123	9	5	effective	effective	ADJ
ct-10123	9	6	against	against	ADP
ct-10123	9	7	grampositive	grampositive	ADJ
ct-10123	9	8	organisms	organism	NOUN
ct-10123	9	9	,	,	PUNCT
ct-10123	9	10	however	however	ADV
ct-10123	9	11	they	they	PRON
ct-10123	9	12	vary	vary	VERB
ct-10123	9	13	in	in	ADP
ct-10123	9	14	efficacy	efficacy	NOUN
ct-10123	9	15	against	against	ADP
ct-10123	9	16	gram	gram	NOUN
ct-10123	9	17	-	-	PUNCT
ct-10123	9	18	negative	negative	ADJ
ct-10123	9	19	organisms	organism	NOUN
ct-10123	9	20	.	.	PUNCT
ct-10123	10	1	differences	difference	NOUN
ct-10123	10	2	in	in	ADP
ct-10123	10	3	organism	organism	NOUN
ct-10123	10	4	susceptibility	susceptibility	NOUN
ct-10123	10	5	are	be	AUX
ct-10123	10	6	attributable	attributable	ADJ
ct-10123	10	7	to	to	ADP
ct-10123	10	8	differences	difference	NOUN
ct-10123	10	9	in	in	ADP
ct-10123	10	10	penicillin	penicillin	NOUN
ct-10123	10	11	-	-	PUNCT
ct-10123	10	12	binding	bind	VERB
ct-10123	10	13	protein	protein	NOUN
ct-10123	10	14	receptor	receptor	NOUN
ct-10123	10	15	sites	site	NOUN
ct-10123	10	16	,	,	PUNCT
ct-10123	10	17	the	the	DET
ct-10123	10	18	amount	amount	NOUN
ct-10123	10	19	of	of	ADP
ct-10123	10	20	peptidoglycan	peptidoglycan	ADJ
ct-10123	10	21	present	present	ADJ
ct-10123	10	22	in	in	ADP
ct-10123	10	23	the	the	DET
ct-10123	10	24	cell	cell	NOUN
ct-10123	10	25	wall	wall	NOUN
ct-10123	10	26	,	,	PUNCT
ct-10123	10	27	drug	drug	NOUN
ct-10123	10	28	penetration	penetration	NOUN
ct-10123	10	29	of	of	ADP
ct-10123	10	30	the	the	DET
ct-10123	10	31	outer	outer	ADJ
ct-10123	10	32	cell	cell	NOUN
ct-10123	10	33	membrane	membrane	NOUN
ct-10123	10	34	of	of	ADP
ct-10123	10	35	gramnegative	gramnegative	ADJ
ct-10123	10	36	bacteria	bacteria	NOUN
ct-10123	10	37	,	,	PUNCT
ct-10123	10	38	and	and	CCONJ
ct-10123	10	39	beta	beta	NOUN
ct-10123	10	40	-	-	PUNCT
ct-10123	10	41	lactamase	lactamase	NOUN
ct-10123	10	42	-	-	PUNCT
ct-10123	10	43	induced	induce	VERB
ct-10123	10	44	resistance	resistance	NOUN
ct-10123	10	45	.	.	PUNCT
ct-10123	11	1	distribution	distribution	NOUN
ct-10123	11	2	.	.	PUNCT
ct-10123	12	1	penicillins	penicillin	NOUN
ct-10123	12	2	are	be	AUX
ct-10123	12	3	well	well	ADV
ct-10123	12	4	distributed	distribute	VERB
ct-10123	12	5	throughout	throughout	ADP
ct-10123	12	6	the	the	DET
ct-10123	12	7	body	body	NOUN
ct-10123	12	8	,	,	PUNCT
ct-10123	12	9	reaching	reach	VERB
ct-10123	12	10	mic	mic	NOUN
ct-10123	12	11	in	in	ADP
ct-10123	12	12	most	most	ADJ
ct-10123	12	13	organs	organ	NOUN
ct-10123	12	14	including	include	VERB
ct-10123	12	15	the	the	DET
ct-10123	12	16	reproductive	reproductive	ADJ
ct-10123	12	17	tract	tract	NOUN
ct-10123	12	18	.	.	PUNCT
ct-10123	13	1	they	they	PRON
ct-10123	13	2	are	be	AUX
ct-10123	13	3	ionized	ionize	VERB
ct-10123	13	4	,	,	PUNCT
ct-10123	13	5	poorly	poorly	ADV
ct-10123	13	6	lipid	lipid	NOUN
ct-10123	13	7	soluble	soluble	ADJ
ct-10123	13	8	,	,	PUNCT
ct-10123	13	9	and	and	CCONJ
ct-10123	13	10	tend	tend	VERB
ct-10123	13	11	to	to	PART
ct-10123	13	12	cross	cross	VERB
ct-10123	13	13	biological	biological	ADJ
ct-10123	13	14	membranes	membrane	NOUN
ct-10123	13	15	poorly	poorly	ADV
ct-10123	13	16	.	.	PUNCT
ct-10123	14	1	they	they	PRON
ct-10123	14	2	are	be	AUX
ct-10123	14	3	excreted	excrete	VERB
ct-10123	14	4	almost	almost	ADV
ct-10123	14	5	entirely	entirely	ADV
ct-10123	14	6	by	by	ADP
ct-10123	14	7	the	the	DET
ct-10123	14	8	kidney	kidney	NOUN
ct-10123	14	9	and	and	CCONJ
ct-10123	14	10	thus	thus	ADV
ct-10123	14	11	can	can	AUX
ct-10123	14	12	be	be	AUX
ct-10123	14	13	useful	useful	ADJ
ct-10123	14	14	to	to	PART
ct-10123	14	15	treat	treat	VERB
ct-10123	14	16	urinary	urinary	ADJ
ct-10123	14	17	tract	tract	NOUN
ct-10123	14	18	infections	infection	NOUN
ct-10123	14	19	caused	cause	VERB
ct-10123	14	20	by	by	ADP
ct-10123	14	21	sensitive	sensitive	ADJ
ct-10123	14	22	organisms	organism	NOUN
ct-10123	14	23	.	.	PUNCT
ct-10123	15	1	503	503	NUM
ct-10123	15	2	clinical	clinical	ADJ
ct-10123	15	3	theriogenology	theriogenology	NOUN
ct-10123	15	4	•	•	NOUN
ct-10123	15	5	volume	volume	NOUN
ct-10123	15	6	5	5	NUM
ct-10123	15	7	,	,	PUNCT
ct-10123	15	8	number	number	NOUN
ct-10123	15	9	4	4	NUM
ct-10123	15	10	•	•	NOUN
ct-10123	15	11	december	december	PROPN
ct-10123	15	12	2013	2013	NUM
ct-10123	15	13	synergism	synergism	NOUN
ct-10123	15	14	.	.	PUNCT
ct-10123	16	1	beta	beta	ADJ
ct-10123	16	2	lactams	lactam	NOUN
ct-10123	16	3	are	be	AUX
ct-10123	16	4	synergistic	synergistic	ADJ
ct-10123	16	5	with	with	ADP
ct-10123	16	6	aminoglycosides	aminoglycoside	NOUN
ct-10123	16	7	evaluation	evaluation	NOUN
ct-10123	16	8	of	of	ADP
ct-10123	16	9	endometrial	endometrial	ADJ
ct-10123	16	10	ampicillin	ampicillin	NOUN
ct-10123	16	11	concentration	concentration	NOUN
ct-10123	16	12	24	24	NUM
ct-10123	16	13	hours	hour	NOUN
ct-10123	16	14	after	after	SCONJ
ct-10123	16	15	a	a	DET
ct-10123	16	16	three	three	NUM
ct-10123	16	17	-	-	PUNCT
ct-10123	16	18	gram	gram	NOUN
ct-10123	16	19	intrauterine	intrauterine	ADJ
ct-10123	16	20	infusion	infusion	NOUN
ct-10123	16	21	of	of	ADP
ct-10123	16	22	ampicillin	ampicillin	NOUN
ct-10123	16	23	revealed	reveal	VERB
ct-10123	16	24	drug	drug	NOUN
ct-10123	16	25	concentrations	concentration	NOUN
ct-10123	16	26	above	above	ADP
ct-10123	16	27	mic	mic	NOUN
ct-10123	16	28	for	for	ADP
ct-10123	16	29	investigated	investigate	VERB
ct-10123	16	30	isolates	isolate	NOUN
ct-10123	16	31	24	24	NUM
ct-10123	16	32	hours	hour	NOUN
ct-10123	16	33	after	after	SCONJ
ct-10123	16	34	infusion.3	infusion.3	PROPN
ct-10123	16	35	intrauterine	intrauterine	ADJ
ct-10123	16	36	infusion	infusion	NOUN
ct-10123	16	37	of	of	ADP
ct-10123	16	38	6.2	6.2	NUM
ct-10123	16	39	-	-	PUNCT
ct-10123	16	40	g	g	NOUN
ct-10123	16	41	ticarcillin	ticarcillin	NOUN
ct-10123	16	42	/	/	SYM
ct-10123	16	43	clavulanic	clavulanic	NOUN
ct-10123	16	44	acid	acid	NOUN
ct-10123	16	45	resulted	result	VERB
ct-10123	16	46	in	in	ADP
ct-10123	16	47	endometrial	endometrial	ADJ
ct-10123	16	48	tissue	tissue	NOUN
ct-10123	16	49	concentrations	concentration	NOUN
ct-10123	16	50	of	of	ADP
ct-10123	16	51	150	150	NUM
ct-10123	16	52	-	-	SYM
ct-10123	16	53	424	424	NUM
ct-10123	16	54	micrograms	microgram	NOUN
ct-10123	16	55	/	/	SYM
ct-10123	16	56	g	g	PROPN
ct-10123	16	57	60	60	NUM
ct-10123	16	58	minutes	minute	NOUN
ct-10123	16	59	after	after	ADP
ct-10123	16	60	infusion	infusion	NOUN
ct-10123	16	61	.	.	PUNCT
ct-10123	17	1	clearance	clearance	NOUN
ct-10123	17	2	is	be	AUX
ct-10123	17	3	rapid	rapid	ADJ
ct-10123	17	4	,	,	PUNCT
ct-10123	17	5	potentially	potentially	ADV
ct-10123	17	6	necessitating	necessitate	VERB
ct-10123	17	7	frequent	frequent	ADJ
ct-10123	17	8	administration	administration	NOUN
ct-10123	17	9	to	to	PART
ct-10123	17	10	maintain	maintain	VERB
ct-10123	17	11	concentrations.4	concentrations.4	PROPN
ct-10123	17	12	systemically	systemically	ADV
ct-10123	17	13	administered	administer	VERB
ct-10123	17	14	potassium	potassium	NOUN
ct-10123	17	15	penicillin	penicillin	NOUN
ct-10123	17	16	achieved	achieve	VERB
ct-10123	17	17	mic	mic	NOUN
ct-10123	17	18	for	for	ADP
ct-10123	17	19	streptococcus	streptococcus	NOUN
ct-10123	17	20	equi	equi	NOUN
ct-10123	17	21	subspecies	subspecie	NOUN
ct-10123	17	22	zooepidemicus	zooepidemicus	NOUN
ct-10123	17	23	(	(	PUNCT
ct-10123	17	24	hereafter	hereafter	NOUN
ct-10123	17	25	s.	s.	PROPN
ct-10123	17	26	zooepidemicus	zooepidemicus	PROPN
ct-10123	17	27	)	)	PUNCT
ct-10123	17	28	in	in	ADP
ct-10123	17	29	allantoic	allantoic	ADJ
ct-10123	17	30	fluid.5	fluid.5	PROPN
ct-10123	17	31	penicillins	penicillin	NOUN
ct-10123	17	32	are	be	AUX
ct-10123	17	33	also	also	ADV
ct-10123	17	34	used	use	VERB
ct-10123	17	35	for	for	ADP
ct-10123	17	36	treatment	treatment	NOUN
ct-10123	17	37	of	of	ADP
ct-10123	17	38	leptospirosis	leptospirosis	NOUN
ct-10123	17	39	.	.	PUNCT
ct-10123	18	1	addition	addition	NOUN
ct-10123	18	2	of	of	ADP
ct-10123	18	3	timentin	timentin	NOUN
ct-10123	18	4	®	®	NOUN
ct-10123	18	5	(	(	PUNCT
ct-10123	18	6	ticarcillin	ticarcillin	NOUN
ct-10123	18	7	plus	plus	CCONJ
ct-10123	18	8	clavulanic	clavulanic	ADJ
ct-10123	18	9	acid	acid	NOUN
ct-10123	18	10	)	)	PUNCT
ct-10123	18	11	to	to	ADP
ct-10123	18	12	inra96	inra96	ADJ
ct-10123	18	13	®	®	NOUN
ct-10123	18	14	semen	semen	NOUN
ct-10123	18	15	extender	extender	NOUN
ct-10123	18	16	to	to	ADP
ct-10123	18	17	a	a	DET
ct-10123	18	18	final	final	ADJ
ct-10123	18	19	concentration	concentration	NOUN
ct-10123	18	20	of	of	ADP
ct-10123	18	21	0.5	0.5	NUM
ct-10123	18	22	to	to	PART
ct-10123	18	23	1.5	1.5	NUM
ct-10123	18	24	mg	mg	NOUN
ct-10123	18	25	/	/	SYM
ct-10123	18	26	ml	ml	PROPN
ct-10123	18	27	can	can	AUX
ct-10123	18	28	limit	limit	VERB
ct-10123	18	29	the	the	DET
ct-10123	18	30	growth	growth	NOUN
ct-10123	18	31	of	of	ADP
ct-10123	18	32	taylorella	taylorella	NOUN
ct-10123	18	33	equigenitalis.6	equigenitalis.6	PROPN
ct-10123	18	34	addition	addition	NOUN
ct-10123	18	35	of	of	ADP
ct-10123	18	36	timentin	timentin	NOUN
ct-10123	18	37	®	®	NOUN
ct-10123	18	38	to	to	ADP
ct-10123	18	39	semen	semen	NOUN
ct-10123	18	40	extender	extender	NOUN
ct-10123	18	41	(	(	PUNCT
ct-10123	18	42	1	1	NUM
ct-10123	18	43	mg	mg	NUM
ct-10123	18	44	/	/	SYM
ct-10123	18	45	ml	ml	NOUN
ct-10123	18	46	)	)	PUNCT
ct-10123	18	47	did	do	AUX
ct-10123	18	48	not	not	PART
ct-10123	18	49	impair	impair	VERB
ct-10123	18	50	sperm	sperm	NOUN
ct-10123	18	51	quality	quality	NOUN
ct-10123	18	52	but	but	CCONJ
ct-10123	18	53	did	do	AUX
ct-10123	18	54	not	not	PART
ct-10123	18	55	provide	provide	VERB
ct-10123	18	56	added	add	VERB
ct-10123	18	57	protection	protection	NOUN
ct-10123	18	58	against	against	ADP
ct-10123	18	59	bacteria	bacteria	NOUN
ct-10123	18	60	commonly	commonly	ADV
ct-10123	18	61	found	find	VERB
ct-10123	18	62	in	in	ADP
ct-10123	18	63	equine	equine	NOUN
ct-10123	18	64	semen.7	semen.7	PROPN
ct-10123	18	65	beta	beta	NOUN
ct-10123	18	66	-	-	PUNCT
ct-10123	18	67	lactams	lactam	NOUN
ct-10123	18	68	:	:	PUNCT
ct-10123	18	69	cephalosporins	cephalosporin	NOUN
ct-10123	18	70	commonly	commonly	ADV
ct-10123	18	71	used	use	VERB
ct-10123	18	72	formulations	formulation	NOUN
ct-10123	18	73	are	be	AUX
ct-10123	18	74	ceftiofur	ceftiofur	NOUN
ct-10123	18	75	sodium	sodium	NOUN
ct-10123	18	76	,	,	PUNCT
ct-10123	18	77	ceftiofur	ceftiofur	VERB
ct-10123	18	78	crystalline	crystalline	NOUN
ct-10123	18	79	free	free	ADJ
ct-10123	18	80	acid	acid	NOUN
ct-10123	18	81	,	,	PUNCT
ct-10123	18	82	ceftiofur	ceftiofur	VERB
ct-10123	18	83	hydrochloride	hydrochloride	NOUN
ct-10123	18	84	mechanism	mechanism	NOUN
ct-10123	18	85	of	of	ADP
ct-10123	18	86	action	action	NOUN
ct-10123	18	87	:	:	PUNCT
ct-10123	18	88	cephalosporins	cephalosporin	NOUN
ct-10123	18	89	are	be	AUX
ct-10123	18	90	also	also	ADV
ct-10123	18	91	beta	beta	NOUN
ct-10123	18	92	-	-	PUNCT
ct-10123	18	93	lactam	lactam	NOUN
ct-10123	18	94	antimicrobials	antimicrobial	NOUN
ct-10123	18	95	,	,	PUNCT
ct-10123	18	96	however	however	ADV
ct-10123	18	97	the	the	DET
ct-10123	18	98	molecular	molecular	ADJ
ct-10123	18	99	structure	structure	NOUN
ct-10123	18	100	of	of	ADP
ct-10123	18	101	the	the	DET
ct-10123	18	102	cephalosporin	cephalosporin	NOUN
ct-10123	18	103	group	group	NOUN
ct-10123	18	104	of	of	ADP
ct-10123	18	105	antimicrobials	antimicrobial	NOUN
ct-10123	18	106	make	make	VERB
ct-10123	18	107	them	they	PRON
ct-10123	18	108	inherently	inherently	ADV
ct-10123	18	109	more	more	ADV
ct-10123	18	110	resistant	resistant	ADJ
ct-10123	18	111	to	to	ADP
ct-10123	18	112	betalactamases	betalactamase	NOUN
ct-10123	18	113	.	.	PUNCT
ct-10123	19	1	cephalosporins	cephalosporin	NOUN
ct-10123	19	2	are	be	AUX
ct-10123	19	3	grouped	group	VERB
ct-10123	19	4	in	in	ADP
ct-10123	19	5	their	their	PRON
ct-10123	19	6	order	order	NOUN
ct-10123	19	7	of	of	ADP
ct-10123	19	8	development	development	NOUN
ct-10123	19	9	.	.	PUNCT
ct-10123	20	1	ceftiofur	ceftiofur	NOUN
ct-10123	20	2	is	be	AUX
ct-10123	20	3	a	a	DET
ct-10123	20	4	third	third	ADJ
ct-10123	20	5	generation	generation	NOUN
ct-10123	20	6	cephalosporin	cephalosporin	NOUN
ct-10123	20	7	in	in	ADP
ct-10123	20	8	common	common	ADJ
ct-10123	20	9	usage	usage	NOUN
ct-10123	20	10	in	in	ADP
ct-10123	20	11	equine	equine	NOUN
ct-10123	20	12	medicine	medicine	NOUN
ct-10123	20	13	.	.	PUNCT
ct-10123	21	1	ceftiofur	ceftiofur	NOUN
ct-10123	21	2	is	be	AUX
ct-10123	21	3	rapidly	rapidly	ADV
ct-10123	21	4	metabolized	metabolize	VERB
ct-10123	21	5	by	by	ADP
ct-10123	21	6	plasma	plasma	NOUN
ct-10123	21	7	esterases	esterase	NOUN
ct-10123	21	8	to	to	ADP
ct-10123	21	9	the	the	DET
ct-10123	21	10	active	active	ADJ
ct-10123	21	11	metabolite	metabolite	NOUN
ct-10123	21	12	,	,	PUNCT
ct-10123	21	13	desfuroylceftiofur	desfuroylceftiofur	NOUN
ct-10123	21	14	.	.	PUNCT
ct-10123	22	1	distribution	distribution	NOUN
ct-10123	22	2	.	.	PUNCT
ct-10123	23	1	widespread	widespread	ADJ
ct-10123	23	2	distribution	distribution	NOUN
ct-10123	23	3	into	into	ADP
ct-10123	23	4	tissues	tissue	NOUN
ct-10123	23	5	in	in	ADP
ct-10123	23	6	extracellular	extracellular	ADJ
ct-10123	23	7	fluid	fluid	NOUN
ct-10123	23	8	is	be	AUX
ct-10123	23	9	achieved	achieve	VERB
ct-10123	23	10	however	however	ADV
ct-10123	23	11	passage	passage	NOUN
ct-10123	23	12	across	across	ADP
ct-10123	23	13	membranes	membrane	NOUN
ct-10123	23	14	and	and	CCONJ
ct-10123	23	15	physiological	physiological	ADJ
ct-10123	23	16	barriers	barrier	NOUN
ct-10123	23	17	is	be	AUX
ct-10123	23	18	poor	poor	ADJ
ct-10123	23	19	.	.	PUNCT
ct-10123	24	1	excretion	excretion	NOUN
ct-10123	24	2	is	be	AUX
ct-10123	24	3	largely	largely	ADV
ct-10123	24	4	through	through	ADP
ct-10123	24	5	the	the	DET
ct-10123	24	6	urinary	urinary	ADJ
ct-10123	24	7	tract	tract	NOUN
ct-10123	24	8	.	.	PUNCT
ct-10123	25	1	uses	use	VERB
ct-10123	25	2	in	in	ADP
ct-10123	25	3	reproduction	reproduction	NOUN
ct-10123	25	4	.	.	PUNCT
ct-10123	26	1	in	in	ADP
ct-10123	26	2	mares	mare	NOUN
ct-10123	26	3	administered	administer	VERB
ct-10123	26	4	ceftiofur	ceftiofur	NOUN
ct-10123	26	5	sodium	sodium	NOUN
ct-10123	26	6	(	(	PUNCT
ct-10123	26	7	2	2	NUM
ct-10123	26	8	mg	mg	NUM
ct-10123	26	9	/	/	SYM
ct-10123	26	10	kg	kg	NOUN
ct-10123	27	1	i	i	PRON
ct-10123	27	2	m	m	AUX
ct-10123	27	3	bid	bid	ADJ
ct-10123	27	4	)	)	PUNCT
ct-10123	27	5	,	,	PUNCT
ct-10123	27	6	ceftiofur	ceftiofur	NOUN
ct-10123	27	7	sodium	sodium	NOUN
ct-10123	27	8	was	be	AUX
ct-10123	27	9	not	not	PART
ct-10123	27	10	detected	detect	VERB
ct-10123	27	11	in	in	ADP
ct-10123	27	12	endometrial	endometrial	ADJ
ct-10123	27	13	tissue	tissue	NOUN
ct-10123	27	14	after	after	ADP
ct-10123	27	15	the	the	DET
ct-10123	27	16	fifth	fifth	ADJ
ct-10123	27	17	dose	dose	NOUN
ct-10123	27	18	when	when	SCONJ
ct-10123	27	19	steady	steady	ADJ
ct-10123	27	20	state	state	NOUN
ct-10123	27	21	concentrations	concentration	NOUN
ct-10123	27	22	were	be	AUX
ct-10123	27	23	achieved.8	achieved.8	ADJ
ct-10123	27	24	in	in	ADP
ct-10123	27	25	mares	mare	NOUN
ct-10123	27	26	administered	administer	VERB
ct-10123	27	27	ceftiofur	ceftiofur	NOUN
ct-10123	27	28	hydrochloride	hydrochloride	NOUN
ct-10123	27	29	(	(	PUNCT
ct-10123	27	30	2.2	2.2	NUM
ct-10123	27	31	mg	mg	NOUN
ct-10123	27	32	/	/	SYM
ct-10123	27	33	kg	kg	PROPN
ct-10123	27	34	i	i	NOUN
ct-10123	27	35	m	m	PROPN
ct-10123	27	36	)	)	PUNCT
ct-10123	27	37	,	,	PUNCT
ct-10123	27	38	a	a	DET
ct-10123	27	39	ceftiofur	ceftiofur	NOUN
ct-10123	27	40	derivative	derivative	NOUN
ct-10123	27	41	was	be	AUX
ct-10123	27	42	detected	detect	VERB
ct-10123	27	43	in	in	ADP
ct-10123	27	44	endometrial	endometrial	ADJ
ct-10123	27	45	tissue	tissue	NOUN
ct-10123	27	46	24	24	NUM
ct-10123	27	47	hours	hour	NOUN
ct-10123	27	48	after	after	ADP
ct-10123	27	49	administration	administration	NOUN
ct-10123	27	50	at	at	ADP
ct-10123	27	51	concentrations	concentration	NOUN
ct-10123	27	52	above	above	ADP
ct-10123	27	53	reported	report	VERB
ct-10123	27	54	mic	mic	NOUN
ct-10123	27	55	for	for	ADP
ct-10123	27	56	s.	s.	PROPN
ct-10123	27	57	zooepidemicus	zooepidemicus	PROPN
ct-10123	27	58	and	and	CCONJ
ct-10123	27	59	escherichia	escherichia	ADJ
ct-10123	27	60	coli.9	coli.9	ADJ
ct-10123	27	61	in	in	ADP
ct-10123	27	62	mares	mare	NOUN
ct-10123	27	63	administered	administer	VERB
ct-10123	27	64	ceftiofur	ceftiofur	NOUN
ct-10123	27	65	crystalline	crystalline	NOUN
ct-10123	27	66	free	free	ADJ
ct-10123	27	67	acid	acid	NOUN
ct-10123	27	68	(	(	PUNCT
ct-10123	27	69	6.6	6.6	NUM
ct-10123	27	70	mg	mg	NOUN
ct-10123	27	71	/	/	SYM
ct-10123	27	72	kg	kg	PROPN
ct-10123	27	73	i	i	NOUN
ct-10123	27	74	m	m	PROPN
ct-10123	27	75	)	)	PUNCT
ct-10123	27	76	,	,	PUNCT
ct-10123	27	77	endometrial	endometrial	ADJ
ct-10123	27	78	drug	drug	NOUN
ct-10123	27	79	concentrations	concentration	NOUN
ct-10123	27	80	remained	remain	VERB
ct-10123	27	81	above	above	ADP
ct-10123	27	82	mic	mic	NOUN
ct-10123	27	83	for	for	ADP
ct-10123	27	84	s.	s.	PROPN
ct-10123	27	85	zooepidemicus	zooepidemicus	PROPN
ct-10123	27	86	for	for	ADP
ct-10123	27	87	96	96	NUM
ct-10123	27	88	hours.10	hours.10	NOUN
ct-10123	27	89	in	in	ADP
ct-10123	27	90	a	a	DET
ct-10123	27	91	study	study	NOUN
ct-10123	27	92	evaluating	evaluating	NOUN
ct-10123	27	93	efficacy	efficacy	NOUN
ct-10123	27	94	of	of	ADP
ct-10123	27	95	ceftiofur	ceftiofur	NOUN
ct-10123	27	96	crystalline	crystalline	VERB
ct-10123	27	97	free	free	ADJ
ct-10123	27	98	acid	acid	NOUN
ct-10123	27	99	in	in	ADP
ct-10123	27	100	equine	equine	NOUN
ct-10123	27	101	placentitis	placentitis	PROPN
ct-10123	27	102	,	,	PUNCT
ct-10123	27	103	the	the	DET
ct-10123	27	104	drug	drug	NOUN
ct-10123	27	105	was	be	AUX
ct-10123	27	106	not	not	PART
ct-10123	27	107	found	find	VERB
ct-10123	27	108	in	in	ADP
ct-10123	27	109	effective	effective	ADJ
ct-10123	27	110	concentrations	concentration	NOUN
ct-10123	27	111	in	in	ADP
ct-10123	27	112	the	the	DET
ct-10123	27	113	placenta	placenta	NOUN
ct-10123	27	114	,	,	PUNCT
ct-10123	27	115	fetal	fetal	ADJ
ct-10123	27	116	tissue	tissue	NOUN
ct-10123	27	117	,	,	PUNCT
ct-10123	27	118	amnionic	amnionic	ADJ
ct-10123	27	119	fluid	fluid	NOUN
ct-10123	27	120	or	or	CCONJ
ct-10123	27	121	fetal	fetal	ADJ
ct-10123	27	122	serum	serum	NOUN
ct-10123	27	123	and	and	CCONJ
ct-10123	27	124	did	do	AUX
ct-10123	27	125	not	not	PART
ct-10123	27	126	improve	improve	VERB
ct-10123	27	127	foal	foal	NOUN
ct-10123	27	128	survival	survival	NOUN
ct-10123	27	129	rates.11	rates.11	VERB
ct-10123	27	130	intrauterine	intrauterine	ADJ
ct-10123	27	131	ceftiofur	ceftiofur	NOUN
ct-10123	27	132	sodium	sodium	NOUN
ct-10123	27	133	(	(	PUNCT
ct-10123	27	134	1	1	NUM
ct-10123	27	135	g	g	NOUN
ct-10123	27	136	in	in	ADP
ct-10123	27	137	100	100	NUM
ct-10123	27	138	ml	ml	X
ct-10123	27	139	saline	saline	NOUN
ct-10123	27	140	)	)	PUNCT
ct-10123	27	141	has	have	AUX
ct-10123	27	142	been	be	AUX
ct-10123	27	143	found	find	VERB
ct-10123	27	144	to	to	PART
ct-10123	27	145	be	be	AUX
ct-10123	27	146	safe	safe	ADJ
ct-10123	27	147	and	and	CCONJ
ct-10123	27	148	effective.12	effective.12	NOUN
ct-10123	27	149	beta	beta	NOUN
ct-10123	27	150	-	-	PUNCT
ct-10123	27	151	lactamase	lactamase	ADJ
ct-10123	27	152	inhibitors	inhibitor	NOUN
ct-10123	27	153	clavulanic	clavulanic	VERB
ct-10123	27	154	acid	acid	NOUN
ct-10123	27	155	,	,	PUNCT
ct-10123	27	156	a	a	DET
ct-10123	27	157	broad	broad	ADJ
ct-10123	27	158	-	-	PUNCT
ct-10123	27	159	spectrum	spectrum	NOUN
ct-10123	27	160	beta	beta	NOUN
ct-10123	27	161	-	-	PUNCT
ct-10123	27	162	lactamase	lactamase	NOUN
ct-10123	27	163	inhibitor	inhibitor	NOUN
ct-10123	27	164	,	,	PUNCT
ct-10123	27	165	is	be	AUX
ct-10123	27	166	used	use	VERB
ct-10123	27	167	in	in	ADP
ct-10123	27	168	combination	combination	NOUN
ct-10123	27	169	with	with	ADP
ct-10123	27	170	other	other	ADJ
ct-10123	27	171	antimicrobials	antimicrobial	NOUN
ct-10123	27	172	such	such	ADJ
ct-10123	27	173	as	as	ADP
ct-10123	27	174	ticarcillin	ticarcillin	NOUN
ct-10123	27	175	.	.	PUNCT
ct-10123	28	1	certain	certain	ADJ
ct-10123	28	2	bacteria	bacteria	NOUN
ct-10123	28	3	can	can	AUX
ct-10123	28	4	resist	resist	VERB
ct-10123	28	5	the	the	DET
ct-10123	28	6	action	action	NOUN
ct-10123	28	7	of	of	ADP
ct-10123	28	8	beta	beta	NOUN
ct-10123	28	9	-	-	PUNCT
ct-10123	28	10	lactam	lactam	NOUN
ct-10123	28	11	antimicrobials	antimicrobial	NOUN
ct-10123	28	12	by	by	ADP
ct-10123	28	13	producing	produce	VERB
ct-10123	28	14	beta	beta	NOUN
ct-10123	28	15	-	-	PUNCT
ct-10123	28	16	lactamases	lactamase	NOUN
ct-10123	28	17	,	,	PUNCT
ct-10123	28	18	enzymes	enzyme	NOUN
ct-10123	28	19	that	that	PRON
ct-10123	28	20	degrade	degrade	VERB
ct-10123	28	21	beta	beta	NOUN
ct-10123	28	22	-	-	PUNCT
ct-10123	28	23	lactam	lactam	NOUN
ct-10123	28	24	antimicrobials	antimicrobial	NOUN
ct-10123	28	25	by	by	ADP
ct-10123	28	26	opening	open	VERB
ct-10123	28	27	the	the	DET
ct-10123	28	28	beta	beta	NOUN
ct-10123	28	29	-	-	PUNCT
ct-10123	28	30	lactam	lactam	NOUN
ct-10123	28	31	ring	ring	NOUN
ct-10123	28	32	.	.	PUNCT
ct-10123	29	1	genes	gene	NOUN
ct-10123	29	2	encoding	encode	VERB
ct-10123	29	3	beta	beta	NOUN
ct-10123	29	4	-	-	PUNCT
ct-10123	29	5	lactamase	lactamase	NOUN
ct-10123	29	6	are	be	AUX
ct-10123	29	7	transmitted	transmit	VERB
ct-10123	29	8	through	through	ADP
ct-10123	29	9	bacterial	bacterial	ADJ
ct-10123	29	10	populations	population	NOUN
ct-10123	29	11	with	with	ADP
ct-10123	29	12	plasmids	plasmid	NOUN
ct-10123	29	13	and	and	CCONJ
ct-10123	29	14	transposons	transposon	NOUN
ct-10123	29	15	as	as	ADP
ct-10123	29	16	an	an	DET
ct-10123	29	17	important	important	ADJ
ct-10123	29	18	mechanism	mechanism	NOUN
ct-10123	29	19	of	of	ADP
ct-10123	29	20	spreading	spread	VERB
ct-10123	29	21	resistance	resistance	NOUN
ct-10123	29	22	.	.	PUNCT
ct-10123	30	1	beta	beta	NOUN
ct-10123	30	2	-	-	PUNCT
ct-10123	30	3	lactamase	lactamase	NOUN
ct-10123	30	4	inhibitors	inhibitor	NOUN
ct-10123	30	5	bind	bind	VERB
ct-10123	30	6	irreversibly	irreversibly	ADV
ct-10123	30	7	to	to	ADP
ct-10123	30	8	beta	beta	NOUN
ct-10123	30	9	-	-	PUNCT
ct-10123	30	10	lactamases	lactamase	NOUN
ct-10123	30	11	allowing	allow	VERB
ct-10123	30	12	the	the	DET
ct-10123	30	13	accompanying	accompanying	ADJ
ct-10123	30	14	beta	beta	NOUN
ct-10123	30	15	-	-	PUNCT
ct-10123	30	16	lactam	lactam	NOUN
ct-10123	30	17	antibiotic	antibiotic	NOUN
ct-10123	30	18	to	to	PART
ct-10123	30	19	bind	bind	VERB
ct-10123	30	20	to	to	ADP
ct-10123	30	21	the	the	DET
ct-10123	30	22	penicillin	penicillin	NOUN
ct-10123	30	23	binding	bind	VERB
ct-10123	30	24	protein	protein	NOUN
ct-10123	30	25	.	.	PUNCT
ct-10123	31	1	peptide	peptide	NOUN
ct-10123	31	2	antibiotics	antibiotic	NOUN
ct-10123	31	3	a	a	DET
ct-10123	31	4	commonly	commonly	ADV
ct-10123	31	5	used	use	VERB
ct-10123	31	6	formulationis	formulationis	PROPN
ct-10123	31	7	polymyxin	polymyxin	PROPN
ct-10123	31	8	b	b	PROPN
ct-10123	31	9	504clinical	504clinical	PROPN
ct-10123	31	10	theriogenology	theriogenology	NOUN
ct-10123	31	11	•	•	NUM
ct-10123	31	12	volume	volume	NOUN
ct-10123	31	13	5	5	NUM
ct-10123	31	14	,	,	PUNCT
ct-10123	31	15	number	number	NOUN
ct-10123	31	16	4	4	NUM
ct-10123	31	17	•	•	NOUN
ct-10123	31	18	december	december	PROPN
ct-10123	31	19	2013	2013	NUM
ct-10123	31	20	mechanism	mechanism	NOUN
ct-10123	31	21	of	of	ADP
ct-10123	31	22	action	action	NOUN
ct-10123	31	23	.	.	PUNCT
ct-10123	32	1	polymyxins	polymyxin	NOUN
ct-10123	32	2	are	be	AUX
ct-10123	32	3	peptide	peptide	ADJ
ct-10123	32	4	antibiotic	antibiotic	ADJ
ct-10123	32	5	products	product	NOUN
ct-10123	32	6	of	of	ADP
ct-10123	32	7	bacillus	bacillus	NOUN
ct-10123	32	8	polymyxa	polymyxa	NOUN
ct-10123	32	9	.	.	PUNCT
ct-10123	33	1	polymyxin	polymyxin	PROPN
ct-10123	33	2	b	b	PROPN
ct-10123	33	3	is	be	AUX
ct-10123	33	4	toxic	toxic	ADJ
ct-10123	33	5	at	at	ADP
ct-10123	33	6	systemic	systemic	ADJ
ct-10123	33	7	antimicrobial	antimicrobial	ADJ
ct-10123	33	8	doses	dose	NOUN
ct-10123	33	9	with	with	ADP
ct-10123	33	10	nephrotoxic	nephrotoxic	ADJ
ct-10123	33	11	,	,	PUNCT
ct-10123	33	12	neurotoxic	neurotoxic	ADJ
ct-10123	33	13	,	,	PUNCT
ct-10123	33	14	and	and	CCONJ
ct-10123	33	15	neuromuscular	neuromuscular	ADJ
ct-10123	33	16	blocking	blocking	NOUN
ct-10123	33	17	effects	effect	NOUN
ct-10123	33	18	,	,	PUNCT
ct-10123	33	19	thus	thus	ADV
ct-10123	33	20	it	it	PRON
ct-10123	33	21	is	be	AUX
ct-10123	33	22	used	use	VERB
ct-10123	33	23	topically	topically	ADV
ct-10123	33	24	for	for	ADP
ct-10123	33	25	its	its	PRON
ct-10123	33	26	antimicrobial	antimicrobial	ADJ
ct-10123	33	27	properties	property	NOUN
ct-10123	33	28	and	and	CCONJ
ct-10123	33	29	used	use	VERB
ct-10123	33	30	systemically	systemically	ADV
ct-10123	33	31	at	at	ADP
ct-10123	33	32	subantimicrobial	subantimicrobial	ADJ
ct-10123	33	33	doses	dose	NOUN
ct-10123	33	34	for	for	ADP
ct-10123	33	35	binding	bind	VERB
ct-10123	33	36	and	and	CCONJ
ct-10123	33	37	inactivating	inactivate	VERB
ct-10123	33	38	endotoxin	endotoxin	NOUN
ct-10123	33	39	(	(	PUNCT
ct-10123	33	40	lipopolysaccharide	lipopolysaccharide	NOUN
ct-10123	33	41	)	)	PUNCT
ct-10123	33	42	.	.	PUNCT
ct-10123	34	1	when	when	SCONJ
ct-10123	34	2	used	use	VERB
ct-10123	34	3	as	as	ADP
ct-10123	34	4	an	an	DET
ct-10123	34	5	antimicrobial	antimicrobial	ADJ
ct-10123	34	6	,	,	PUNCT
ct-10123	34	7	polymyxin	polymyxin	PROPN
ct-10123	34	8	b	b	PROPN
ct-10123	34	9	is	be	AUX
ct-10123	34	10	bactericidal	bactericidal	ADJ
ct-10123	34	11	and	and	CCONJ
ct-10123	34	12	concentration	concentration	NOUN
ct-10123	34	13	-	-	PUNCT
ct-10123	34	14	dependent	dependent	ADJ
ct-10123	34	15	.	.	PUNCT
ct-10123	35	1	this	this	DET
ct-10123	35	2	cationic	cationic	ADJ
ct-10123	35	3	peptide	peptide	NOUN
ct-10123	35	4	disrupts	disrupt	VERB
ct-10123	35	5	the	the	DET
ct-10123	35	6	outer	outer	ADJ
ct-10123	35	7	membrane	membrane	NOUN
ct-10123	35	8	of	of	ADP
ct-10123	35	9	gram	gram	NOUN
ct-10123	35	10	-	-	PUNCT
ct-10123	35	11	negative	negative	ADJ
ct-10123	35	12	bacteria	bacteria	NOUN
ct-10123	35	13	by	by	ADP
ct-10123	35	14	binding	bind	VERB
ct-10123	35	15	lipopolysaccharide	lipopolysaccharide	NOUN
ct-10123	35	16	(	(	PUNCT
ct-10123	35	17	lps	lps	PROPN
ct-10123	35	18	)	)	PUNCT
ct-10123	35	19	,	,	PUNCT
ct-10123	35	20	and	and	CCONJ
ct-10123	35	21	increasing	increase	VERB
ct-10123	35	22	cell	cell	NOUN
ct-10123	35	23	permeability	permeability	NOUN
ct-10123	35	24	.	.	PUNCT
ct-10123	36	1	gram	gram	NOUN
ct-10123	36	2	-	-	PUNCT
ct-10123	36	3	positive	positive	ADJ
ct-10123	36	4	bacteria	bacteria	NOUN
ct-10123	36	5	are	be	AUX
ct-10123	36	6	resistant	resistant	ADJ
ct-10123	36	7	.	.	PUNCT
ct-10123	37	1	distribution	distribution	NOUN
ct-10123	37	2	.	.	PUNCT
ct-10123	38	1	polymyxin	polymyxin	ADJ
ct-10123	38	2	diffuses	diffuse	NOUN
ct-10123	38	3	poorly	poorly	ADV
ct-10123	38	4	through	through	ADP
ct-10123	38	5	biologic	biologic	NOUN
ct-10123	38	6	membranes	membrane	NOUN
ct-10123	38	7	and	and	CCONJ
ct-10123	38	8	attains	attain	VERB
ct-10123	38	9	low	low	ADJ
ct-10123	38	10	concentrations	concentration	NOUN
ct-10123	38	11	in	in	ADP
ct-10123	38	12	transcellular	transcellular	NOUN
ct-10123	38	13	fluids	fluid	NOUN
ct-10123	38	14	.	.	PUNCT
ct-10123	39	1	uses	use	VERB
ct-10123	39	2	in	in	ADP
ct-10123	39	3	reproduction	reproduction	NOUN
ct-10123	39	4	.	.	PUNCT
ct-10123	40	1	polymyxin	polymyxin	PROPN
ct-10123	40	2	b	b	PROPN
ct-10123	40	3	can	can	AUX
ct-10123	40	4	be	be	AUX
ct-10123	40	5	infused	infuse	VERB
ct-10123	40	6	into	into	ADP
ct-10123	40	7	the	the	DET
ct-10123	40	8	uterus	uterus	NOUN
ct-10123	40	9	for	for	ADP
ct-10123	40	10	gram	gram	NOUN
ct-10123	40	11	-	-	PUNCT
ct-10123	40	12	negative	negative	ADJ
ct-10123	40	13	bacterial	bacterial	ADJ
ct-10123	40	14	infections	infection	NOUN
ct-10123	40	15	and	and	CCONJ
ct-10123	40	16	used	use	VERB
ct-10123	40	17	systemically	systemically	ADV
ct-10123	40	18	for	for	ADP
ct-10123	40	19	endotoxemia	endotoxemia	NOUN
ct-10123	40	20	as	as	SCONJ
ct-10123	40	21	may	may	AUX
ct-10123	40	22	be	be	AUX
ct-10123	40	23	seen	see	VERB
ct-10123	40	24	in	in	ADP
ct-10123	40	25	post	post	ADJ
ct-10123	40	26	-	-	ADJ
ct-10123	40	27	foaling	foal	VERB
ct-10123	40	28	complications	complication	NOUN
ct-10123	40	29	.	.	PUNCT
ct-10123	41	1	macrolides	macrolide	NOUN
ct-10123	41	2	macrolides	macrolide	NOUN
ct-10123	41	3	(	(	PUNCT
ct-10123	41	4	erythromycin	erythromycin	PROPN
ct-10123	41	5	,	,	PUNCT
ct-10123	41	6	azithromycin	azithromycin	NOUN
ct-10123	41	7	,	,	PUNCT
ct-10123	41	8	clarithromycin	clarithromycin	PROPN
ct-10123	41	9	)	)	PUNCT
ct-10123	41	10	are	be	AUX
ct-10123	41	11	predominantly	predominantly	ADV
ct-10123	41	12	bacteriostatic	bacteriostatic	ADJ
ct-10123	41	13	antimicrobials	antimicrobial	NOUN
ct-10123	41	14	that	that	PRON
ct-10123	41	15	inhibit	inhibit	VERB
ct-10123	41	16	protein	protein	NOUN
ct-10123	41	17	synthesis	synthesis	NOUN
ct-10123	41	18	by	by	ADP
ct-10123	41	19	reversibly	reversibly	ADV
ct-10123	41	20	binding	bind	VERB
ct-10123	41	21	to	to	ADP
ct-10123	41	22	the	the	DET
ct-10123	41	23	50s	50	NOUN
ct-10123	41	24	ribosomal	ribosomal	NOUN
ct-10123	41	25	subunit	subunit	NOUN
ct-10123	41	26	,	,	PUNCT
ct-10123	41	27	and	and	CCONJ
ct-10123	41	28	thus	thus	ADV
ct-10123	41	29	are	be	AUX
ct-10123	41	30	specific	specific	ADJ
ct-10123	41	31	for	for	ADP
ct-10123	41	32	prokaryotic	prokaryotic	ADJ
ct-10123	41	33	cells	cell	NOUN
ct-10123	41	34	.	.	PUNCT
ct-10123	42	1	in	in	ADP
ct-10123	42	2	adult	adult	NOUN
ct-10123	42	3	horses	horse	NOUN
ct-10123	42	4	,	,	PUNCT
ct-10123	42	5	macrolide	macrolide	ADJ
ct-10123	42	6	use	use	NOUN
ct-10123	42	7	can	can	AUX
ct-10123	42	8	be	be	AUX
ct-10123	42	9	associated	associate	VERB
ct-10123	42	10	with	with	ADP
ct-10123	42	11	severe	severe	ADJ
ct-10123	42	12	diarrhea	diarrhea	NOUN
ct-10123	42	13	.	.	PUNCT
ct-10123	43	1	macrolides	macrolide	NOUN
ct-10123	43	2	are	be	AUX
ct-10123	43	3	infrequently	infrequently	ADV
ct-10123	43	4	used	use	VERB
ct-10123	43	5	in	in	ADP
ct-10123	43	6	mare	mare	NOUN
ct-10123	43	7	reproduction	reproduction	NOUN
ct-10123	43	8	and	and	CCONJ
ct-10123	43	9	will	will	AUX
ct-10123	43	10	certainly	certainly	ADV
ct-10123	43	11	be	be	AUX
ct-10123	43	12	highlighted	highlight	VERB
ct-10123	43	13	in	in	ADP
ct-10123	43	14	discussion	discussion	NOUN
ct-10123	43	15	on	on	ADP
ct-10123	43	16	antimicrobial	antimicrobial	ADJ
ct-10123	43	17	use	use	NOUN
ct-10123	43	18	in	in	ADP
ct-10123	43	19	foals	foal	NOUN
ct-10123	43	20	and	and	CCONJ
ct-10123	43	21	weanlings	weanling	NOUN
ct-10123	43	22	.	.	PUNCT
ct-10123	44	1	aminoglycosides	aminoglycoside	NOUN
ct-10123	44	2	commonly	commonly	ADV
ct-10123	44	3	used	use	VERB
ct-10123	44	4	formulations	formulation	NOUN
ct-10123	44	5	are	be	AUX
ct-10123	44	6	entamicin	entamicin	ADJ
ct-10123	44	7	and	and	CCONJ
ct-10123	44	8	amikacin	amikacin	PROPN
ct-10123	44	9	;	;	PUNCT
ct-10123	44	10	others	other	NOUN
ct-10123	44	11	include	include	VERB
ct-10123	44	12	kanamycin	kanamycin	NOUN
ct-10123	44	13	,	,	PUNCT
ct-10123	44	14	neomycin	neomycin	NOUN
ct-10123	44	15	,	,	PUNCT
ct-10123	44	16	streptomycin	streptomycin	PROPN
ct-10123	44	17	,	,	PUNCT
ct-10123	44	18	dihydrostreptomycin	dihydrostreptomycin	PROPN
ct-10123	44	19	,	,	PUNCT
ct-10123	44	20	tobramycin	tobramycin	PROPN
ct-10123	44	21	.	.	PUNCT
ct-10123	45	1	mechanism	mechanism	NOUN
ct-10123	45	2	of	of	ADP
ct-10123	45	3	action	action	NOUN
ct-10123	45	4	.	.	PUNCT
ct-10123	46	1	aminoglycosides	aminoglycoside	NOUN
ct-10123	46	2	are	be	AUX
ct-10123	46	3	bactericidal	bactericidal	ADJ
ct-10123	46	4	,	,	PUNCT
ct-10123	46	5	concentration	concentration	NOUN
ct-10123	46	6	dependent	dependent	ADJ
ct-10123	46	7	antimicrobials	antimicrobial	NOUN
ct-10123	46	8	used	use	VERB
ct-10123	46	9	primarily	primarily	ADV
ct-10123	46	10	to	to	PART
ct-10123	46	11	treat	treat	VERB
ct-10123	46	12	aerobic	aerobic	ADJ
ct-10123	46	13	gram	gram	NOUN
ct-10123	46	14	-	-	PUNCT
ct-10123	46	15	negative	negative	ADJ
ct-10123	46	16	bacteria	bacteria	NOUN
ct-10123	46	17	and	and	CCONJ
ct-10123	46	18	staphylococci	staphylococci	NOUN
ct-10123	46	19	.	.	PUNCT
ct-10123	47	1	their	their	PRON
ct-10123	47	2	bactericidal	bactericidal	ADJ
ct-10123	47	3	action	action	NOUN
ct-10123	47	4	is	be	AUX
ct-10123	47	5	influenced	influence	VERB
ct-10123	47	6	by	by	ADP
ct-10123	47	7	ph	ph	NOUN
ct-10123	47	8	,	,	PUNCT
ct-10123	47	9	being	be	AUX
ct-10123	47	10	most	most	ADV
ct-10123	47	11	active	active	ADJ
ct-10123	47	12	in	in	ADP
ct-10123	47	13	alkaline	alkaline	NOUN
ct-10123	47	14	ph	ph	PROPN
ct-10123	47	15	.	.	PROPN
ct-10123	47	16	aminoglycosides	aminoglycoside	NOUN
ct-10123	47	17	must	must	AUX
ct-10123	47	18	penetrate	penetrate	VERB
ct-10123	47	19	bacterial	bacterial	ADJ
ct-10123	47	20	cell	cell	NOUN
ct-10123	47	21	walls	wall	NOUN
ct-10123	47	22	,	,	PUNCT
ct-10123	47	23	with	with	ADP
ct-10123	47	24	penetration	penetration	NOUN
ct-10123	47	25	enhanced	enhance	VERB
ct-10123	47	26	when	when	SCONJ
ct-10123	47	27	in	in	ADP
ct-10123	47	28	combination	combination	NOUN
ct-10123	47	29	with	with	ADP
ct-10123	47	30	drugs	drug	NOUN
ct-10123	47	31	that	that	PRON
ct-10123	47	32	interfere	interfere	VERB
ct-10123	47	33	with	with	ADP
ct-10123	47	34	the	the	DET
ct-10123	47	35	cell	cell	NOUN
ct-10123	47	36	wall	wall	NOUN
ct-10123	47	37	(	(	PUNCT
ct-10123	47	38	e.g.	e.g.	ADV
ct-10123	47	39	,	,	PUNCT
ct-10123	47	40	penicillins	penicillin	NOUN
ct-10123	47	41	)	)	PUNCT
ct-10123	47	42	.	.	PUNCT
ct-10123	48	1	once	once	ADV
ct-10123	48	2	within	within	ADP
ct-10123	48	3	the	the	DET
ct-10123	48	4	bacteria	bacteria	NOUN
ct-10123	48	5	,	,	PUNCT
ct-10123	48	6	they	they	PRON
ct-10123	48	7	bind	bind	VERB
ct-10123	48	8	to	to	ADP
ct-10123	48	9	the	the	DET
ct-10123	48	10	30s	30	NOUN
ct-10123	48	11	ribosomal	ribosomal	NOUN
ct-10123	48	12	subunit	subunit	NOUN
ct-10123	48	13	(	(	PUNCT
ct-10123	48	14	prokaryotic	prokaryotic	ADJ
ct-10123	48	15	)	)	PUNCT
ct-10123	48	16	and	and	CCONJ
ct-10123	48	17	inhibit	inhibit	VERB
ct-10123	48	18	bacterial	bacterial	ADJ
ct-10123	48	19	protein	protein	NOUN
ct-10123	48	20	synthesis	synthesis	NOUN
ct-10123	48	21	.	.	PUNCT
ct-10123	49	1	the	the	DET
ct-10123	49	2	most	most	ADV
ct-10123	49	3	clinically	clinically	ADV
ct-10123	49	4	important	important	ADJ
ct-10123	49	5	resistance	resistance	NOUN
ct-10123	49	6	is	be	AUX
ct-10123	49	7	due	due	ADJ
ct-10123	49	8	to	to	ADP
ct-10123	49	9	enzymes	enzyme	NOUN
ct-10123	49	10	from	from	ADP
ct-10123	49	11	plasmids	plasmid	NOUN
ct-10123	49	12	that	that	PRON
ct-10123	49	13	are	be	AUX
ct-10123	49	14	transferrable	transferrable	ADJ
ct-10123	49	15	between	between	ADP
ct-10123	49	16	bacteria	bacteria	NOUN
ct-10123	49	17	.	.	PUNCT
ct-10123	50	1	elimination	elimination	NOUN
ct-10123	50	2	is	be	AUX
ct-10123	50	3	by	by	ADP
ct-10123	50	4	renal	renal	ADJ
ct-10123	50	5	excretion	excretion	NOUN
ct-10123	50	6	(	(	PUNCT
ct-10123	50	7	glomerular	glomerular	ADJ
ct-10123	50	8	filtration	filtration	NOUN
ct-10123	50	9	)	)	PUNCT
ct-10123	50	10	and	and	CCONJ
ct-10123	50	11	nephrotoxicity	nephrotoxicity	NOUN
ct-10123	50	12	is	be	AUX
ct-10123	50	13	an	an	DET
ct-10123	50	14	important	important	ADJ
ct-10123	50	15	side	side	NOUN
ct-10123	50	16	effect	effect	NOUN
ct-10123	50	17	.	.	PUNCT
ct-10123	51	1	risk	risk	NOUN
ct-10123	51	2	factors	factor	NOUN
ct-10123	51	3	for	for	ADP
ct-10123	51	4	aminoglycoside	aminoglycoside	ADJ
ct-10123	51	5	toxicity	toxicity	NOUN
ct-10123	51	6	include	include	VERB
ct-10123	51	7	prolonged	prolonged	ADJ
ct-10123	51	8	therapy	therapy	NOUN
ct-10123	51	9	(	(	PUNCT
ct-10123	51	10	>	>	X
ct-10123	51	11	7	7	NUM
ct-10123	51	12	-	-	SYM
ct-10123	51	13	10	10	NUM
ct-10123	51	14	days	day	NOUN
ct-10123	51	15	)	)	PUNCT
ct-10123	51	16	,	,	PUNCT
ct-10123	51	17	multiple	multiple	ADJ
ct-10123	51	18	doses	dose	NOUN
ct-10123	51	19	per	per	ADP
ct-10123	51	20	day	day	NOUN
ct-10123	51	21	,	,	PUNCT
ct-10123	51	22	acidosis	acidosis	NOUN
ct-10123	51	23	,	,	PUNCT
ct-10123	51	24	electrolyte	electrolyte	NOUN
ct-10123	51	25	disturbances	disturbance	NOUN
ct-10123	51	26	,	,	PUNCT
ct-10123	51	27	dehydration	dehydration	NOUN
ct-10123	51	28	,	,	PUNCT
ct-10123	51	29	concurrent	concurrent	ADJ
ct-10123	51	30	nephrotoxic	nephrotoxic	ADJ
ct-10123	51	31	drug	drug	NOUN
ct-10123	51	32	therapy	therapy	NOUN
ct-10123	51	33	,	,	PUNCT
ct-10123	51	34	age	age	NOUN
ct-10123	51	35	,	,	PUNCT
ct-10123	51	36	pre	pre	ADJ
ct-10123	51	37	-	-	ADJ
ct-10123	51	38	existing	existing	ADJ
ct-10123	51	39	renal	renal	ADJ
ct-10123	51	40	disease	disease	NOUN
ct-10123	51	41	,	,	PUNCT
ct-10123	51	42	and	and	CCONJ
ct-10123	51	43	elevated	elevated	ADJ
ct-10123	51	44	plasma	plasma	NOUN
ct-10123	51	45	trough	trough	NOUN
ct-10123	51	46	concentrations	concentration	NOUN
ct-10123	51	47	.	.	PUNCT
ct-10123	52	1	ototoxicity	ototoxicity	NOUN
ct-10123	52	2	may	may	AUX
ct-10123	52	3	also	also	ADV
ct-10123	52	4	occur	occur	VERB
ct-10123	52	5	.	.	PUNCT
ct-10123	53	1	amikacin	amikacin	PROPN
ct-10123	53	2	has	have	VERB
ct-10123	53	3	the	the	DET
ct-10123	53	4	broadest	broad	ADJ
ct-10123	53	5	spectrum	spectrum	NOUN
ct-10123	53	6	of	of	ADP
ct-10123	53	7	the	the	DET
ct-10123	53	8	aminoglycosides	aminoglycoside	NOUN
ct-10123	53	9	,	,	PUNCT
ct-10123	53	10	and	and	CCONJ
ct-10123	53	11	is	be	AUX
ct-10123	53	12	the	the	DET
ct-10123	53	13	least	least	ADV
ct-10123	53	14	nephrotoxic	nephrotoxic	ADJ
ct-10123	53	15	.	.	PUNCT
ct-10123	54	1	concurrent	concurrent	ADJ
ct-10123	54	2	administration	administration	NOUN
ct-10123	54	3	of	of	ADP
ct-10123	54	4	gentamicin	gentamicin	NOUN
ct-10123	54	5	with	with	ADP
ct-10123	54	6	phenylbutazone	phenylbutazone	NOUN
ct-10123	54	7	was	be	AUX
ct-10123	54	8	found	find	VERB
ct-10123	54	9	to	to	PART
ct-10123	54	10	decrease	decrease	VERB
ct-10123	54	11	elimination	elimination	NOUN
ct-10123	54	12	half	half	ADJ
ct-10123	54	13	-	-	PUNCT
ct-10123	54	14	life	life	NOUN
ct-10123	54	15	of	of	ADP
ct-10123	54	16	gentamicin	gentamicin	NOUN
ct-10123	54	17	by	by	ADP
ct-10123	54	18	23	23	NUM
ct-10123	54	19	%	%	NOUN
ct-10123	54	20	and	and	CCONJ
ct-10123	54	21	decrease	decrease	VERB
ct-10123	54	22	the	the	DET
ct-10123	54	23	volume	volume	NOUN
ct-10123	54	24	of	of	ADP
ct-10123	54	25	distribution	distribution	NOUN
ct-10123	54	26	by	by	ADP
ct-10123	54	27	26	26	NUM
ct-10123	54	28	%	%	NOUN
ct-10123	54	29	while	while	SCONJ
ct-10123	54	30	pharmacokinetics	pharmacokinetic	NOUN
ct-10123	54	31	of	of	ADP
ct-10123	54	32	phenylbutazone	phenylbutazone	NOUN
ct-10123	54	33	were	be	AUX
ct-10123	54	34	not	not	PART
ct-10123	54	35	affected	affect	VERB
ct-10123	54	36	.	.	PUNCT
ct-10123	55	1	aminoglycosides	aminoglycoside	NOUN
ct-10123	55	2	are	be	AUX
ct-10123	55	3	pharmaceutically	pharmaceutically	ADV
ct-10123	55	4	incompatible	incompatible	ADJ
ct-10123	55	5	with	with	ADP
ct-10123	55	6	many	many	ADJ
ct-10123	55	7	beta	beta	NOUN
ct-10123	55	8	-	-	PUNCT
ct-10123	55	9	lactams	lactam	NOUN
ct-10123	55	10	and	and	CCONJ
ct-10123	55	11	should	should	AUX
ct-10123	55	12	not	not	PART
ct-10123	55	13	be	be	AUX
ct-10123	55	14	mixed	mix	VERB
ct-10123	55	15	in	in	ADP
ct-10123	55	16	same	same	ADJ
ct-10123	55	17	syringe.2	syringe.2	PROPN
ct-10123	55	18	distribution	distribution	NOUN
ct-10123	55	19	.	.	PUNCT
ct-10123	56	1	aminoglycosides	aminoglycoside	NOUN
ct-10123	56	2	are	be	AUX
ct-10123	56	3	large	large	ADJ
ct-10123	56	4	polycationic	polycationic	ADJ
ct-10123	56	5	molecules	molecule	NOUN
ct-10123	56	6	that	that	PRON
ct-10123	56	7	are	be	AUX
ct-10123	56	8	poorly	poorly	ADV
ct-10123	56	9	lipid	lipid	NOUN
ct-10123	56	10	soluble	soluble	ADJ
ct-10123	56	11	,	,	PUNCT
ct-10123	56	12	with	with	ADP
ct-10123	56	13	limited	limited	ADJ
ct-10123	56	14	ability	ability	NOUN
ct-10123	56	15	to	to	PART
ct-10123	56	16	enter	enter	VERB
ct-10123	56	17	cells	cell	NOUN
ct-10123	56	18	and	and	CCONJ
ct-10123	56	19	penetrate	penetrate	VERB
ct-10123	56	20	cellular	cellular	ADJ
ct-10123	56	21	barriers	barrier	NOUN
ct-10123	56	22	unaided	unaided	ADJ
ct-10123	56	23	.	.	PUNCT
ct-10123	57	1	purulent	purulent	ADJ
ct-10123	57	2	or	or	CCONJ
ct-10123	57	3	necrotic	necrotic	ADJ
ct-10123	57	4	debris	debris	NOUN
ct-10123	57	5	bind	bind	NOUN
ct-10123	57	6	and	and	CCONJ
ct-10123	57	7	inactivate	inactivate	VERB
ct-10123	57	8	aminoglycosides	aminoglycoside	NOUN
ct-10123	57	9	.	.	PUNCT
ct-10123	58	1	synergism	synergism	NOUN
ct-10123	58	2	.	.	PUNCT
ct-10123	59	1	aminoglycosides	aminoglycoside	NOUN
ct-10123	59	2	are	be	AUX
ct-10123	59	3	synergistic	synergistic	ADJ
ct-10123	59	4	with	with	ADP
ct-10123	59	5	beta	beta	NOUN
ct-10123	59	6	-	-	PUNCT
ct-10123	59	7	lactams	lactam	NOUN
ct-10123	59	8	and	and	CCONJ
ct-10123	59	9	trimethoprim	trimethoprim	NOUN
ct-10123	59	10	-	-	PUNCT
ct-10123	59	11	sulfonamide	sulfonamide	NOUN
ct-10123	59	12	.	.	PUNCT
ct-10123	60	1	antagonism	antagonism	NOUN
ct-10123	60	2	.	.	PUNCT
ct-10123	61	1	antagonism	antagonism	NOUN
ct-10123	61	2	may	may	AUX
ct-10123	61	3	occur	occur	VERB
ct-10123	61	4	with	with	ADP
ct-10123	61	5	chloramphenicol	chloramphenicol	NOUN
ct-10123	61	6	,	,	PUNCT
ct-10123	61	7	tetracycline	tetracycline	NOUN
ct-10123	61	8	,	,	PUNCT
ct-10123	61	9	erythromycin	erythromycin	NOUN
ct-10123	61	10	;	;	PUNCT
ct-10123	61	11	should	should	AUX
ct-10123	61	12	not	not	PART
ct-10123	61	13	be	be	AUX
ct-10123	61	14	mixed	mix	VERB
ct-10123	61	15	with	with	ADP
ct-10123	61	16	penicillins	penicillin	NOUN
ct-10123	61	17	in	in	ADP
ct-10123	61	18	vitro.2	vitro.2	PROPN
ct-10123	61	19	505	505	NUM
ct-10123	61	20	clinical	clinical	ADJ
ct-10123	61	21	theriogenology	theriogenology	NOUN
ct-10123	61	22	•	•	NOUN
ct-10123	61	23	volume	volume	NOUN
ct-10123	61	24	5	5	NUM
ct-10123	61	25	,	,	PUNCT
ct-10123	61	26	number	number	NOUN
ct-10123	61	27	4	4	NUM
ct-10123	61	28	•	•	NOUN
ct-10123	61	29	december	december	PROPN
ct-10123	61	30	2013	2013	NUM
ct-10123	61	31	uses	use	VERB
ct-10123	61	32	in	in	ADP
ct-10123	61	33	reproduction	reproduction	NOUN
ct-10123	61	34	.	.	PUNCT
ct-10123	62	1	intravenous	intravenous	ADJ
ct-10123	62	2	gentamicin	gentamicin	NOUN
ct-10123	62	3	(	(	PUNCT
ct-10123	62	4	6.6	6.6	NUM
ct-10123	62	5	mg	mg	NOUN
ct-10123	62	6	/	/	SYM
ct-10123	62	7	kg	kg	PROPN
ct-10123	62	8	iv	iv	NUM
ct-10123	62	9	sid	sid	PROPN
ct-10123	62	10	)	)	PUNCT
ct-10123	62	11	yielded	yield	VERB
ct-10123	62	12	concentrations	concentration	NOUN
ct-10123	62	13	in	in	ADP
ct-10123	62	14	allantoic	allantoic	NOUN
ct-10123	62	15	fluid	fluid	NOUN
ct-10123	62	16	above	above	ADP
ct-10123	62	17	mic	mic	NOUN
ct-10123	62	18	for	for	ADP
ct-10123	62	19	potential	potential	ADJ
ct-10123	62	20	gram	gram	NOUN
ct-10123	62	21	-	-	PUNCT
ct-10123	62	22	negative	negative	ADJ
ct-10123	62	23	pathogens	pathogen	NOUN
ct-10123	62	24	such	such	ADJ
ct-10123	62	25	as	as	ADP
ct-10123	62	26	e.	e.	PROPN
ct-10123	62	27	coli.5	coli.5	PROPN
ct-10123	62	28	amikacin	amikacin	PROPN
ct-10123	62	29	is	be	AUX
ct-10123	62	30	labeled	label	VERB
ct-10123	62	31	for	for	ADP
ct-10123	62	32	intrauterine	intrauterine	ADJ
ct-10123	62	33	use	use	NOUN
ct-10123	62	34	at	at	ADP
ct-10123	62	35	a	a	DET
ct-10123	62	36	dose	dose	NOUN
ct-10123	62	37	2	2	NUM
ct-10123	62	38	g	g	NOUN
ct-10123	62	39	in	in	ADP
ct-10123	62	40	200	200	NUM
ct-10123	62	41	ml	ml	NOUN
ct-10123	62	42	saline	saline	NOUN
ct-10123	62	43	q	q	PROPN
ct-10123	62	44	24	24	NUM
ct-10123	62	45	hrs	hrs	NOUN
ct-10123	62	46	for	for	ADP
ct-10123	62	47	three	three	NUM
ct-10123	62	48	consecutive	consecutive	ADJ
ct-10123	62	49	days	day	NOUN
ct-10123	62	50	for	for	ADP
ct-10123	62	51	endometritis	endometritis	NOUN
ct-10123	62	52	,	,	PUNCT
ct-10123	62	53	metritis	metritis	NOUN
ct-10123	62	54	,	,	PUNCT
ct-10123	62	55	and	and	CCONJ
ct-10123	62	56	pyometra	pyometra	NOUN
ct-10123	62	57	in	in	ADP
ct-10123	62	58	mares	mare	NOUN
ct-10123	62	59	.	.	PUNCT
ct-10123	63	1	gentamicin	gentamicin	NOUN
ct-10123	63	2	(	(	PUNCT
ct-10123	63	3	2	2	NUM
ct-10123	63	4	g	g	NOUN
ct-10123	63	5	in	in	ADP
ct-10123	63	6	80	80	NUM
ct-10123	63	7	ml	ml	NOUN
ct-10123	63	8	saline	saline	NOUN
ct-10123	63	9	)	)	PUNCT
ct-10123	63	10	intrauterine	intrauterine	ADJ
ct-10123	63	11	infusion	infusion	NOUN
ct-10123	63	12	has	have	AUX
ct-10123	63	13	been	be	AUX
ct-10123	63	14	associated	associate	VERB
ct-10123	63	15	with	with	ADP
ct-10123	63	16	shorter	short	ADJ
ct-10123	63	17	duration	duration	NOUN
ct-10123	63	18	histologic	histologic	ADJ
ct-10123	63	19	inflammation	inflammation	NOUN
ct-10123	63	20	though	though	SCONJ
ct-10123	63	21	more	more	ADJ
ct-10123	63	22	cellular	cellular	ADJ
ct-10123	63	23	changes	change	NOUN
ct-10123	63	24	were	be	AUX
ct-10123	63	25	seen	see	VERB
ct-10123	63	26	with	with	ADP
ct-10123	63	27	scanning	scan	VERB
ct-10123	63	28	electron	electron	NOUN
ct-10123	63	29	microscopy	microscopy	NOUN
ct-10123	63	30	compared	compare	VERB
ct-10123	63	31	to	to	ADP
ct-10123	63	32	saline	saline	VERB
ct-10123	63	33	controls.13,14	controls.13,14	NOUN
ct-10123	63	34	it	it	PRON
ct-10123	63	35	is	be	AUX
ct-10123	63	36	generally	generally	ADV
ct-10123	63	37	recommended	recommend	VERB
ct-10123	63	38	that	that	SCONJ
ct-10123	63	39	gentamicin	gentamicin	NOUN
ct-10123	63	40	be	be	AUX
ct-10123	63	41	buffered	buffer	VERB
ct-10123	63	42	or	or	CCONJ
ct-10123	63	43	well	well	ADV
ct-10123	63	44	diluted	dilute	VERB
ct-10123	63	45	in	in	ADP
ct-10123	63	46	saline	saline	NOUN
ct-10123	63	47	to	to	PART
ct-10123	63	48	minimize	minimize	VERB
ct-10123	63	49	irritation	irritation	NOUN
ct-10123	63	50	.	.	PUNCT
ct-10123	64	1	tetracyclines	tetracycline	NOUN
ct-10123	64	2	commonly	commonly	ADV
ct-10123	64	3	used	use	VERB
ct-10123	64	4	formulations	formulation	NOUN
ct-10123	64	5	are	be	AUX
ct-10123	64	6	oxytetracycline	oxytetracycline	ADJ
ct-10123	64	7	and	and	CCONJ
ct-10123	64	8	doxycycline	doxycycline	NOUN
ct-10123	64	9	mechanism	mechanism	NOUN
ct-10123	64	10	of	of	ADP
ct-10123	64	11	action	action	NOUN
ct-10123	64	12	.	.	PUNCT
ct-10123	65	1	tetracyclines	tetracycline	NOUN
ct-10123	65	2	are	be	AUX
ct-10123	65	3	broad	broad	ADJ
ct-10123	65	4	spectrum	spectrum	NOUN
ct-10123	65	5	,	,	PUNCT
ct-10123	65	6	bacteristatic	bacteristatic	ADJ
ct-10123	65	7	antimicrobials	antimicrobial	NOUN
ct-10123	65	8	that	that	PRON
ct-10123	65	9	diffuse	diffuse	VERB
ct-10123	65	10	through	through	ADP
ct-10123	65	11	the	the	DET
ct-10123	65	12	outer	outer	ADJ
ct-10123	65	13	cell	cell	NOUN
ct-10123	65	14	membrane	membrane	NOUN
ct-10123	65	15	to	to	PART
ct-10123	65	16	reversibly	reversibly	ADV
ct-10123	65	17	bind	bind	VERB
ct-10123	65	18	to	to	ADP
ct-10123	65	19	the	the	DET
ct-10123	65	20	30s	30	NOUN
ct-10123	65	21	ribosomal	ribosomal	NOUN
ct-10123	65	22	subunit	subunit	NOUN
ct-10123	65	23	to	to	PART
ct-10123	65	24	inhibit	inhibit	VERB
ct-10123	65	25	protein	protein	NOUN
ct-10123	65	26	synthesis	synthesis	NOUN
ct-10123	65	27	.	.	PUNCT
ct-10123	66	1	they	they	PRON
ct-10123	66	2	are	be	AUX
ct-10123	66	3	strong	strong	ADJ
ct-10123	66	4	chelating	chelate	VERB
ct-10123	66	5	agents	agent	NOUN
ct-10123	66	6	with	with	ADP
ct-10123	66	7	the	the	DET
ct-10123	66	8	ability	ability	NOUN
ct-10123	66	9	to	to	PART
ct-10123	66	10	chelate	chelate	VERB
ct-10123	66	11	divalent	divalent	NOUN
ct-10123	66	12	and	and	CCONJ
ct-10123	66	13	trivalent	trivalent	NOUN
ct-10123	66	14	ions	ion	NOUN
ct-10123	66	15	such	such	ADJ
ct-10123	66	16	as	as	ADP
ct-10123	66	17	calcium	calcium	NOUN
ct-10123	66	18	,	,	PUNCT
ct-10123	66	19	with	with	ADP
ct-10123	66	20	potential	potential	NOUN
ct-10123	66	21	to	to	PART
ct-10123	66	22	cause	cause	VERB
ct-10123	66	23	tooth	tooth	NOUN
ct-10123	66	24	discoloration	discoloration	NOUN
ct-10123	66	25	.	.	PUNCT
ct-10123	67	1	there	there	PRON
ct-10123	67	2	is	be	VERB
ct-10123	67	3	widespread	widespread	ADJ
ct-10123	67	4	acquired	acquire	VERB
ct-10123	67	5	resistance	resistance	NOUN
ct-10123	67	6	particularly	particularly	ADV
ct-10123	67	7	among	among	ADP
ct-10123	67	8	gram	gram	NOUN
ct-10123	67	9	-	-	PUNCT
ct-10123	67	10	negative	negative	ADJ
ct-10123	67	11	bacteria	bacteria	NOUN
ct-10123	67	12	and	and	CCONJ
ct-10123	67	13	variable	variable	ADJ
ct-10123	67	14	susceptibility	susceptibility	NOUN
ct-10123	67	15	in	in	ADP
ct-10123	67	16	many	many	ADJ
ct-10123	67	17	staphylococcus	staphylococcus	NOUN
ct-10123	67	18	sp	sp	NOUN
ct-10123	67	19	.	.	PROPN
ct-10123	67	20	,	,	PUNCT
ct-10123	67	21	streptococcus	streptococcus	VERB
ct-10123	67	22	sp	sp	NOUN
ct-10123	67	23	.	.	PROPN
ct-10123	67	24	,	,	PUNCT
ct-10123	67	25	enterococcus	enterococcus	NOUN
ct-10123	67	26	sp	sp	PROPN
ct-10123	67	27	.	.	PROPN
ct-10123	67	28	,	,	PUNCT
ct-10123	67	29	e.	e.	PROPN
ct-10123	67	30	coli	coli	PROPN
ct-10123	67	31	,	,	PUNCT
ct-10123	67	32	and	and	CCONJ
ct-10123	67	33	klebsiella	klebsiella	PROPN
ct-10123	67	34	sp	sp	PROPN
ct-10123	67	35	.	.	PROPN
ct-10123	67	36	resistance	resistance	NOUN
ct-10123	67	37	is	be	AUX
ct-10123	67	38	rare	rare	ADJ
ct-10123	67	39	in	in	ADP
ct-10123	67	40	obligate	obligate	NOUN
ct-10123	67	41	intracellular	intracellular	ADJ
ct-10123	67	42	pathogens	pathogen	NOUN
ct-10123	67	43	such	such	ADJ
ct-10123	67	44	as	as	ADP
ct-10123	67	45	ehrlichia	ehrlichia	NOUN
ct-10123	67	46	sp	sp	NOUN
ct-10123	67	47	.	.	NOUN
ct-10123	67	48	and	and	CCONJ
ct-10123	67	49	anaplasma	anaplasma	PROPN
ct-10123	67	50	sp	sp	PROPN
ct-10123	67	51	.	.	PROPN
ct-10123	67	52	doxycycline	doxycycline	NOUN
ct-10123	67	53	(	(	PUNCT
ct-10123	67	54	semi	semi	ADJ
ct-10123	67	55	-	-	ADJ
ct-10123	67	56	synthetic	synthetic	ADJ
ct-10123	67	57	)	)	PUNCT
ct-10123	67	58	is	be	AUX
ct-10123	67	59	more	more	ADJ
ct-10123	67	60	lipid	lipid	NOUN
ct-10123	67	61	soluble	soluble	ADJ
ct-10123	67	62	than	than	ADP
ct-10123	67	63	oxytetracycline	oxytetracycline	ADJ
ct-10123	67	64	.	.	PUNCT
ct-10123	68	1	tetracyclines	tetracycline	NOUN
ct-10123	68	2	are	be	AUX
ct-10123	68	3	relatively	relatively	ADV
ct-10123	68	4	safe	safe	ADJ
ct-10123	68	5	,	,	PUNCT
ct-10123	68	6	with	with	ADP
ct-10123	68	7	reported	report	VERB
ct-10123	68	8	risks	risk	NOUN
ct-10123	68	9	of	of	ADP
ct-10123	68	10	enterocolitis	enterocolitis	ADJ
ct-10123	68	11	,	,	PUNCT
ct-10123	68	12	occasional	occasional	ADJ
ct-10123	68	13	fatal	fatal	ADJ
ct-10123	68	14	anaphylaxis	anaphylaxis	ADJ
ct-10123	68	15	,	,	PUNCT
ct-10123	68	16	and	and	CCONJ
ct-10123	68	17	collapse	collapse	VERB
ct-10123	68	18	if	if	SCONJ
ct-10123	68	19	intravenous	intravenous	ADJ
ct-10123	68	20	administration	administration	NOUN
ct-10123	68	21	is	be	AUX
ct-10123	68	22	not	not	PART
ct-10123	68	23	slow	slow	ADJ
ct-10123	68	24	.	.	PUNCT
ct-10123	69	1	renal	renal	ADJ
ct-10123	69	2	tubular	tubular	ADJ
ct-10123	69	3	damage	damage	NOUN
ct-10123	69	4	may	may	AUX
ct-10123	69	5	occur	occur	VERB
ct-10123	69	6	if	if	SCONJ
ct-10123	69	7	outdated	outdated	ADJ
ct-10123	69	8	product	product	NOUN
ct-10123	69	9	used	use	VERB
ct-10123	69	10	.	.	PUNCT
ct-10123	70	1	distribution	distribution	NOUN
ct-10123	70	2	.	.	PUNCT
ct-10123	71	1	tetracyclines	tetracycline	NOUN
ct-10123	71	2	are	be	AUX
ct-10123	71	3	widely	widely	ADV
ct-10123	71	4	distributed	distribute	VERB
ct-10123	71	5	.	.	PUNCT
ct-10123	72	1	synergism	synergism	NOUN
ct-10123	72	2	.	.	PUNCT
ct-10123	73	1	tetracyclines	tetracycline	NOUN
ct-10123	73	2	are	be	AUX
ct-10123	73	3	synergistic	synergistic	ADJ
ct-10123	73	4	with	with	ADP
ct-10123	73	5	polymyxins	polymyxin	NOUN
ct-10123	73	6	by	by	ADP
ct-10123	73	7	enhancing	enhance	VERB
ct-10123	73	8	bacterial	bacterial	ADJ
ct-10123	73	9	uptake	uptake	ADJ
ct-10123	73	10	uses	use	NOUN
ct-10123	73	11	in	in	ADP
ct-10123	73	12	reproduction	reproduction	NOUN
ct-10123	73	13	.	.	PUNCT
ct-10123	74	1	after	after	ADP
ct-10123	74	2	intragastric	intragastric	ADJ
ct-10123	74	3	administration	administration	NOUN
ct-10123	74	4	of	of	ADP
ct-10123	74	5	doxycycline	doxycycline	NOUN
ct-10123	74	6	(	(	PUNCT
ct-10123	74	7	five	five	NUM
ct-10123	74	8	doses	dose	NOUN
ct-10123	74	9	,	,	PUNCT
ct-10123	74	10	10	10	NUM
ct-10123	74	11	mg	mg	NUM
ct-10123	74	12	/	/	SYM
ct-10123	74	13	kg	kg	PROPN
ct-10123	74	14	bid	bid	NOUN
ct-10123	74	15	)	)	PUNCT
ct-10123	74	16	,	,	PUNCT
ct-10123	74	17	the	the	DET
ct-10123	74	18	endometrial	endometrial	ADJ
ct-10123	74	19	concentration	concentration	NOUN
ct-10123	74	20	was	be	AUX
ct-10123	74	21	approximately	approximately	ADV
ct-10123	74	22	1.3	1.3	NUM
ct-10123	74	23	micrograms	microgram	NOUN
ct-10123	74	24	/	/	SYM
ct-10123	74	25	ml	ml	NOUN
ct-10123	74	26	,	,	PUNCT
ct-10123	74	27	above	above	ADP
ct-10123	74	28	the	the	DET
ct-10123	74	29	mic	mic	NOUN
ct-10123	74	30	for	for	ADP
ct-10123	74	31	the	the	DET
ct-10123	74	32	evaluated	evaluate	VERB
ct-10123	74	33	strains	strain	NOUN
ct-10123	74	34	of	of	ADP
ct-10123	74	35	s.	s.	PROPN
ct-10123	74	36	zooepidemicus	zooepidemicus	PROPN
ct-10123	74	37	and	and	CCONJ
ct-10123	74	38	staphylococcus	staphylococcus	NOUN
ct-10123	74	39	aureus.15	aureus.15	PROPN
ct-10123	74	40	tetracyclines	tetracyclines	PROPN
ct-10123	74	41	can	can	AUX
ct-10123	74	42	be	be	AUX
ct-10123	74	43	used	use	VERB
ct-10123	74	44	systemically	systemically	ADV
ct-10123	74	45	for	for	ADP
ct-10123	74	46	treatment	treatment	NOUN
ct-10123	74	47	of	of	ADP
ct-10123	74	48	leptospirosis	leptospirosis	NOUN
ct-10123	74	49	.	.	PUNCT
ct-10123	75	1	in	in	ADP
ct-10123	75	2	a	a	DET
ct-10123	75	3	study	study	NOUN
ct-10123	75	4	evaluating	evaluate	VERB
ct-10123	75	5	the	the	DET
ct-10123	75	6	efficacy	efficacy	NOUN
ct-10123	75	7	and	and	CCONJ
ct-10123	75	8	safety	safety	NOUN
ct-10123	75	9	of	of	ADP
ct-10123	75	10	intrauterine	intrauterine	ADJ
ct-10123	75	11	oxytetracycline	oxytetracycline	NOUN
ct-10123	75	12	,	,	PUNCT
ct-10123	75	13	six	six	NUM
ct-10123	75	14	grams	gram	NOUN
ct-10123	75	15	of	of	ADP
ct-10123	75	16	oxytetracycline	oxytetracycline	NOUN
ct-10123	75	17	was	be	AUX
ct-10123	75	18	infused	infuse	VERB
ct-10123	75	19	daily	daily	ADV
ct-10123	75	20	for	for	ADP
ct-10123	75	21	three	three	NUM
ct-10123	75	22	days	day	NOUN
ct-10123	75	23	.	.	PUNCT
ct-10123	76	1	endometrial	endometrial	ADJ
ct-10123	76	2	oxytetracycline	oxytetracycline	ADJ
ct-10123	76	3	concentration	concentration	NOUN
ct-10123	76	4	remained	remain	VERB
ct-10123	76	5	above	above	ADP
ct-10123	76	6	mic	mic	NOUN
ct-10123	76	7	for	for	ADP
ct-10123	76	8	eight	eight	NUM
ct-10123	76	9	hours	hour	NOUN
ct-10123	76	10	after	after	ADP
ct-10123	76	11	infusion	infusion	NOUN
ct-10123	76	12	for	for	ADP
ct-10123	76	13	s.	s.	PROPN
ct-10123	76	14	zooepidemicus	zooepidemicus	PROPN
ct-10123	76	15	,	,	PUNCT
ct-10123	76	16	klebsiella	klebsiella	PROPN
ct-10123	76	17	pneumonia	pneumonia	NOUN
ct-10123	76	18	,	,	PUNCT
ct-10123	76	19	pseudomonas	pseudomona	NOUN
ct-10123	76	20	aeruginosa	aeruginosa	NOUN
ct-10123	76	21	,	,	PUNCT
ct-10123	76	22	and	and	CCONJ
ct-10123	76	23	e.	e.	PROPN
ct-10123	76	24	coli	coli	PROPN
ct-10123	76	25	,	,	PUNCT
ct-10123	76	26	with	with	ADP
ct-10123	76	27	observation	observation	NOUN
ct-10123	76	28	of	of	ADP
ct-10123	76	29	transient	transient	ADJ
ct-10123	76	30	endometrial	endometrial	ADJ
ct-10123	76	31	inflammation	inflammation	NOUN
ct-10123	76	32	,	,	PUNCT
ct-10123	76	33	and	and	CCONJ
ct-10123	76	34	thus	thus	ADV
ct-10123	76	35	the	the	DET
ct-10123	76	36	recommendation	recommendation	NOUN
ct-10123	76	37	for	for	ADP
ct-10123	76	38	further	further	ADJ
ct-10123	76	39	evaluation	evaluation	NOUN
ct-10123	76	40	prior	prior	ADV
ct-10123	76	41	to	to	ADP
ct-10123	76	42	routine	routine	ADJ
ct-10123	76	43	intrauterine	intrauterine	NOUN
ct-10123	76	44	use.16	use.16	PROPN
ct-10123	76	45	chloramphenicol	chloramphenicol	NOUN
ct-10123	76	46	mechanism	mechanism	NOUN
ct-10123	76	47	of	of	ADP
ct-10123	76	48	action	action	NOUN
ct-10123	76	49	.	.	PUNCT
ct-10123	77	1	chloramphenicol	chloramphenicol	NOUN
ct-10123	77	2	is	be	AUX
ct-10123	77	3	a	a	DET
ct-10123	77	4	bacteriostatic	bacteriostatic	ADJ
ct-10123	77	5	,	,	PUNCT
ct-10123	77	6	lipid	lipid	NOUN
ct-10123	77	7	soluble	soluble	ADJ
ct-10123	77	8	,	,	PUNCT
ct-10123	77	9	neutral	neutral	ADJ
ct-10123	77	10	,	,	PUNCT
ct-10123	77	11	broad	broad	ADJ
ct-10123	77	12	spectrum	spectrum	NOUN
ct-10123	77	13	antimicrobial	antimicrobial	ADJ
ct-10123	77	14	.	.	PUNCT
ct-10123	78	1	it	it	PRON
ct-10123	78	2	irreversibly	irreversibly	ADV
ct-10123	78	3	binds	bind	VERB
ct-10123	78	4	to	to	ADP
ct-10123	78	5	the	the	DET
ct-10123	78	6	50s	50	NOUN
ct-10123	78	7	subunit	subunit	NOUN
ct-10123	78	8	of	of	ADP
ct-10123	78	9	bacterial	bacterial	ADJ
ct-10123	78	10	ribosomes	ribosome	NOUN
ct-10123	78	11	and	and	CCONJ
ct-10123	78	12	also	also	ADV
ct-10123	78	13	inhibits	inhibit	VERB
ct-10123	78	14	mitochondrial	mitochondrial	ADJ
ct-10123	78	15	protein	protein	NOUN
ct-10123	78	16	synthesis	synthesis	NOUN
ct-10123	78	17	is	be	AUX
ct-10123	78	18	mammalian	mammalian	ADJ
ct-10123	78	19	bone	bone	NOUN
ct-10123	78	20	marrow	marrow	NOUN
ct-10123	78	21	cells	cell	NOUN
ct-10123	78	22	in	in	ADP
ct-10123	78	23	a	a	DET
ct-10123	78	24	dose	dose	NOUN
ct-10123	78	25	-	-	PUNCT
ct-10123	78	26	dependent	dependent	ADJ
ct-10123	78	27	manner	manner	NOUN
ct-10123	78	28	.	.	PUNCT
ct-10123	79	1	resistance	resistance	NOUN
ct-10123	79	2	occurs	occur	VERB
ct-10123	79	3	via	via	ADP
ct-10123	79	4	inactivation	inactivation	NOUN
ct-10123	79	5	by	by	ADP
ct-10123	79	6	chloramphenicol	chloramphenicol	NOUN
ct-10123	79	7	acetyltransferases	acetyltransferase	NOUN
ct-10123	79	8	(	(	PUNCT
ct-10123	79	9	cats	cat	NOUN
ct-10123	79	10	)	)	PUNCT
ct-10123	79	11	shared	share	VERB
ct-10123	79	12	via	via	ADP
ct-10123	79	13	plasmids	plasmid	NOUN
ct-10123	79	14	,	,	PUNCT
ct-10123	79	15	transposons	transposon	NOUN
ct-10123	79	16	,	,	PUNCT
ct-10123	79	17	and	and	CCONJ
ct-10123	79	18	integrons	integron	NOUN
ct-10123	79	19	.	.	PUNCT
ct-10123	80	1	elimination	elimination	NOUN
ct-10123	80	2	occurs	occur	VERB
ct-10123	80	3	through	through	ADP
ct-10123	80	4	the	the	DET
ct-10123	80	5	liver	liver	NOUN
ct-10123	80	6	.	.	PUNCT
ct-10123	81	1	chloramphenicol	chloramphenicol	NOUN
ct-10123	81	2	is	be	AUX
ct-10123	81	3	associated	associate	VERB
ct-10123	81	4	with	with	ADP
ct-10123	81	5	idiosyncratic	idiosyncratic	ADJ
ct-10123	81	6	aplastic	aplastic	ADJ
ct-10123	81	7	anemia	anemia	NOUN
ct-10123	81	8	in	in	ADP
ct-10123	81	9	humans	human	NOUN
ct-10123	81	10	and	and	CCONJ
ct-10123	81	11	is	be	AUX
ct-10123	81	12	restricted	restrict	VERB
ct-10123	81	13	in	in	ADP
ct-10123	81	14	some	some	DET
ct-10123	81	15	countries	country	NOUN
ct-10123	81	16	because	because	SCONJ
ct-10123	81	17	of	of	ADP
ct-10123	81	18	bacterial	bacterial	ADJ
ct-10123	81	19	resistance	resistance	NOUN
ct-10123	81	20	and	and	CCONJ
ct-10123	81	21	risk	risk	NOUN
ct-10123	81	22	of	of	ADP
ct-10123	81	23	aplastic	aplastic	ADJ
ct-10123	81	24	anemia	anemia	NOUN
ct-10123	81	25	.	.	PUNCT
ct-10123	82	1	distribution	distribution	NOUN
ct-10123	82	2	.	.	PUNCT
ct-10123	83	1	chloramphenicol	chloramphenicol	NOUN
ct-10123	83	2	is	be	AUX
ct-10123	83	3	widely	widely	ADV
ct-10123	83	4	distributed	distribute	VERB
ct-10123	83	5	.	.	PUNCT
ct-10123	84	1	uses	use	VERB
ct-10123	84	2	in	in	ADP
ct-10123	84	3	reproduction	reproduction	NOUN
ct-10123	84	4	.	.	PUNCT
ct-10123	85	1	anecdotally	anecdotally	ADV
ct-10123	85	2	used	use	VERB
ct-10123	85	3	for	for	ADP
ct-10123	85	4	intrauterine	intrauterine	ADJ
ct-10123	85	5	infusion	infusion	NOUN
ct-10123	85	6	when	when	SCONJ
ct-10123	85	7	proteinaceous	proteinaceous	ADJ
ct-10123	85	8	debris	debris	NOUN
ct-10123	85	9	is	be	AUX
ct-10123	85	10	present	present	ADJ
ct-10123	85	11	(	(	PUNCT
ct-10123	85	12	w.	w.	PROPN
ct-10123	85	13	zent	zent	PROPN
ct-10123	85	14	,	,	PUNCT
ct-10123	85	15	personal	personal	ADJ
ct-10123	85	16	comminication	comminication	NOUN
ct-10123	85	17	)	)	PUNCT
ct-10123	85	18	.	.	PUNCT
ct-10123	86	1	systemic	systemic	ADJ
ct-10123	86	2	use	use	NOUN
ct-10123	86	3	is	be	AUX
ct-10123	86	4	based	base	VERB
ct-10123	86	5	on	on	ADP
ct-10123	86	6	clinical	clinical	ADJ
ct-10123	86	7	necessity	necessity	NOUN
ct-10123	86	8	.	.	PUNCT
ct-10123	87	1	sulfonamides	sulfonamide	NOUN
ct-10123	87	2	506clinical	506clinical	PROPN
ct-10123	87	3	theriogenology	theriogenology	NOUN
ct-10123	87	4	•	•	NOUN
ct-10123	87	5	volume	volume	NOUN
ct-10123	87	6	5	5	NUM
ct-10123	87	7	,	,	PUNCT
ct-10123	87	8	number	number	NOUN
ct-10123	87	9	4	4	NUM
ct-10123	87	10	•	•	NOUN
ct-10123	87	11	december	december	PROPN
ct-10123	87	12	2013	2013	NUM
ct-10123	87	13	commonly	commonly	ADV
ct-10123	87	14	used	use	VERB
ct-10123	87	15	formulations	formulation	NOUN
ct-10123	87	16	are	be	AUX
ct-10123	87	17	sulfadiazine	sulfadiazine	NOUN
ct-10123	87	18	,	,	PUNCT
ct-10123	87	19	sulfasalazine	sulfasalazine	NOUN
ct-10123	87	20	,	,	PUNCT
ct-10123	87	21	and	and	CCONJ
ct-10123	87	22	sulfamethoxazole	sulfamethoxazole	NOUN
ct-10123	87	23	mechanism	mechanism	NOUN
ct-10123	87	24	of	of	ADP
ct-10123	87	25	action	action	NOUN
ct-10123	87	26	.	.	PUNCT
ct-10123	88	1	sulfonamides	sulfonamide	NOUN
ct-10123	88	2	are	be	AUX
ct-10123	88	3	bacteriostatic	bacteriostatic	ADJ
ct-10123	88	4	when	when	SCONJ
ct-10123	88	5	used	use	VERB
ct-10123	88	6	alone	alone	ADV
ct-10123	88	7	and	and	CCONJ
ct-10123	88	8	bactericidal	bactericidal	NOUN
ct-10123	88	9	when	when	SCONJ
ct-10123	88	10	combined	combine	VERB
ct-10123	88	11	with	with	ADP
ct-10123	88	12	trimethoprim	trimethoprim	NOUN
ct-10123	88	13	.	.	PUNCT
ct-10123	89	1	they	they	PRON
ct-10123	89	2	interfere	interfere	VERB
ct-10123	89	3	with	with	ADP
ct-10123	89	4	biosynthesis	biosynthesis	NOUN
ct-10123	89	5	of	of	ADP
ct-10123	89	6	folic	folic	ADJ
ct-10123	89	7	acid	acid	NOUN
ct-10123	89	8	in	in	ADP
ct-10123	89	9	bacterial	bacterial	ADJ
ct-10123	89	10	cells	cell	NOUN
ct-10123	89	11	by	by	ADP
ct-10123	89	12	competitively	competitively	ADV
ct-10123	89	13	preventing	prevent	VERB
ct-10123	89	14	para	para	ADJ
ct-10123	89	15	-	-	PUNCT
ct-10123	89	16	aminobenzoic	aminobenzoic	NOUN
ct-10123	89	17	acid	acid	NOUN
ct-10123	89	18	(	(	PUNCT
ct-10123	89	19	paba	paba	NOUN
ct-10123	89	20	)	)	PUNCT
ct-10123	89	21	incorporation	incorporation	NOUN
ct-10123	89	22	into	into	ADP
ct-10123	89	23	folic	folic	ADJ
ct-10123	89	24	acid	acid	NOUN
ct-10123	89	25	molecule	molecule	NOUN
ct-10123	89	26	by	by	ADP
ct-10123	89	27	competing	compete	VERB
ct-10123	89	28	with	with	ADP
ct-10123	89	29	paba	paba	PROPN
ct-10123	89	30	for	for	ADP
ct-10123	89	31	dihydropteroate	dihydropteroate	NOUN
ct-10123	89	32	synthetase	synthetase	NOUN
ct-10123	89	33	.	.	PUNCT
ct-10123	90	1	bacteriostatic	bacteriostatic	ADJ
ct-10123	90	2	action	action	NOUN
ct-10123	90	3	depends	depend	VERB
ct-10123	90	4	on	on	ADP
ct-10123	90	5	the	the	DET
ct-10123	90	6	requirement	requirement	NOUN
ct-10123	90	7	for	for	ADP
ct-10123	90	8	folic	folic	ADJ
ct-10123	90	9	acid	acid	NOUN
ct-10123	90	10	;	;	PUNCT
ct-10123	90	11	susceptible	susceptible	ADJ
ct-10123	90	12	microorganisms	microorganism	NOUN
ct-10123	90	13	must	must	AUX
ct-10123	90	14	synthesize	synthesize	VERB
ct-10123	90	15	folic	folic	ADJ
ct-10123	90	16	acid	acid	NOUN
ct-10123	90	17	while	while	SCONJ
ct-10123	90	18	mammalian	mammalian	ADJ
ct-10123	90	19	cells	cell	NOUN
ct-10123	90	20	use	use	VERB
ct-10123	90	21	preformed	preformed	ADJ
ct-10123	90	22	folic	folic	ADJ
ct-10123	90	23	acid	acid	NOUN
ct-10123	90	24	.	.	PUNCT
ct-10123	91	1	tissue	tissue	NOUN
ct-10123	91	2	exudate	exudate	VERB
ct-10123	91	3	or	or	CCONJ
ct-10123	91	4	necrotic	necrotic	ADJ
ct-10123	91	5	tissue	tissue	NOUN
ct-10123	91	6	must	must	AUX
ct-10123	91	7	be	be	AUX
ct-10123	91	8	removed	remove	VERB
ct-10123	91	9	for	for	ADP
ct-10123	91	10	penetration	penetration	NOUN
ct-10123	91	11	.	.	PUNCT
ct-10123	92	1	bacterial	bacterial	ADJ
ct-10123	92	2	resistance	resistance	NOUN
ct-10123	92	3	is	be	AUX
ct-10123	92	4	extensive	extensive	ADJ
ct-10123	92	5	.	.	PUNCT
ct-10123	93	1	elimination	elimination	NOUN
ct-10123	93	2	occurs	occur	VERB
ct-10123	93	3	through	through	ADP
ct-10123	93	4	a	a	DET
ct-10123	93	5	combination	combination	NOUN
ct-10123	93	6	of	of	ADP
ct-10123	93	7	renal	renal	ADJ
ct-10123	93	8	excretion	excretion	NOUN
ct-10123	93	9	and	and	CCONJ
ct-10123	93	10	metabolic	metabolic	NOUN
ct-10123	93	11	transformation	transformation	NOUN
ct-10123	93	12	.	.	PUNCT
ct-10123	94	1	adverse	adverse	ADJ
ct-10123	94	2	side	side	NOUN
ct-10123	94	3	effects	effect	NOUN
ct-10123	94	4	,	,	PUNCT
ct-10123	94	5	though	though	SCONJ
ct-10123	94	6	uncommon	uncommon	ADJ
ct-10123	94	7	,	,	PUNCT
ct-10123	94	8	may	may	AUX
ct-10123	94	9	include	include	VERB
ct-10123	94	10	urinary	urinary	ADJ
ct-10123	94	11	tract	tract	NOUN
ct-10123	94	12	disturbances	disturbance	NOUN
ct-10123	94	13	,	,	PUNCT
ct-10123	94	14	hematopoietic	hematopoietic	ADJ
ct-10123	94	15	disorders	disorder	NOUN
ct-10123	94	16	,	,	PUNCT
ct-10123	94	17	dermatologic	dermatologic	ADJ
ct-10123	94	18	disorders	disorder	NOUN
ct-10123	94	19	,	,	PUNCT
ct-10123	94	20	and	and	CCONJ
ct-10123	94	21	keratoconjunctivitis	keratoconjunctivitis	PROPN
ct-10123	94	22	sicca	sicca	NOUN
ct-10123	94	23	in	in	ADP
ct-10123	94	24	dogs	dog	NOUN
ct-10123	94	25	.	.	PUNCT
ct-10123	95	1	distribution	distribution	NOUN
ct-10123	95	2	.	.	PUNCT
ct-10123	96	1	sulfonamides	sulfonamide	NOUN
ct-10123	96	2	are	be	AUX
ct-10123	96	3	widely	widely	ADV
ct-10123	96	4	distributed	distribute	VERB
ct-10123	96	5	.	.	PUNCT
ct-10123	97	1	uses	use	VERB
ct-10123	97	2	in	in	ADP
ct-10123	97	3	reproduction	reproduction	NOUN
ct-10123	97	4	.	.	PUNCT
ct-10123	98	1	systemic	systemic	ADJ
ct-10123	98	2	administration	administration	NOUN
ct-10123	98	3	of	of	ADP
ct-10123	98	4	trimethoprim	trimethoprim	PROPN
ct-10123	98	5	sulfamethoxazole	sulfamethoxazole	NOUN
ct-10123	98	6	(	(	PUNCT
ct-10123	98	7	30	30	NUM
ct-10123	98	8	mg	mg	NUM
ct-10123	98	9	/	/	SYM
ct-10123	98	10	kg	kg	PROPN
ct-10123	98	11	po	po	NOUN
ct-10123	98	12	bid	bid	NOUN
ct-10123	98	13	)	)	PUNCT
ct-10123	98	14	in	in	ADP
ct-10123	98	15	combination	combination	NOUN
ct-10123	98	16	with	with	ADP
ct-10123	98	17	pentoxifylline	pentoxifylline	NOUN
ct-10123	98	18	and	and	CCONJ
ct-10123	98	19	altrenogest	altrenogest	NOUN
ct-10123	98	20	have	have	AUX
ct-10123	98	21	been	be	AUX
ct-10123	98	22	well	well	ADV
ct-10123	98	23	evaluated	evaluate	VERB
ct-10123	98	24	in	in	ADP
ct-10123	98	25	placentitis	placentitis	NOUN
ct-10123	98	26	models	model	NOUN
ct-10123	98	27	(	(	PUNCT
ct-10123	98	28	see	see	VERB
ct-10123	98	29	below	below	ADV
ct-10123	98	30	)	)	PUNCT
ct-10123	98	31	.	.	PUNCT
ct-10123	99	1	diaminopyrimidines	diaminopyrimidine	VERB
ct-10123	99	2	a	a	DET
ct-10123	99	3	commonly	commonly	ADV
ct-10123	99	4	used	use	VERB
ct-10123	99	5	formulation	formulation	NOUN
ct-10123	99	6	is	be	AUX
ct-10123	99	7	trimethoprim	trimethoprim	ADJ
ct-10123	99	8	in	in	ADP
ct-10123	99	9	conjunction	conjunction	NOUN
ct-10123	99	10	with	with	ADP
ct-10123	99	11	sulfonamides	sulfonamide	NOUN
ct-10123	99	12	.	.	PUNCT
ct-10123	100	1	mechanism	mechanism	NOUN
ct-10123	100	2	of	of	ADP
ct-10123	100	3	action	action	NOUN
ct-10123	100	4	.	.	PUNCT
ct-10123	101	1	trimethoprim	trimethoprim	PROPN
ct-10123	101	2	interferes	interfere	VERB
ct-10123	101	3	with	with	ADP
ct-10123	101	4	folic	folic	ADJ
ct-10123	101	5	acid	acid	NOUN
ct-10123	101	6	production	production	NOUN
ct-10123	101	7	by	by	ADP
ct-10123	101	8	inhibition	inhibition	NOUN
ct-10123	101	9	of	of	ADP
ct-10123	101	10	dihydrofolate	dihydrofolate	ADJ
ct-10123	101	11	reductase	reductase	NOUN
ct-10123	101	12	with	with	ADP
ct-10123	101	13	greater	great	ADJ
ct-10123	101	14	affinity	affinity	NOUN
ct-10123	101	15	for	for	ADP
ct-10123	101	16	bacterial	bacterial	ADJ
ct-10123	101	17	versus	versus	X
ct-10123	101	18	mammalian	mammalian	ADJ
ct-10123	101	19	enzymes	enzyme	NOUN
ct-10123	101	20	,	,	PUNCT
ct-10123	101	21	preventing	prevent	VERB
ct-10123	101	22	synthesis	synthesis	NOUN
ct-10123	101	23	of	of	ADP
ct-10123	101	24	purines	purine	NOUN
ct-10123	101	25	and	and	CCONJ
ct-10123	101	26	thus	thus	ADV
ct-10123	101	27	dna	dna	PROPN
ct-10123	101	28	.	.	PUNCT
ct-10123	102	1	they	they	PRON
ct-10123	102	2	are	be	AUX
ct-10123	102	3	bacteriostatic	bacteriostatic	ADJ
ct-10123	102	4	when	when	SCONJ
ct-10123	102	5	used	use	VERB
ct-10123	102	6	alone	alone	ADV
ct-10123	102	7	.	.	PUNCT
ct-10123	103	1	efficacy	efficacy	NOUN
ct-10123	103	2	is	be	AUX
ct-10123	103	3	decreased	decrease	VERB
ct-10123	103	4	with	with	ADP
ct-10123	103	5	plasmid	plasmid	NOUN
ct-10123	103	6	associated	associated	ADJ
ct-10123	103	7	resistance	resistance	NOUN
ct-10123	103	8	,	,	PUNCT
ct-10123	103	9	and	and	CCONJ
ct-10123	103	10	antagonism	antagonism	NOUN
ct-10123	103	11	by	by	ADP
ct-10123	103	12	tissue	tissue	NOUN
ct-10123	103	13	debris	debris	NOUN
ct-10123	103	14	.	.	PUNCT
ct-10123	104	1	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	104	2	commonly	commonly	ADV
ct-10123	104	3	used	use	VERB
ct-10123	104	4	formulations	formulation	NOUN
ct-10123	104	5	are	be	AUX
ct-10123	104	6	enrofloxacin	enrofloxacin	PRON
ct-10123	104	7	and	and	CCONJ
ct-10123	104	8	ciprofloxacin	ciprofloxacin	PROPN
ct-10123	104	9	.	.	PUNCT
ct-10123	105	1	mechanism	mechanism	NOUN
ct-10123	105	2	of	of	ADP
ct-10123	105	3	action	action	NOUN
ct-10123	105	4	.	.	PUNCT
ct-10123	106	1	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	106	2	are	be	AUX
ct-10123	106	3	concentration	concentration	NOUN
ct-10123	106	4	dependent	dependent	ADJ
ct-10123	106	5	,	,	PUNCT
ct-10123	106	6	bactericidal	bactericidal	ADJ
ct-10123	106	7	antimicrobials	antimicrobial	NOUN
ct-10123	106	8	that	that	PRON
ct-10123	106	9	bind	bind	VERB
ct-10123	106	10	dna	dna	NOUN
ct-10123	106	11	-	-	PUNCT
ct-10123	106	12	gyrase	gyrase	NOUN
ct-10123	106	13	-	-	PUNCT
ct-10123	106	14	dna	dna	NOUN
ct-10123	106	15	complexes	complex	NOUN
ct-10123	106	16	to	to	PART
ct-10123	106	17	impair	impair	VERB
ct-10123	106	18	negative	negative	ADJ
ct-10123	106	19	supercoiling	supercoiling	NOUN
ct-10123	106	20	and	and	CCONJ
ct-10123	106	21	target	target	VERB
ct-10123	106	22	dna	dna	PROPN
ct-10123	106	23	topoisomerase	topoisomerase	NOUN
ct-10123	106	24	,	,	PUNCT
ct-10123	106	25	disrupting	disrupt	VERB
ct-10123	106	26	replication	replication	NOUN
ct-10123	106	27	.	.	PUNCT
ct-10123	107	1	they	they	PRON
ct-10123	107	2	have	have	VERB
ct-10123	107	3	activity	activity	NOUN
ct-10123	107	4	against	against	ADP
ct-10123	107	5	a	a	DET
ct-10123	107	6	wide	wide	ADJ
ct-10123	107	7	range	range	NOUN
ct-10123	107	8	of	of	ADP
ct-10123	107	9	gram	gram	NOUN
ct-10123	107	10	-	-	PUNCT
ct-10123	107	11	negative	negative	ADJ
ct-10123	107	12	bacteria	bacteria	NOUN
ct-10123	107	13	,	,	PUNCT
ct-10123	107	14	with	with	ADP
ct-10123	107	15	ciprofloxacin	ciprofloxacin	NOUN
ct-10123	107	16	being	be	AUX
ct-10123	107	17	most	most	ADV
ct-10123	107	18	potent	potent	ADJ
ct-10123	107	19	against	against	ADP
ct-10123	107	20	pseudomonas	pseudomona	NOUN
ct-10123	107	21	sp	sp	NOUN
ct-10123	107	22	.	.	PUNCT
ct-10123	108	1	the	the	DET
ct-10123	108	2	drug	drug	NOUN
ct-10123	108	3	is	be	AUX
ct-10123	108	4	concentrated	concentrate	VERB
ct-10123	108	5	within	within	ADP
ct-10123	108	6	phagocytic	phagocytic	ADJ
ct-10123	108	7	cells	cell	NOUN
ct-10123	108	8	and	and	CCONJ
ct-10123	108	9	largely	largely	ADV
ct-10123	108	10	excreted	excrete	VERB
ct-10123	108	11	in	in	ADP
ct-10123	108	12	urine	urine	NOUN
ct-10123	108	13	.	.	PUNCT
ct-10123	109	1	protein	protein	NOUN
ct-10123	109	2	synthesis	synthesis	NOUN
ct-10123	109	3	inhibitors	inhibitor	NOUN
ct-10123	109	4	such	such	ADJ
ct-10123	109	5	as	as	ADP
ct-10123	109	6	chloramphenicol	chloramphenicol	NOUN
ct-10123	109	7	and	and	CCONJ
ct-10123	109	8	rna	rna	NOUN
ct-10123	109	9	synthesis	synthesis	NOUN
ct-10123	109	10	inhibitors	inhibitor	NOUN
ct-10123	109	11	such	such	ADJ
ct-10123	109	12	as	as	ADP
ct-10123	109	13	rifampin	rifampin	NOUN
ct-10123	109	14	may	may	AUX
ct-10123	109	15	reduce	reduce	VERB
ct-10123	109	16	efficacy	efficacy	NOUN
ct-10123	109	17	.	.	PUNCT
ct-10123	110	1	resistance	resistance	NOUN
ct-10123	110	2	is	be	AUX
ct-10123	110	3	not	not	PART
ct-10123	110	4	thought	think	VERB
ct-10123	110	5	to	to	PART
ct-10123	110	6	be	be	AUX
ct-10123	110	7	plasmid	plasmid	NOUN
ct-10123	110	8	associated	associate	VERB
ct-10123	110	9	.	.	PUNCT
ct-10123	111	1	enrofloxacin	enrofloxacin	PROPN
ct-10123	111	2	inhibits	inhibit	VERB
ct-10123	111	3	cell	cell	NOUN
ct-10123	111	4	proliferation	proliferation	NOUN
ct-10123	111	5	,	,	PUNCT
ct-10123	111	6	induces	induce	VERB
ct-10123	111	7	morphological	morphological	ADJ
ct-10123	111	8	changes	change	NOUN
ct-10123	111	9	and	and	CCONJ
ct-10123	111	10	alters	alter	VERB
ct-10123	111	11	equine	equine	NOUN
ct-10123	111	12	tendon	tendon	NOUN
ct-10123	111	13	structure	structure	NOUN
ct-10123	111	14	,	,	PUNCT
ct-10123	111	15	more	more	ADV
ct-10123	111	16	pronounced	pronounce	VERB
ct-10123	111	17	in	in	ADP
ct-10123	111	18	juvenile	juvenile	ADJ
ct-10123	111	19	tendon	tendon	NOUN
ct-10123	111	20	cells	cell	NOUN
ct-10123	111	21	.	.	PUNCT
ct-10123	112	1	arthropathies	arthropathy	NOUN
ct-10123	112	2	have	have	AUX
ct-10123	112	3	been	be	AUX
ct-10123	112	4	documented	document	VERB
ct-10123	112	5	in	in	ADP
ct-10123	112	6	two	two	NUM
ct-10123	112	7	-	-	PUNCT
ct-10123	112	8	week	week	NOUN
ct-10123	112	9	old	old	ADJ
ct-10123	112	10	foals	foal	NOUN
ct-10123	112	11	,	,	PUNCT
ct-10123	112	12	though	though	SCONJ
ct-10123	112	13	not	not	PART
ct-10123	112	14	in	in	ADP
ct-10123	112	15	adults	adult	NOUN
ct-10123	112	16	.	.	PUNCT
ct-10123	113	1	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	113	2	are	be	AUX
ct-10123	113	3	not	not	PART
ct-10123	113	4	recommended	recommend	VERB
ct-10123	113	5	in	in	ADP
ct-10123	113	6	pregnant	pregnant	ADJ
ct-10123	113	7	animals	animal	NOUN
ct-10123	113	8	,	,	PUNCT
ct-10123	113	9	though	though	SCONJ
ct-10123	113	10	they	they	PRON
ct-10123	113	11	have	have	AUX
ct-10123	113	12	been	be	AUX
ct-10123	113	13	used	use	VERB
ct-10123	113	14	in	in	ADP
ct-10123	113	15	a	a	DET
ct-10123	113	16	pregnant	pregnant	ADJ
ct-10123	113	17	mare	mare	NOUN
ct-10123	113	18	with	with	ADP
ct-10123	113	19	no	no	DET
ct-10123	113	20	known	know	VERB
ct-10123	113	21	detrimental	detrimental	ADJ
ct-10123	113	22	effect	effect	NOUN
ct-10123	113	23	on	on	ADP
ct-10123	113	24	the	the	DET
ct-10123	113	25	foal.2	foal.2	PROPN
ct-10123	113	26	transient	transient	ADJ
ct-10123	113	27	neurologic	neurologic	ADJ
ct-10123	113	28	signs	sign	NOUN
ct-10123	113	29	have	have	AUX
ct-10123	113	30	been	be	AUX
ct-10123	113	31	seen	see	VERB
ct-10123	113	32	with	with	ADP
ct-10123	113	33	rapid	rapid	ADJ
ct-10123	113	34	administration	administration	NOUN
ct-10123	113	35	.	.	PUNCT
ct-10123	114	1	distribution	distribution	NOUN
ct-10123	114	2	.	.	PUNCT
ct-10123	115	1	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	115	2	are	be	AUX
ct-10123	115	3	widely	widely	ADV
ct-10123	115	4	distributed	distribute	VERB
ct-10123	115	5	.	.	PUNCT
ct-10123	116	1	synergism	synergism	NOUN
ct-10123	116	2	.	.	PUNCT
ct-10123	117	1	fluoroquinolones	fluoroquinolone	NOUN
ct-10123	117	2	are	be	AUX
ct-10123	117	3	synergistic	synergistic	ADJ
ct-10123	117	4	with	with	ADP
ct-10123	117	5	beta	beta	NOUN
ct-10123	117	6	-	-	PUNCT
ct-10123	117	7	lactams	lactam	NOUN
ct-10123	117	8	,	,	PUNCT
ct-10123	117	9	aminoglycosides	aminoglycoside	NOUN
ct-10123	117	10	,	,	PUNCT
ct-10123	117	11	and	and	CCONJ
ct-10123	117	12	vancomycin	vancomycin	PROPN
ct-10123	117	13	.	.	PUNCT
ct-10123	118	1	antagonism	antagonism	NOUN
ct-10123	118	2	.	.	PUNCT
ct-10123	119	1	in	in	ADP
ct-10123	119	2	vitro	vitro	X
ct-10123	119	3	antagonism	antagonism	NOUN
ct-10123	119	4	is	be	AUX
ct-10123	119	5	seen	see	VERB
ct-10123	119	6	between	between	ADP
ct-10123	119	7	ciprofloxacin	ciprofloxacin	NOUN
ct-10123	119	8	and	and	CCONJ
ct-10123	119	9	chloramphenicol	chloramphenicol	NOUN
ct-10123	119	10	and	and	CCONJ
ct-10123	119	11	ciprofloxacin	ciprofloxacin	NOUN
ct-10123	119	12	and	and	CCONJ
ct-10123	119	13	rifampin	rifampin	NOUN
ct-10123	119	14	.	.	PUNCT
ct-10123	120	1	507	507	NUM
ct-10123	120	2	clinical	clinical	ADJ
ct-10123	120	3	theriogenology	theriogenology	NOUN
ct-10123	120	4	•	•	NOUN
ct-10123	120	5	volume	volume	NOUN
ct-10123	120	6	5	5	NUM
ct-10123	120	7	,	,	PUNCT
ct-10123	120	8	number	number	NOUN
ct-10123	120	9	4	4	NUM
ct-10123	120	10	•	•	NOUN
ct-10123	120	11	december	december	PROPN
ct-10123	120	12	2013	2013	NUM
ct-10123	120	13	uses	use	VERB
ct-10123	120	14	in	in	ADP
ct-10123	120	15	reproduction	reproduction	NOUN
ct-10123	120	16	.	.	PUNCT
ct-10123	121	1	systemic	systemic	ADJ
ct-10123	121	2	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	3	(	(	PUNCT
ct-10123	121	4	5	5	NUM
ct-10123	121	5	mg	mg	PROPN
ct-10123	121	6	/	/	SYM
ct-10123	121	7	kg	kg	PROPN
ct-10123	121	8	iv	iv	NOUN
ct-10123	121	9	)	)	PUNCT
ct-10123	121	10	achieved	achieve	VERB
ct-10123	121	11	sufficient	sufficient	ADJ
ct-10123	121	12	endometrial	endometrial	ADJ
ct-10123	121	13	tissue	tissue	NOUN
ct-10123	121	14	concentrations	concentration	NOUN
ct-10123	121	15	to	to	PART
ct-10123	121	16	be	be	AUX
ct-10123	121	17	used	use	VERB
ct-10123	121	18	to	to	PART
ct-10123	121	19	treat	treat	VERB
ct-10123	121	20	endometritis	endometritis	NOUN
ct-10123	121	21	caused	cause	VERB
ct-10123	121	22	by	by	ADP
ct-10123	121	23	susceptible	susceptible	ADJ
ct-10123	121	24	bacteria.17	bacteria.17	NOUN
ct-10123	121	25	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	26	(	(	PUNCT
ct-10123	121	27	5	5	NUM
ct-10123	121	28	mg	mg	PROPN
ct-10123	121	29	/	/	SYM
ct-10123	121	30	kg	kg	PROPN
ct-10123	121	31	iv	iv	X
ct-10123	121	32	)	)	PUNCT
ct-10123	121	33	has	have	AUX
ct-10123	121	34	also	also	ADV
ct-10123	121	35	been	be	AUX
ct-10123	121	36	proposed	propose	VERB
ct-10123	121	37	as	as	ADP
ct-10123	121	38	a	a	DET
ct-10123	121	39	therapeutic	therapeutic	ADJ
ct-10123	121	40	strategy	strategy	NOUN
ct-10123	121	41	for	for	ADP
ct-10123	121	42	the	the	DET
ct-10123	121	43	prevention	prevention	NOUN
ct-10123	121	44	of	of	ADP
ct-10123	121	45	endometritis	endometritis	PROPN
ct-10123	121	46	is	be	AUX
ct-10123	121	47	susceptible	susceptible	ADJ
ct-10123	121	48	mares	mare	NOUN
ct-10123	121	49	with	with	ADP
ct-10123	121	50	a	a	DET
ct-10123	121	51	recommended	recommend	VERB
ct-10123	121	52	dose	dose	NOUN
ct-10123	121	53	(	(	PUNCT
ct-10123	121	54	5	5	NUM
ct-10123	121	55	mg	mg	PROPN
ct-10123	121	56	/	/	SYM
ct-10123	121	57	kg	kg	PROPN
ct-10123	121	58	iv	iv	NOUN
ct-10123	121	59	)	)	PUNCT
ct-10123	121	60	pre	pre	ADJ
ct-10123	121	61	-	-	ADJ
ct-10123	121	62	breeding	breeding	NOUN
ct-10123	121	63	followed	follow	VERB
ct-10123	121	64	by	by	ADP
ct-10123	121	65	two	two	NUM
ct-10123	121	66	further	further	ADJ
ct-10123	121	67	doses	dose	NOUN
ct-10123	121	68	36	36	NUM
ct-10123	121	69	to	to	PART
ct-10123	121	70	48	48	NUM
ct-10123	121	71	hours	hour	NOUN
ct-10123	121	72	post	post	ADJ
ct-10123	121	73	-	-	ADJ
ct-10123	121	74	breeding.18	breeding.18	ADJ
ct-10123	121	75	systemic	systemic	ADJ
ct-10123	121	76	ciprofloxacin	ciprofloxacin	PROPN
ct-10123	121	77	(	(	PUNCT
ct-10123	121	78	2.5	2.5	NUM
ct-10123	121	79	g	g	PROPN
ct-10123	121	80	po	po	PROPN
ct-10123	121	81	sid	sid	PROPN
ct-10123	121	82	)	)	PUNCT
ct-10123	121	83	and	and	CCONJ
ct-10123	121	84	probenecid	probenecid	PROPN
ct-10123	121	85	(	(	PUNCT
ct-10123	121	86	1	1	NUM
ct-10123	121	87	g	g	PROPN
ct-10123	121	88	po	po	PROPN
ct-10123	121	89	sid	sid	PROPN
ct-10123	121	90	)	)	PUNCT
ct-10123	121	91	has	have	AUX
ct-10123	121	92	been	be	AUX
ct-10123	121	93	reported	report	VERB
ct-10123	121	94	to	to	PART
ct-10123	121	95	effective	effective	ADJ
ct-10123	121	96	against	against	ADP
ct-10123	121	97	pseudomonas	pseudomona	NOUN
ct-10123	121	98	infection.19	infection.19	NOUN
ct-10123	121	99	intrauterine	intrauterine	ADJ
ct-10123	121	100	infusion	infusion	NOUN
ct-10123	121	101	of	of	ADP
ct-10123	121	102	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	103	has	have	AUX
ct-10123	121	104	been	be	AUX
ct-10123	121	105	evaluated	evaluate	VERB
ct-10123	121	106	with	with	ADP
ct-10123	121	107	one	one	NUM
ct-10123	121	108	author	author	NOUN
ct-10123	121	109	reporting	report	VERB
ct-10123	121	110	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	111	concentrations	concentration	NOUN
ct-10123	121	112	remaining	remain	VERB
ct-10123	121	113	above	above	ADP
ct-10123	121	114	mic	mic	NOUN
ct-10123	121	115	for	for	ADP
ct-10123	121	116	susceptible	susceptible	ADJ
ct-10123	121	117	bacteria	bacteria	NOUN
ct-10123	121	118	24	24	NUM
ct-10123	121	119	hours	hour	NOUN
ct-10123	121	120	after	after	ADP
ct-10123	121	121	infusion	infusion	NOUN
ct-10123	121	122	of	of	ADP
ct-10123	121	123	2.5	2.5	NUM
ct-10123	121	124	mg	mg	NOUN
ct-10123	121	125	/	/	SYM
ct-10123	121	126	kg	kg	PROPN
ct-10123	121	127	enrofloxacin.20	enrofloxacin.20	NOUN
ct-10123	121	128	a	a	DET
ct-10123	121	129	more	more	ADV
ct-10123	121	130	recent	recent	ADJ
ct-10123	121	131	study	study	NOUN
ct-10123	121	132	found	find	VERB
ct-10123	121	133	endometrial	endometrial	ADJ
ct-10123	121	134	biopsy	biopsy	NOUN
ct-10123	121	135	grades	grade	NOUN
ct-10123	121	136	worsening	worsen	VERB
ct-10123	121	137	from	from	ADP
ct-10123	121	138	kenney	kenney	PROPN
ct-10123	121	139	doig	doig	PROPN
ct-10123	121	140	grade	grade	PROPN
ct-10123	121	141	i	i	PROPN
ct-10123	121	142	to	to	ADP
ct-10123	121	143	grade	grade	NOUN
ct-10123	121	144	iii	iii	NOUN
ct-10123	121	145	over	over	ADP
ct-10123	121	146	a	a	DET
ct-10123	121	147	60	60	NUM
ct-10123	121	148	day	day	NOUN
ct-10123	121	149	period	period	NOUN
ct-10123	121	150	following	follow	VERB
ct-10123	121	151	intrauterine	intrauterine	ADJ
ct-10123	121	152	infusion	infusion	NOUN
ct-10123	121	153	of	of	ADP
ct-10123	121	154	2.5	2.5	NUM
ct-10123	121	155	mg	mg	NOUN
ct-10123	121	156	/	/	SYM
ct-10123	121	157	kg	kg	PROPN
ct-10123	121	158	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	159	daily	daily	ADV
ct-10123	121	160	for	for	ADP
ct-10123	121	161	three	three	NUM
ct-10123	121	162	days	day	NOUN
ct-10123	121	163	and	and	CCONJ
ct-10123	121	164	concluded	conclude	VERB
ct-10123	121	165	that	that	SCONJ
ct-10123	121	166	enrofloxacin	enrofloxacin	PROPN
ct-10123	121	167	is	be	AUX
ct-10123	121	168	not	not	PART
ct-10123	121	169	suitable	suitable	ADJ
ct-10123	121	170	for	for	ADP
ct-10123	121	171	conventional	conventional	ADJ
ct-10123	121	172	intrauterine	intrauterine	ADJ
ct-10123	121	173	infusion	infusion	NOUN
ct-10123	121	174	treatment	treatment	NOUN
ct-10123	121	175	in	in	ADP
ct-10123	121	176	mares.21	mares.21	PROPN
ct-10123	121	177	nitroimidazole	nitroimidazole	PROPN
ct-10123	121	178	a	a	DET
ct-10123	121	179	commonly	commonly	ADV
ct-10123	121	180	used	use	VERB
ct-10123	121	181	formulation	formulation	NOUN
ct-10123	121	182	is	be	AUX
ct-10123	121	183	metronidazole	metronidazole	NOUN
ct-10123	121	184	.	.	PUNCT
ct-10123	122	1	mechanism	mechanism	NOUN
ct-10123	122	2	of	of	ADP
ct-10123	122	3	action	action	NOUN
ct-10123	122	4	.	.	PUNCT
ct-10123	123	1	metronidazole	metronidazole	NOUN
ct-10123	123	2	undergoes	undergoe	NOUN
ct-10123	123	3	reduction	reduction	NOUN
ct-10123	123	4	of	of	ADP
ct-10123	123	5	the	the	DET
ct-10123	123	6	nitro	nitro	NOUN
ct-10123	123	7	group	group	NOUN
ct-10123	123	8	to	to	PART
ct-10123	123	9	yield	yield	VERB
ct-10123	123	10	unstable	unstable	ADJ
ct-10123	123	11	intermediates	intermediate	NOUN
ct-10123	123	12	some	some	PRON
ct-10123	123	13	of	of	ADP
ct-10123	123	14	which	which	PRON
ct-10123	123	15	interact	interact	VERB
ct-10123	123	16	with	with	ADP
ct-10123	123	17	bacterial	bacterial	ADJ
ct-10123	123	18	or	or	CCONJ
ct-10123	123	19	protozoal	protozoal	NOUN
ct-10123	123	20	dna	dna	NOUN
ct-10123	124	1	;	;	PUNCT
ct-10123	124	2	the	the	DET
ct-10123	124	3	reduction	reduction	NOUN
ct-10123	124	4	occurs	occur	VERB
ct-10123	124	5	under	under	ADP
ct-10123	124	6	anaerobic	anaerobic	ADJ
ct-10123	124	7	conditions	condition	NOUN
ct-10123	124	8	.	.	PUNCT
ct-10123	125	1	resistance	resistance	NOUN
ct-10123	125	2	is	be	AUX
ct-10123	125	3	rare	rare	ADJ
ct-10123	125	4	among	among	ADP
ct-10123	125	5	usually	usually	ADV
ct-10123	125	6	susceptible	susceptible	ADJ
ct-10123	125	7	bacteria	bacteria	NOUN
ct-10123	125	8	.	.	PUNCT
ct-10123	126	1	anorexia	anorexia	PROPN
ct-10123	126	2	can	can	AUX
ct-10123	126	3	be	be	AUX
ct-10123	126	4	seen	see	VERB
ct-10123	126	5	with	with	ADP
ct-10123	126	6	oral	oral	ADJ
ct-10123	126	7	use	use	NOUN
ct-10123	126	8	.	.	PUNCT
ct-10123	127	1	occasional	occasional	ADJ
ct-10123	127	2	neurological	neurological	ADJ
ct-10123	127	3	signs	sign	NOUN
ct-10123	127	4	have	have	AUX
ct-10123	127	5	been	be	AUX
ct-10123	127	6	reported	report	VERB
ct-10123	127	7	in	in	ADP
ct-10123	127	8	other	other	ADJ
ct-10123	127	9	species	specie	NOUN
ct-10123	127	10	with	with	ADP
ct-10123	127	11	recovery	recovery	NOUN
ct-10123	127	12	facilitated	facilitate	VERB
ct-10123	127	13	by	by	ADP
ct-10123	127	14	diazepam	diazepam	NOUN
ct-10123	127	15	.	.	PUNCT
ct-10123	128	1	distribution	distribution	NOUN
ct-10123	128	2	.	.	PUNCT
ct-10123	129	1	metronidazole	metronidazole	NOUN
ct-10123	129	2	is	be	AUX
ct-10123	129	3	rapidly	rapidly	ADV
ct-10123	129	4	and	and	CCONJ
ct-10123	129	5	well	well	ADV
ct-10123	129	6	absorbed	absorb	VERB
ct-10123	129	7	and	and	CCONJ
ct-10123	129	8	lipophilic	lipophilic	ADJ
ct-10123	129	9	.	.	PUNCT
ct-10123	130	1	it	it	PRON
ct-10123	130	2	is	be	AUX
ct-10123	130	3	metabolized	metabolize	VERB
ct-10123	130	4	in	in	ADP
ct-10123	130	5	the	the	DET
ct-10123	130	6	liver	liver	NOUN
ct-10123	130	7	and	and	CCONJ
ct-10123	130	8	eliminated	eliminate	VERB
ct-10123	130	9	in	in	ADP
ct-10123	130	10	the	the	DET
ct-10123	130	11	urine	urine	NOUN
ct-10123	130	12	and	and	CCONJ
ct-10123	130	13	manure	manure	NOUN
ct-10123	130	14	.	.	PUNCT
ct-10123	131	1	hepatic	hepatic	ADJ
ct-10123	131	2	metabolism	metabolism	NOUN
ct-10123	131	3	may	may	AUX
ct-10123	131	4	be	be	AUX
ct-10123	131	5	decreased	decrease	VERB
ct-10123	131	6	when	when	SCONJ
ct-10123	131	7	concurrent	concurrent	ADJ
ct-10123	131	8	with	with	ADP
ct-10123	131	9	cimetidine	cimetidine	NOUN
ct-10123	131	10	,	,	PUNCT
ct-10123	131	11	thus	thus	ADV
ct-10123	131	12	delaying	delay	VERB
ct-10123	131	13	elimination	elimination	NOUN
ct-10123	131	14	.	.	PUNCT
ct-10123	132	1	uses	use	VERB
ct-10123	132	2	in	in	ADP
ct-10123	132	3	reproduction	reproduction	NOUN
ct-10123	132	4	.	.	PUNCT
ct-10123	133	1	uncommonly	uncommonly	ADV
ct-10123	133	2	used	use	VERB
ct-10123	133	3	unless	unless	SCONJ
ct-10123	133	4	an	an	DET
ct-10123	133	5	anaerobic	anaerobic	NOUN
ct-10123	133	6	infection	infection	NOUN
ct-10123	133	7	in	in	ADP
ct-10123	133	8	suspected	suspect	VERB
ct-10123	133	9	.	.	PUNCT
ct-10123	134	1	after	after	ADP
ct-10123	134	2	systemic	systemic	ADJ
ct-10123	134	3	administration	administration	NOUN
ct-10123	134	4	of	of	ADP
ct-10123	134	5	metronidazole	metronidazole	NOUN
ct-10123	134	6	(	(	PUNCT
ct-10123	134	7	15	15	NUM
ct-10123	134	8	mg	mg	PROPN
ct-10123	134	9	/	/	SYM
ct-10123	134	10	kg	kg	NOUN
ct-10123	134	11	loading	loading	NOUN
ct-10123	134	12	followed	follow	VERB
ct-10123	134	13	by	by	ADP
ct-10123	134	14	7.5	7.5	NUM
ct-10123	134	15	mg	mg	NUM
ct-10123	134	16	/	/	SYM
ct-10123	134	17	kg	kg	NOUN
ct-10123	134	18	q6h	q6h	NOUN
ct-10123	134	19	via	via	ADP
ct-10123	134	20	nasogastric	nasogastric	ADJ
ct-10123	134	21	tube	tube	NOUN
ct-10123	134	22	)	)	PUNCT
ct-10123	134	23	,	,	PUNCT
ct-10123	134	24	the	the	DET
ct-10123	134	25	mean	mean	ADJ
ct-10123	134	26	endometrial	endometrial	ADJ
ct-10123	134	27	concentration	concentration	NOUN
ct-10123	134	28	of	of	ADP
ct-10123	134	29	metronidazole	metronidazole	NOUN
ct-10123	134	30	was	be	AUX
ct-10123	134	31	approximately	approximately	ADV
ct-10123	134	32	0.9	0.9	NUM
ct-10123	134	33	micrograms	microgram	NOUN
ct-10123	134	34	/	/	SYM
ct-10123	134	35	ml.22	ml.22	NOUN
ct-10123	134	36	rifamycins	rifamycin	VERB
ct-10123	134	37	a	a	DET
ct-10123	134	38	commonly	commonly	ADV
ct-10123	134	39	used	use	VERB
ct-10123	134	40	formulation	formulation	NOUN
ct-10123	134	41	is	be	AUX
ct-10123	134	42	rifampin	rifampin	NOUN
ct-10123	134	43	.	.	PUNCT
ct-10123	135	1	mechanism	mechanism	NOUN
ct-10123	135	2	of	of	ADP
ct-10123	135	3	action	action	NOUN
ct-10123	135	4	.	.	PUNCT
ct-10123	136	1	rifampin	rifampin	PROPN
ct-10123	136	2	is	be	AUX
ct-10123	136	3	bactericidal	bactericidal	ADJ
ct-10123	136	4	,	,	PUNCT
ct-10123	136	5	broad	broad	ADJ
ct-10123	136	6	spectrum	spectrum	NOUN
ct-10123	136	7	,	,	PUNCT
ct-10123	136	8	and	and	CCONJ
ct-10123	136	9	active	active	ADJ
ct-10123	136	10	against	against	ADP
ct-10123	136	11	both	both	CCONJ
ct-10123	136	12	extracellular	extracellular	ADJ
ct-10123	136	13	and	and	CCONJ
ct-10123	136	14	intracellular	intracellular	ADJ
ct-10123	136	15	pathogens	pathogen	NOUN
ct-10123	136	16	.	.	PUNCT
ct-10123	137	1	it	it	PRON
ct-10123	137	2	inhibits	inhibit	VERB
ct-10123	137	3	dna	dna	PROPN
ct-10123	137	4	-	-	PUNCT
ct-10123	137	5	dependent	dependent	ADJ
ct-10123	137	6	rna	rna	NOUN
ct-10123	137	7	polymerase	polymerase	NOUN
ct-10123	137	8	.	.	PUNCT
ct-10123	138	1	because	because	SCONJ
ct-10123	138	2	of	of	ADP
ct-10123	138	3	rapid	rapid	ADJ
ct-10123	138	4	development	development	NOUN
ct-10123	138	5	of	of	ADP
ct-10123	138	6	resistance	resistance	NOUN
ct-10123	138	7	,	,	PUNCT
ct-10123	138	8	rifampin	rifampin	NOUN
ct-10123	138	9	is	be	AUX
ct-10123	138	10	usually	usually	ADV
ct-10123	138	11	administered	administer	VERB
ct-10123	138	12	in	in	ADP
ct-10123	138	13	conjunction	conjunction	NOUN
ct-10123	138	14	with	with	ADP
ct-10123	138	15	other	other	ADJ
ct-10123	138	16	antimicrobials	antimicrobial	NOUN
ct-10123	138	17	.	.	PUNCT
ct-10123	139	1	distribution	distribution	NOUN
ct-10123	139	2	.	.	PUNCT
ct-10123	140	1	rifampin	rifampin	NOUN
ct-10123	140	2	is	be	AUX
ct-10123	140	3	very	very	ADV
ct-10123	140	4	lipophilic	lipophilic	ADJ
ct-10123	140	5	and	and	CCONJ
ct-10123	140	6	penetrates	penetrate	VERB
ct-10123	140	7	most	most	ADJ
ct-10123	140	8	tissues	tissue	NOUN
ct-10123	140	9	including	include	VERB
ct-10123	140	10	abscesses	abscess	NOUN
ct-10123	140	11	,	,	PUNCT
ct-10123	140	12	bone	bone	NOUN
ct-10123	140	13	,	,	PUNCT
ct-10123	140	14	milk	milk	NOUN
ct-10123	140	15	and	and	CCONJ
ct-10123	140	16	the	the	DET
ct-10123	140	17	central	central	ADJ
ct-10123	140	18	nervous	nervous	ADJ
ct-10123	140	19	system	system	NOUN
ct-10123	140	20	.	.	PUNCT
ct-10123	141	1	rifampin	rifampin	PROPN
ct-10123	141	2	crosses	cross	VERB
ct-10123	141	3	the	the	DET
ct-10123	141	4	placenta	placenta	NOUN
ct-10123	141	5	and	and	CCONJ
ct-10123	141	6	is	be	AUX
ct-10123	141	7	teratogenic	teratogenic	ADJ
ct-10123	141	8	in	in	ADP
ct-10123	141	9	rodents	rodent	NOUN
ct-10123	141	10	.	.	PUNCT
ct-10123	142	1	rifampin	rifampin	NOUN
ct-10123	142	2	is	be	AUX
ct-10123	142	3	eliminated	eliminate	VERB
ct-10123	142	4	via	via	ADP
ct-10123	142	5	the	the	DET
ct-10123	142	6	liver	liver	NOUN
ct-10123	142	7	.	.	PUNCT
ct-10123	143	1	uses	use	VERB
ct-10123	143	2	in	in	ADP
ct-10123	143	3	reproduction	reproduction	NOUN
ct-10123	143	4	.	.	PUNCT
ct-10123	144	1	uncommonly	uncommonly	ADV
ct-10123	144	2	used	use	VERB
ct-10123	144	3	in	in	ADP
ct-10123	144	4	reproduction	reproduction	NOUN
ct-10123	144	5	but	but	CCONJ
ct-10123	144	6	can	can	AUX
ct-10123	144	7	be	be	AUX
ct-10123	144	8	useful	useful	ADJ
ct-10123	144	9	in	in	ADP
ct-10123	144	10	reproductive	reproductive	ADJ
ct-10123	144	11	tract	tract	NOUN
ct-10123	144	12	associated	associate	VERB
ct-10123	144	13	abscesses	abscess	NOUN
ct-10123	144	14	(	(	PUNCT
ct-10123	144	15	e.g.	e.g.	ADV
ct-10123	144	16	abscessed	abscesse	VERB
ct-10123	144	17	broad	broad	ADJ
ct-10123	144	18	ligament	ligament	NOUN
ct-10123	144	19	hematomas	hematoma	NOUN
ct-10123	144	20	or	or	CCONJ
ct-10123	144	21	retroperitoneal	retroperitoneal	ADJ
ct-10123	144	22	abscesses	abscess	NOUN
ct-10123	144	23	)	)	PUNCT
ct-10123	144	24	.	.	PUNCT
ct-10123	145	1	antifungals	antifungal	VERB
ct-10123	145	2	the	the	DET
ct-10123	145	3	main	main	ADJ
ct-10123	145	4	sites	site	NOUN
ct-10123	145	5	of	of	ADP
ct-10123	145	6	action	action	NOUN
ct-10123	145	7	of	of	ADP
ct-10123	145	8	antifungal	antifungal	ADJ
ct-10123	145	9	drugs	drug	NOUN
ct-10123	145	10	are	be	AUX
ct-10123	145	11	the	the	DET
ct-10123	145	12	cytoplasmic	cytoplasmic	ADJ
ct-10123	145	13	membrane	membrane	NOUN
ct-10123	145	14	(	(	PUNCT
ct-10123	145	15	polyenes	polyene	NOUN
ct-10123	145	16	,	,	PUNCT
ct-10123	145	17	azoles	azole	NOUN
ct-10123	145	18	)	)	PUNCT
ct-10123	145	19	,	,	PUNCT
ct-10123	145	20	the	the	DET
ct-10123	145	21	cell	cell	NOUN
ct-10123	145	22	wall	wall	NOUN
ct-10123	145	23	,	,	PUNCT
ct-10123	145	24	and	and	CCONJ
ct-10123	145	25	dna	dna	NOUN
ct-10123	145	26	or	or	CCONJ
ct-10123	145	27	protein	protein	NOUN
ct-10123	145	28	synthesis	synthesis	NOUN
ct-10123	145	29	.	.	PUNCT
ct-10123	146	1	polyenes	polyene	NOUN
ct-10123	146	2	commonly	commonly	ADV
ct-10123	146	3	used	use	VERB
ct-10123	146	4	formulations	formulation	NOUN
ct-10123	146	5	are	be	AUX
ct-10123	146	6	amphotericin	amphotericin	VERB
ct-10123	146	7	b	b	ADP
ct-10123	146	8	,	,	PUNCT
ct-10123	146	9	natamycin	natamycin	NOUN
ct-10123	146	10	,	,	PUNCT
ct-10123	146	11	and	and	CCONJ
ct-10123	146	12	nystatin	nystatin	NOUN
ct-10123	146	13	.	.	PUNCT
ct-10123	147	1	508clinical	508clinical	ADJ
ct-10123	147	2	theriogenology	theriogenology	NOUN
ct-10123	147	3	•	•	NOUN
ct-10123	147	4	volume	volume	NOUN
ct-10123	147	5	5	5	NUM
ct-10123	147	6	,	,	PUNCT
ct-10123	147	7	number	number	NOUN
ct-10123	147	8	4	4	NUM
ct-10123	147	9	•	•	NOUN
ct-10123	147	10	december	december	PROPN
ct-10123	147	11	2013	2013	NUM
ct-10123	147	12	mechanism	mechanism	NOUN
ct-10123	147	13	of	of	ADP
ct-10123	147	14	action	action	NOUN
ct-10123	147	15	.	.	PUNCT
ct-10123	148	1	polyenes	polyene	NOUN
ct-10123	148	2	bind	bind	VERB
ct-10123	148	3	ergosterol	ergosterol	NOUN
ct-10123	148	4	,	,	PUNCT
ct-10123	148	5	the	the	DET
ct-10123	148	6	principal	principal	ADJ
ct-10123	148	7	sterol	sterol	NOUN
ct-10123	148	8	of	of	ADP
ct-10123	148	9	the	the	DET
ct-10123	148	10	fungal	fungal	ADJ
ct-10123	148	11	cell	cell	NOUN
ct-10123	148	12	membrane	membrane	NOUN
ct-10123	148	13	,	,	PUNCT
ct-10123	148	14	causing	cause	VERB
ct-10123	148	15	leakage	leakage	NOUN
ct-10123	148	16	of	of	ADP
ct-10123	148	17	cell	cell	NOUN
ct-10123	148	18	contents	content	NOUN
ct-10123	148	19	.	.	PUNCT
ct-10123	149	1	they	they	PRON
ct-10123	149	2	also	also	ADV
ct-10123	149	3	bind	bind	VERB
ct-10123	149	4	cholesterol	cholesterol	NOUN
ct-10123	149	5	in	in	ADP
ct-10123	149	6	mammalian	mammalian	ADJ
ct-10123	149	7	cell	cell	NOUN
ct-10123	149	8	membranes	membrane	NOUN
ct-10123	149	9	(	(	PUNCT
ct-10123	149	10	less	less	ADV
ct-10123	149	11	avidly	avidly	ADV
ct-10123	149	12	)	)	PUNCT
ct-10123	149	13	which	which	PRON
ct-10123	149	14	makes	make	VERB
ct-10123	149	15	them	they	PRON
ct-10123	149	16	the	the	DET
ct-10123	149	17	most	most	ADV
ct-10123	149	18	toxic	toxic	ADJ
ct-10123	149	19	of	of	ADP
ct-10123	149	20	clinically	clinically	ADV
ct-10123	149	21	used	use	VERB
ct-10123	149	22	antifungals	antifungal	NOUN
ct-10123	149	23	.	.	PUNCT
ct-10123	150	1	polyenes	polyene	NOUN
ct-10123	150	2	are	be	AUX
ct-10123	150	3	associated	associate	VERB
ct-10123	150	4	with	with	ADP
ct-10123	150	5	renal	renal	ADJ
ct-10123	150	6	toxicity	toxicity	NOUN
ct-10123	150	7	.	.	PUNCT
ct-10123	151	1	amphotericin	amphotericin	ADP
ct-10123	151	2	b	b	X
ct-10123	151	3	is	be	AUX
ct-10123	151	4	the	the	DET
ct-10123	151	5	mainstay	mainstay	NOUN
ct-10123	151	6	for	for	ADP
ct-10123	151	7	systemic	systemic	ADJ
ct-10123	151	8	fungicidal	fungicidal	ADJ
ct-10123	151	9	treatment	treatment	NOUN
ct-10123	151	10	of	of	ADP
ct-10123	151	11	filamentous	filamentous	ADJ
ct-10123	151	12	fungal	fungal	ADJ
ct-10123	151	13	infection	infection	NOUN
ct-10123	151	14	.	.	PUNCT
ct-10123	152	1	it	it	PRON
ct-10123	152	2	is	be	AUX
ct-10123	152	3	poorly	poorly	ADV
ct-10123	152	4	soluble	soluble	ADJ
ct-10123	152	5	in	in	ADP
ct-10123	152	6	water	water	NOUN
ct-10123	152	7	,	,	PUNCT
ct-10123	152	8	unstable	unstable	ADJ
ct-10123	152	9	at	at	ADP
ct-10123	152	10	37	37	NUM
ct-10123	152	11	°	°	NOUN
ct-10123	152	12	c	c	NOUN
ct-10123	152	13	,	,	PUNCT
ct-10123	152	14	with	with	ADP
ct-10123	152	15	maximal	maximal	ADJ
ct-10123	152	16	antifungal	antifungal	ADJ
ct-10123	152	17	effects	effect	NOUN
ct-10123	152	18	at	at	ADP
ct-10123	152	19	ph	ph	PROPN
ct-10123	152	20	6	6	NUM
ct-10123	152	21	-	-	SYM
ct-10123	152	22	7.5	7.5	NUM
ct-10123	152	23	,	,	PUNCT
ct-10123	152	24	and	and	CCONJ
ct-10123	152	25	decreased	decrease	VERB
ct-10123	152	26	effects	effect	NOUN
ct-10123	152	27	at	at	ADP
ct-10123	152	28	low	low	ADJ
ct-10123	152	29	ph	ph	NOUN
ct-10123	152	30	.	.	PROPN
ct-10123	152	31	amphotericin	amphotericin	ADP
ct-10123	152	32	b	b	NOUN
ct-10123	152	33	is	be	AUX
ct-10123	152	34	not	not	PART
ct-10123	152	35	well	well	ADV
ct-10123	152	36	absorbed	absorb	VERB
ct-10123	152	37	orally	orally	ADV
ct-10123	152	38	and	and	CCONJ
ct-10123	152	39	is	be	AUX
ct-10123	152	40	thus	thus	ADV
ct-10123	152	41	intravenously	intravenously	ADV
ct-10123	152	42	administered	administer	VERB
ct-10123	152	43	.	.	PUNCT
ct-10123	153	1	nystatin	nystatin	PROPN
ct-10123	153	2	has	have	VERB
ct-10123	153	3	greater	great	ADJ
ct-10123	153	4	nephrotoxicity	nephrotoxicity	NOUN
ct-10123	153	5	and	and	CCONJ
ct-10123	153	6	is	be	AUX
ct-10123	153	7	thus	thus	ADV
ct-10123	153	8	used	use	VERB
ct-10123	153	9	topically	topically	ADV
ct-10123	153	10	(	(	PUNCT
ct-10123	153	11	e.g.	e.g.	ADV
ct-10123	153	12	intrauterine	intrauterine	NOUN
ct-10123	153	13	)	)	PUNCT
ct-10123	153	14	.	.	PUNCT
ct-10123	154	1	uses	use	VERB
ct-10123	154	2	in	in	ADP
ct-10123	154	3	reproduction	reproduction	NOUN
ct-10123	154	4	.	.	PUNCT
ct-10123	155	1	polyenes	polyene	NOUN
ct-10123	155	2	are	be	AUX
ct-10123	155	3	a	a	DET
ct-10123	155	4	reasonable	reasonable	ADJ
ct-10123	155	5	first	first	ADJ
ct-10123	155	6	choice	choice	NOUN
ct-10123	155	7	for	for	ADP
ct-10123	155	8	treatment	treatment	NOUN
ct-10123	155	9	of	of	ADP
ct-10123	155	10	fungal	fungal	ADJ
ct-10123	155	11	endometritis	endometritis	NOUN
ct-10123	155	12	caused	cause	VERB
ct-10123	155	13	by	by	ADP
ct-10123	155	14	yeast	yeast	NOUN
ct-10123	155	15	.	.	PUNCT
ct-10123	156	1	molds	mold	NOUN
ct-10123	156	2	are	be	AUX
ct-10123	156	3	most	most	ADV
ct-10123	156	4	susceptible	susceptible	ADJ
ct-10123	156	5	to	to	ADP
ct-10123	156	6	polyenes	polyene	NOUN
ct-10123	156	7	and	and	CCONJ
ct-10123	156	8	less	less	ADV
ct-10123	156	9	susceptible	susceptible	ADJ
ct-10123	156	10	to	to	ADP
ct-10123	156	11	imidazoles	imidazole	NOUN
ct-10123	156	12	and	and	CCONJ
ct-10123	156	13	triazoles.23	triazoles.23	PROPN
ct-10123	156	14	azoles	azole	NOUN
ct-10123	156	15	commonly	commonly	ADV
ct-10123	156	16	used	use	VERB
ct-10123	156	17	formulations	formulation	NOUN
ct-10123	156	18	are	be	AUX
ct-10123	156	19	imidazoles	imidazole	NOUN
ct-10123	156	20	(	(	PUNCT
ct-10123	156	21	clotrimazole	clotrimazole	NOUN
ct-10123	156	22	,	,	PUNCT
ct-10123	156	23	ketoconazole	ketoconazole	NOUN
ct-10123	156	24	,	,	PUNCT
ct-10123	156	25	and	and	CCONJ
ct-10123	156	26	miconazole	miconazole	NOUN
ct-10123	156	27	)	)	PUNCT
ct-10123	156	28	and	and	CCONJ
ct-10123	156	29	triazoles	triazole	NOUN
ct-10123	156	30	(	(	PUNCT
ct-10123	156	31	itraconazole	itraconazole	NOUN
ct-10123	156	32	,	,	PUNCT
ct-10123	156	33	fluconazole	fluconazole	NOUN
ct-10123	156	34	,	,	PUNCT
ct-10123	156	35	and	and	CCONJ
ct-10123	156	36	voriconazole	voriconazole	NOUN
ct-10123	156	37	)	)	PUNCT
ct-10123	156	38	.	.	PUNCT
ct-10123	157	1	mechanism	mechanism	NOUN
ct-10123	157	2	of	of	ADP
ct-10123	157	3	action	action	NOUN
ct-10123	157	4	.	.	PUNCT
ct-10123	158	1	azoles	azole	NOUN
ct-10123	158	2	inhibit	inhibit	VERB
ct-10123	158	3	cytochrome	cytochrome	NOUN
ct-10123	158	4	p450	p450	NUM
ct-10123	158	5	dependent	dependent	ADJ
ct-10123	158	6	ergosterol	ergosterol	NOUN
ct-10123	158	7	synthesis	synthesis	NOUN
ct-10123	158	8	leading	lead	VERB
ct-10123	158	9	to	to	ADP
ct-10123	158	10	disruption	disruption	NOUN
ct-10123	158	11	of	of	ADP
ct-10123	158	12	fungal	fungal	ADJ
ct-10123	158	13	membranes	membrane	NOUN
ct-10123	158	14	.	.	PUNCT
ct-10123	159	1	azoles	azole	NOUN
ct-10123	159	2	are	be	AUX
ct-10123	159	3	fungistatic	fungistatic	ADJ
ct-10123	159	4	,	,	PUNCT
ct-10123	159	5	but	but	CCONJ
ct-10123	159	6	fungicidal	fungicidal	NOUN
ct-10123	159	7	at	at	ADP
ct-10123	159	8	high	high	ADJ
ct-10123	159	9	concentrations	concentration	NOUN
ct-10123	159	10	.	.	PUNCT
ct-10123	160	1	ketoconazole	ketoconazole	NOUN
ct-10123	160	2	is	be	AUX
ct-10123	160	3	poorly	poorly	ADV
ct-10123	160	4	water	water	NOUN
ct-10123	160	5	soluble	soluble	ADJ
ct-10123	160	6	,	,	PUNCT
ct-10123	160	7	lipophilic	lipophilic	NOUN
ct-10123	160	8	,	,	PUNCT
ct-10123	160	9	requires	require	VERB
ct-10123	160	10	acid	acid	NOUN
ct-10123	160	11	ph	ph	VERB
ct-10123	160	12	,	,	PUNCT
ct-10123	160	13	requires	require	VERB
ct-10123	160	14	nasogastric	nasogastric	ADJ
ct-10123	160	15	tube	tube	NOUN
ct-10123	160	16	administration	administration	NOUN
ct-10123	160	17	(	(	PUNCT
ct-10123	160	18	if	if	SCONJ
ct-10123	160	19	administered	administer	VERB
ct-10123	160	20	in	in	ADP
ct-10123	160	21	conjunction	conjunction	NOUN
ct-10123	160	22	with	with	ADP
ct-10123	160	23	hcl	hcl	PROPN
ct-10123	160	24	as	as	SCONJ
ct-10123	160	25	recommended	recommend	VERB
ct-10123	160	26	,	,	PUNCT
ct-10123	160	27	the	the	DET
ct-10123	160	28	suspension	suspension	NOUN
ct-10123	160	29	can	can	AUX
ct-10123	160	30	be	be	AUX
ct-10123	160	31	irritating	irritate	VERB
ct-10123	160	32	to	to	ADP
ct-10123	160	33	the	the	DET
ct-10123	160	34	oral	oral	ADJ
ct-10123	160	35	cavity	cavity	NOUN
ct-10123	160	36	and	and	CCONJ
ct-10123	160	37	throat	throat	NOUN
ct-10123	160	38	)	)	PUNCT
ct-10123	160	39	.	.	PUNCT
ct-10123	161	1	oral	oral	ADJ
ct-10123	161	2	administration	administration	NOUN
ct-10123	161	3	at	at	ADP
ct-10123	161	4	30	30	NUM
ct-10123	161	5	mg	mg	PROPN
ct-10123	161	6	/	/	SYM
ct-10123	161	7	kg	kg	PROPN
ct-10123	161	8	does	do	AUX
ct-10123	161	9	not	not	PART
ct-10123	161	10	result	result	VERB
ct-10123	161	11	in	in	ADP
ct-10123	161	12	detectable	detectable	ADJ
ct-10123	161	13	serum	serum	NOUN
ct-10123	161	14	concentrations.2	concentrations.2	PROPN
ct-10123	161	15	itraconazole	itraconazole	NOUN
ct-10123	161	16	is	be	AUX
ct-10123	161	17	poorly	poorly	ADV
ct-10123	161	18	water	water	NOUN
ct-10123	161	19	soluble	soluble	ADJ
ct-10123	161	20	,	,	PUNCT
ct-10123	161	21	lipophilic	lipophilic	ADJ
ct-10123	161	22	,	,	PUNCT
ct-10123	161	23	and	and	CCONJ
ct-10123	161	24	requires	require	VERB
ct-10123	161	25	acid	acid	NOUN
ct-10123	161	26	ph	ph	NOUN
ct-10123	161	27	for	for	ADP
ct-10123	161	28	absorption	absorption	NOUN
ct-10123	161	29	.	.	PUNCT
ct-10123	162	1	fluconazole	fluconazole	NOUN
ct-10123	162	2	is	be	AUX
ct-10123	162	3	water	water	NOUN
ct-10123	162	4	soluble	soluble	ADJ
ct-10123	162	5	,	,	PUNCT
ct-10123	162	6	oral	oral	ADJ
ct-10123	162	7	absorption	absorption	NOUN
ct-10123	162	8	is	be	AUX
ct-10123	162	9	unaffected	unaffected	ADJ
ct-10123	162	10	by	by	ADP
ct-10123	162	11	acid	acid	NOUN
ct-10123	162	12	and	and	CCONJ
ct-10123	162	13	it	it	PRON
ct-10123	162	14	is	be	AUX
ct-10123	162	15	well	well	ADV
ct-10123	162	16	absorbed	absorb	VERB
ct-10123	162	17	after	after	ADP
ct-10123	162	18	oral	oral	ADJ
ct-10123	162	19	administration	administration	NOUN
ct-10123	162	20	,	,	PUNCT
ct-10123	162	21	it	it	PRON
ct-10123	162	22	distributes	distribute	VERB
ct-10123	162	23	widely	widely	ADV
ct-10123	162	24	to	to	ADP
ct-10123	162	25	tissues	tissue	NOUN
ct-10123	162	26	with	with	ADP
ct-10123	162	27	the	the	DET
ct-10123	162	28	half	half	ADJ
ct-10123	162	29	-	-	PUNCT
ct-10123	162	30	life	life	NOUN
ct-10123	162	31	in	in	ADP
ct-10123	162	32	horses	horse	NOUN
ct-10123	162	33	~40	~40	NUM
ct-10123	162	34	hours	hour	NOUN
ct-10123	162	35	,	,	PUNCT
ct-10123	162	36	and	and	CCONJ
ct-10123	162	37	with	with	ADP
ct-10123	162	38	100	100	NUM
ct-10123	162	39	%	%	NOUN
ct-10123	162	40	oral	oral	ADJ
ct-10123	162	41	bioavailability	bioavailability	NOUN
ct-10123	162	42	.	.	PUNCT
ct-10123	163	1	it	it	PRON
ct-10123	163	2	can	can	AUX
ct-10123	163	3	be	be	AUX
ct-10123	163	4	administered	administer	VERB
ct-10123	163	5	orally	orally	ADV
ct-10123	163	6	or	or	CCONJ
ct-10123	163	7	intravenously	intravenously	ADV
ct-10123	163	8	,	,	PUNCT
ct-10123	163	9	though	though	SCONJ
ct-10123	163	10	resistance	resistance	NOUN
ct-10123	163	11	is	be	AUX
ct-10123	163	12	more	more	ADV
ct-10123	163	13	frequent	frequent	ADJ
ct-10123	163	14	.	.	PUNCT
ct-10123	164	1	voriconazole	voriconazole	NOUN
ct-10123	164	2	is	be	AUX
ct-10123	164	3	a	a	DET
ct-10123	164	4	second	second	ADJ
ct-10123	164	5	generation	generation	NOUN
ct-10123	164	6	triazole	triazole	NOUN
ct-10123	164	7	,	,	PUNCT
ct-10123	164	8	with	with	ADP
ct-10123	164	9	a	a	DET
ct-10123	164	10	wide	wide	ADJ
ct-10123	164	11	spectrum	spectrum	NOUN
ct-10123	164	12	,	,	PUNCT
ct-10123	164	13	can	can	AUX
ct-10123	164	14	be	be	AUX
ct-10123	164	15	administered	administer	VERB
ct-10123	164	16	orally	orally	ADV
ct-10123	164	17	or	or	CCONJ
ct-10123	164	18	intravenously	intravenously	ADV
ct-10123	164	19	,	,	PUNCT
ct-10123	164	20	is	be	AUX
ct-10123	164	21	metabolized	metabolize	VERB
ct-10123	164	22	by	by	ADP
ct-10123	164	23	liver	liver	NOUN
ct-10123	164	24	,	,	PUNCT
ct-10123	164	25	with	with	ADP
ct-10123	164	26	excellent	excellent	ADJ
ct-10123	164	27	tissue	tissue	NOUN
ct-10123	164	28	penetration	penetration	NOUN
ct-10123	164	29	,	,	PUNCT
ct-10123	164	30	though	though	SCONJ
ct-10123	164	31	with	with	ADP
ct-10123	164	32	limited	limited	ADJ
ct-10123	164	33	experience	experience	NOUN
ct-10123	164	34	in	in	ADP
ct-10123	164	35	horses	horse	NOUN
ct-10123	164	36	.	.	PUNCT
ct-10123	165	1	topical	topical	ADJ
ct-10123	165	2	azoles	azole	NOUN
ct-10123	165	3	commonly	commonly	ADV
ct-10123	165	4	used	use	VERB
ct-10123	165	5	formulations	formulation	NOUN
ct-10123	165	6	are	be	AUX
ct-10123	165	7	clotrimazole	clotrimazole	NOUN
ct-10123	165	8	and	and	CCONJ
ct-10123	165	9	miconazole	miconazole	NOUN
ct-10123	165	10	.	.	PUNCT
ct-10123	166	1	uses	use	VERB
ct-10123	166	2	in	in	ADP
ct-10123	166	3	reproduction	reproduction	NOUN
ct-10123	166	4	.	.	PUNCT
ct-10123	167	1	ketoconazole	ketoconazole	NOUN
ct-10123	167	2	and	and	CCONJ
ct-10123	167	3	clotrimazole	clotrimazole	NOUN
ct-10123	167	4	are	be	AUX
ct-10123	167	5	reasonable	reasonable	ADJ
ct-10123	167	6	empiric	empiric	ADJ
ct-10123	167	7	treatment	treatment	NOUN
ct-10123	167	8	choices	choice	NOUN
ct-10123	167	9	for	for	ADP
ct-10123	167	10	uterine	uterine	ADJ
ct-10123	167	11	yeast	yeast	NOUN
ct-10123	167	12	infections	infection	NOUN
ct-10123	167	13	based	base	VERB
ct-10123	167	14	on	on	ADP
ct-10123	167	15	a	a	DET
ct-10123	167	16	susceptibility	susceptibility	NOUN
ct-10123	167	17	survey	survey	NOUN
ct-10123	167	18	.	.	PUNCT
ct-10123	168	1	fluconazole	fluconazole	NOUN
ct-10123	168	2	is	be	AUX
ct-10123	168	3	popular	popular	ADJ
ct-10123	168	4	due	due	ADP
ct-10123	168	5	to	to	ADP
ct-10123	168	6	its	its	PRON
ct-10123	168	7	administration	administration	NOUN
ct-10123	168	8	flexibility	flexibility	NOUN
ct-10123	168	9	,	,	PUNCT
ct-10123	168	10	however	however	ADV
ct-10123	168	11	organisms	organism	NOUN
ct-10123	168	12	’	'	PUNCT
ct-10123	168	13	resistance	resistance	NOUN
ct-10123	168	14	to	to	ADP
ct-10123	168	15	this	this	DET
ct-10123	168	16	drug	drug	NOUN
ct-10123	168	17	appears	appear	VERB
ct-10123	168	18	to	to	PART
ct-10123	168	19	be	be	AUX
ct-10123	168	20	increasing.23	increasing.23	PROPN
ct-10123	168	21	ketoconazole	ketoconazole	NOUN
ct-10123	168	22	is	be	AUX
ct-10123	168	23	not	not	PART
ct-10123	168	24	recommended	recommend	VERB
ct-10123	168	25	in	in	ADP
ct-10123	168	26	pregnant	pregnant	ADJ
ct-10123	168	27	animals	animal	NOUN
ct-10123	168	28	.	.	PUNCT
ct-10123	169	1	iodine	iodine	NOUN
ct-10123	169	2	addition	addition	NOUN
ct-10123	169	3	of	of	ADP
ct-10123	169	4	povidone	povidone	NOUN
ct-10123	169	5	-	-	PUNCT
ct-10123	169	6	iodine	iodine	NOUN
ct-10123	169	7	to	to	ADP
ct-10123	169	8	infusions	infusion	NOUN
ct-10123	169	9	or	or	CCONJ
ct-10123	169	10	uterine	uterine	ADJ
ct-10123	169	11	lavage	lavage	NOUN
ct-10123	169	12	solutions	solution	NOUN
ct-10123	169	13	is	be	AUX
ct-10123	169	14	common	common	ADJ
ct-10123	169	15	for	for	ADP
ct-10123	169	16	management	management	NOUN
ct-10123	169	17	of	of	ADP
ct-10123	169	18	microbial	microbial	ADJ
ct-10123	169	19	infections	infection	NOUN
ct-10123	169	20	and	and	CCONJ
ct-10123	169	21	is	be	AUX
ct-10123	169	22	included	include	VERB
ct-10123	169	23	here	here	ADV
ct-10123	169	24	for	for	ADP
ct-10123	169	25	completion	completion	NOUN
ct-10123	169	26	rather	rather	ADV
ct-10123	169	27	than	than	ADP
ct-10123	169	28	an	an	DET
ct-10123	169	29	update	update	NOUN
ct-10123	169	30	.	.	PUNCT
ct-10123	170	1	one	one	NUM
ct-10123	170	2	study	study	NOUN
ct-10123	170	3	found	find	VERB
ct-10123	170	4	that	that	SCONJ
ct-10123	170	5	intrauterine	intrauterine	ADJ
ct-10123	170	6	infusion	infusion	NOUN
ct-10123	170	7	of	of	ADP
ct-10123	170	8	1	1	NUM
ct-10123	170	9	%	%	NOUN
ct-10123	170	10	povidone	povidone	NOUN
ct-10123	170	11	-	-	PUNCT
ct-10123	170	12	iodine	iodine	NOUN
ct-10123	170	13	solution	solution	NOUN
ct-10123	170	14	in	in	ADP
ct-10123	170	15	mares	mare	NOUN
ct-10123	170	16	causes	cause	VERB
ct-10123	170	17	chronic	chronic	ADJ
ct-10123	170	18	inflammatory	inflammatory	ADJ
ct-10123	170	19	changes	change	NOUN
ct-10123	170	20	in	in	ADP
ct-10123	170	21	the	the	DET
ct-10123	170	22	endometrium.24	endometrium.24	NOUN
ct-10123	170	23	a	a	DET
ct-10123	170	24	concentration	concentration	NOUN
ct-10123	170	25	of	of	ADP
ct-10123	170	26	0.5	0.5	NUM
ct-10123	170	27	%	%	NOUN
ct-10123	170	28	povidone	povidone	NOUN
ct-10123	170	29	-	-	PUNCT
ct-10123	170	30	iodine	iodine	NOUN
ct-10123	170	31	still	still	ADV
ct-10123	170	32	demonstrated	demonstrate	VERB
ct-10123	170	33	suppression	suppression	NOUN
ct-10123	170	34	of	of	ADP
ct-10123	170	35	bacterial	bacterial	ADJ
ct-10123	170	36	growth	growth	NOUN
ct-10123	170	37	and	and	CCONJ
ct-10123	170	38	is	be	AUX
ct-10123	170	39	a	a	DET
ct-10123	170	40	commonly	commonly	ADV
ct-10123	170	41	recommended	recommend	VERB
ct-10123	170	42	‘	'	PUNCT
ct-10123	170	43	safer	safe	ADJ
ct-10123	170	44	’	'	PUNCT
ct-10123	170	45	dose.25	dose.25	ADJ
ct-10123	170	46	chelators	chelator	NOUN
ct-10123	170	47	chelators	chelator	NOUN
ct-10123	170	48	increase	increase	VERB
ct-10123	170	49	the	the	DET
ct-10123	170	50	permeability	permeability	NOUN
ct-10123	170	51	of	of	ADP
ct-10123	170	52	the	the	DET
ct-10123	170	53	bacterial	bacterial	ADJ
ct-10123	170	54	cell	cell	NOUN
ct-10123	170	55	wall	wall	NOUN
ct-10123	170	56	and	and	CCONJ
ct-10123	170	57	cell	cell	NOUN
ct-10123	170	58	membrane	membrane	NOUN
ct-10123	170	59	and	and	CCONJ
ct-10123	170	60	are	be	AUX
ct-10123	170	61	synergistic	synergistic	ADJ
ct-10123	170	62	with	with	ADP
ct-10123	170	63	antimicrobials	antimicrobial	NOUN
ct-10123	170	64	including	include	VERB
ct-10123	170	65	gentamicin	gentamicin	NOUN
ct-10123	170	66	,	,	PUNCT
ct-10123	170	67	penicillin	penicillin	NOUN
ct-10123	170	68	,	,	PUNCT
ct-10123	170	69	oxytetracycline	oxytetracycline	NOUN
ct-10123	170	70	and	and	CCONJ
ct-10123	170	71	chloramphenicol	chloramphenicol	NOUN
ct-10123	170	72	.	.	PUNCT
ct-10123	171	1	in	in	ADP
ct-10123	171	2	general	general	ADJ
ct-10123	171	3	,	,	PUNCT
ct-10123	171	4	first	first	ADJ
ct-10123	171	5	and	and	CCONJ
ct-10123	171	6	second	second	ADJ
ct-10123	171	7	generation	generation	NOUN
ct-10123	171	8	chelators	chelator	NOUN
ct-10123	171	9	have	have	VERB
ct-10123	171	10	a	a	DET
ct-10123	171	11	greater	great	ADJ
ct-10123	171	12	application	application	NOUN
ct-10123	171	13	in	in	ADP
ct-10123	171	14	treating	treat	VERB
ct-10123	171	15	gram	gram	NOUN
ct-10123	171	16	-	-	PUNCT
ct-10123	171	17	negative	negative	ADJ
ct-10123	171	18	infections	infection	NOUN
ct-10123	171	19	.	.	PUNCT
ct-10123	172	1	the	the	DET
ct-10123	172	2	third	third	ADJ
ct-10123	172	3	generation	generation	NOUN
ct-10123	172	4	chelator	chelator	NOUN
ct-10123	172	5	,	,	PUNCT
ct-10123	172	6	tricide	tricide	PROPN
ct-10123	172	7	®	®	PROPN
ct-10123	172	8	,	,	PUNCT
ct-10123	172	9	appears	appear	VERB
ct-10123	172	10	to	to	PART
ct-10123	172	11	potentiate	potentiate	VERB
ct-10123	172	12	the	the	DET
ct-10123	172	13	effects	effect	NOUN
ct-10123	172	14	of	of	ADP
ct-10123	172	15	antimicrobials	antimicrobial	NOUN
ct-10123	172	16	against	against	ADP
ct-10123	172	17	gram	gram	NOUN
ct-10123	172	18	-	-	PUNCT
ct-10123	172	19	positive	positive	ADJ
ct-10123	172	20	and	and	CCONJ
ct-10123	172	21	gram	gram	NOUN
ct-10123	172	22	-	-	PUNCT
ct-10123	172	23	negative	negative	ADJ
ct-10123	172	24	bacteria	bacteria	NOUN
ct-10123	172	25	as	as	ADV
ct-10123	172	26	well	well	ADV
ct-10123	172	27	as	as	ADP
ct-10123	172	28	yeast	yeast	NOUN
ct-10123	172	29	and	and	CCONJ
ct-10123	172	30	fungi.26	fungi.26	VERB
ct-10123	172	31	509	509	NUM
ct-10123	172	32	clinical	clinical	ADJ
ct-10123	172	33	theriogenology	theriogenology	NOUN
ct-10123	172	34	•	•	NOUN
ct-10123	172	35	volume	volume	NOUN
ct-10123	172	36	5	5	NUM
ct-10123	172	37	,	,	PUNCT
ct-10123	172	38	number	number	NOUN
ct-10123	172	39	4	4	NUM
ct-10123	172	40	•	•	NOUN
ct-10123	172	41	december	december	PROPN
ct-10123	172	42	2013	2013	NUM
ct-10123	172	43	topical	topical	ADJ
ct-10123	172	44	antimicrobials	antimicrobial	NOUN
ct-10123	172	45	topical	topical	ADJ
ct-10123	172	46	antimicrobials	antimicrobial	NOUN
ct-10123	172	47	are	be	AUX
ct-10123	172	48	important	important	ADJ
ct-10123	172	49	components	component	NOUN
ct-10123	172	50	of	of	ADP
ct-10123	172	51	therapy	therapy	NOUN
ct-10123	172	52	for	for	ADP
ct-10123	172	53	vaginal	vaginal	ADJ
ct-10123	172	54	,	,	PUNCT
ct-10123	172	55	vestibular	vestibular	ADJ
ct-10123	172	56	and	and	CCONJ
ct-10123	172	57	vulvar	vulvar	NOUN
ct-10123	172	58	inflammation	inflammation	NOUN
ct-10123	172	59	and	and	CCONJ
ct-10123	172	60	necrosis	necrosis	NOUN
ct-10123	172	61	as	as	SCONJ
ct-10123	172	62	most	most	ADV
ct-10123	172	63	commonly	commonly	ADV
ct-10123	172	64	occurs	occur	VERB
ct-10123	172	65	post	post	ADJ
ct-10123	172	66	-	-	ADJ
ct-10123	172	67	foaling	foaling	NOUN
ct-10123	172	68	.	.	PUNCT
ct-10123	173	1	additionally	additionally	ADV
ct-10123	173	2	,	,	PUNCT
ct-10123	173	3	the	the	DET
ct-10123	173	4	clitoris	clitoris	NOUN
ct-10123	173	5	can	can	AUX
ct-10123	173	6	occasionally	occasionally	ADV
ct-10123	173	7	be	be	AUX
ct-10123	173	8	found	find	VERB
ct-10123	173	9	to	to	PART
ct-10123	173	10	harbor	harbor	VERB
ct-10123	173	11	pathogenic	pathogenic	ADJ
ct-10123	173	12	organisms	organism	NOUN
ct-10123	173	13	and	and	CCONJ
ct-10123	173	14	maintenance	maintenance	NOUN
ct-10123	173	15	of	of	ADP
ct-10123	173	16	the	the	DET
ct-10123	173	17	mare	mare	NOUN
ct-10123	173	18	’s	’s	PART
ct-10123	173	19	uterine	uterine	ADJ
ct-10123	173	20	health	health	NOUN
ct-10123	173	21	may	may	AUX
ct-10123	173	22	benefit	benefit	VERB
ct-10123	173	23	from	from	ADP
ct-10123	173	24	cleansing	cleanse	VERB
ct-10123	173	25	the	the	DET
ct-10123	173	26	clitoris	clitoris	NOUN
ct-10123	173	27	.	.	PUNCT
ct-10123	174	1	ointments	ointment	NOUN
ct-10123	174	2	that	that	PRON
ct-10123	174	3	have	have	VERB
ct-10123	174	4	anecdotal	anecdotal	ADJ
ct-10123	174	5	utility	utility	NOUN
ct-10123	174	6	include	include	VERB
ct-10123	174	7	nystatin	nystatin	NOUN
ct-10123	174	8	,	,	PUNCT
ct-10123	174	9	neomycin	neomycin	NOUN
ct-10123	174	10	sulfate	sulfate	NOUN
ct-10123	174	11	,	,	PUNCT
ct-10123	174	12	thiostrepton	thiostrepton	NOUN
ct-10123	174	13	and	and	CCONJ
ct-10123	174	14	triamcinolone	triamcinolone	NOUN
ct-10123	174	15	acetonide	acetonide	ADJ
ct-10123	174	16	ointment	ointment	NOUN
ct-10123	174	17	(	(	PUNCT
ct-10123	174	18	animax	animax	PROPN
ct-10123	174	19	®	®	PROPN
ct-10123	174	20	)	)	PUNCT
ct-10123	174	21	,	,	PUNCT
ct-10123	174	22	bovine	bovine	ADJ
ct-10123	174	23	intramammary	intramammary	ADJ
ct-10123	174	24	treatments	treatment	NOUN
ct-10123	174	25	(	(	PUNCT
ct-10123	174	26	cephapirin	cephapirin	NOUN
ct-10123	174	27	)	)	PUNCT
ct-10123	174	28	,	,	PUNCT
ct-10123	174	29	and	and	CCONJ
ct-10123	174	30	sodium	sodium	NOUN
ct-10123	174	31	hypochlorite	hypochlorite	NOUN
ct-10123	174	32	hydrogel	hydrogel	NOUN
ct-10123	174	33	(	(	PUNCT
ct-10123	174	34	anasept	anasept	NOUN
ct-10123	174	35	®	®	NOUN
ct-10123	174	36	)	)	PUNCT
ct-10123	174	37	.	.	PUNCT
ct-10123	175	1	diagnostic	diagnostic	ADJ
ct-10123	175	2	methods	method	NOUN
ct-10123	175	3	for	for	ADP
ct-10123	175	4	identifying	identify	VERB
ct-10123	175	5	infection	infection	NOUN
ct-10123	175	6	the	the	DET
ct-10123	175	7	use	use	NOUN
ct-10123	175	8	of	of	ADP
ct-10123	175	9	intrauterine	intrauterine	ADJ
ct-10123	175	10	or	or	CCONJ
ct-10123	175	11	systemic	systemic	ADJ
ct-10123	175	12	antimicrobials	antimicrobial	NOUN
ct-10123	175	13	for	for	ADP
ct-10123	175	14	endometritis	endometritis	PROPN
ct-10123	175	15	,	,	PUNCT
ct-10123	175	16	the	the	DET
ct-10123	175	17	most	most	ADV
ct-10123	175	18	common	common	ADJ
ct-10123	175	19	mare	mare	NOUN
ct-10123	175	20	reproductive	reproductive	ADJ
ct-10123	175	21	tract	tract	NOUN
ct-10123	175	22	infection	infection	NOUN
ct-10123	175	23	,	,	PUNCT
ct-10123	175	24	is	be	AUX
ct-10123	175	25	ideally	ideally	ADV
ct-10123	175	26	preceded	precede	VERB
ct-10123	175	27	by	by	ADP
ct-10123	175	28	organism	organism	NOUN
ct-10123	175	29	identification	identification	NOUN
ct-10123	175	30	and	and	CCONJ
ct-10123	175	31	antimicrobial	antimicrobial	ADJ
ct-10123	175	32	sensitivity	sensitivity	NOUN
ct-10123	175	33	.	.	PUNCT
ct-10123	176	1	methods	method	NOUN
ct-10123	176	2	for	for	ADP
ct-10123	176	3	diagnosing	diagnose	VERB
ct-10123	176	4	endometritis	endometritis	NOUN
ct-10123	176	5	include	include	VERB
ct-10123	176	6	a	a	DET
ct-10123	176	7	uterine	uterine	ADJ
ct-10123	176	8	swab	swab	NOUN
ct-10123	176	9	for	for	ADP
ct-10123	176	10	microbial	microbial	ADJ
ct-10123	176	11	culture	culture	NOUN
ct-10123	176	12	,	,	PUNCT
ct-10123	176	13	endometrial	endometrial	ADJ
ct-10123	176	14	cytology	cytology	NOUN
ct-10123	176	15	to	to	PART
ct-10123	176	16	evaluate	evaluate	VERB
ct-10123	176	17	for	for	ADP
ct-10123	176	18	the	the	DET
ct-10123	176	19	presence	presence	NOUN
ct-10123	176	20	of	of	ADP
ct-10123	176	21	inflammation	inflammation	NOUN
ct-10123	176	22	,	,	PUNCT
ct-10123	176	23	and	and	CCONJ
ct-10123	176	24	an	an	DET
ct-10123	176	25	endometrial	endometrial	ADJ
ct-10123	176	26	biopsy	biopsy	NOUN
ct-10123	176	27	for	for	ADP
ct-10123	176	28	histopathology	histopathology	NOUN
ct-10123	176	29	and/or	and/or	CCONJ
ct-10123	176	30	microbial	microbial	ADJ
ct-10123	176	31	culture	culture	NOUN
ct-10123	176	32	.	.	PUNCT
ct-10123	177	1	in	in	ADP
ct-10123	177	2	a	a	DET
ct-10123	177	3	comparison	comparison	NOUN
ct-10123	177	4	of	of	ADP
ct-10123	177	5	the	the	DET
ct-10123	177	6	uterine	uterine	ADJ
ct-10123	177	7	swab	swab	PROPN
ct-10123	177	8	versus	versus	ADP
ct-10123	177	9	endometrial	endometrial	ADJ
ct-10123	177	10	biopsy	biopsy	NOUN
ct-10123	177	11	for	for	ADP
ct-10123	177	12	assessment	assessment	NOUN
ct-10123	177	13	of	of	ADP
ct-10123	177	14	any	any	DET
ct-10123	177	15	bacterial	bacterial	ADJ
ct-10123	177	16	growth	growth	NOUN
ct-10123	177	17	,	,	PUNCT
ct-10123	177	18	one	one	NUM
ct-10123	177	19	study	study	NOUN
ct-10123	177	20	found	find	VERB
ct-10123	177	21	that	that	SCONJ
ct-10123	177	22	in	in	ADP
ct-10123	177	23	2	2	NUM
ct-10123	177	24	%	%	NOUN
ct-10123	177	25	of	of	ADP
ct-10123	177	26	all	all	DET
ct-10123	177	27	positive	positive	ADJ
ct-10123	177	28	cultures	culture	NOUN
ct-10123	177	29	,	,	PUNCT
ct-10123	177	30	bacterial	bacterial	ADJ
ct-10123	177	31	growth	growth	NOUN
ct-10123	177	32	was	be	AUX
ct-10123	177	33	observed	observe	VERB
ct-10123	177	34	from	from	ADP
ct-10123	177	35	the	the	DET
ct-10123	177	36	swab	swab	NOUN
ct-10123	177	37	and	and	CCONJ
ct-10123	177	38	not	not	PART
ct-10123	177	39	from	from	ADP
ct-10123	177	40	the	the	DET
ct-10123	177	41	biopsy	biopsy	NOUN
ct-10123	177	42	,	,	PUNCT
ct-10123	177	43	while	while	SCONJ
ct-10123	177	44	in	in	ADP
ct-10123	177	45	55	55	NUM
ct-10123	177	46	%	%	NOUN
ct-10123	177	47	of	of	ADP
ct-10123	177	48	positive	positive	ADJ
ct-10123	177	49	cultures	culture	NOUN
ct-10123	177	50	the	the	DET
ct-10123	177	51	swab	swab	NOUN
ct-10123	177	52	was	be	AUX
ct-10123	177	53	negative	negative	ADJ
ct-10123	177	54	for	for	ADP
ct-10123	177	55	bacterial	bacterial	ADJ
ct-10123	177	56	growth	growth	NOUN
ct-10123	177	57	and	and	CCONJ
ct-10123	177	58	the	the	DET
ct-10123	177	59	biopsy	biopsy	NOUN
ct-10123	177	60	positive	positive	ADJ
ct-10123	177	61	.	.	PUNCT
ct-10123	178	1	calculation	calculation	NOUN
ct-10123	178	2	of	of	ADP
ct-10123	178	3	the	the	DET
ct-10123	178	4	sensitivity	sensitivity	NOUN
ct-10123	178	5	and	and	CCONJ
ct-10123	178	6	specificity	specificity	NOUN
ct-10123	178	7	was	be	AUX
ct-10123	178	8	performed	perform	VERB
ct-10123	178	9	in	in	ADP
ct-10123	178	10	two	two	NUM
ct-10123	178	11	scenarios	scenario	NOUN
ct-10123	178	12	:	:	PUNCT
ct-10123	178	13	culture	culture	NOUN
ct-10123	178	14	using	use	VERB
ct-10123	178	15	a	a	DET
ct-10123	178	16	swab	swab	NOUN
ct-10123	178	17	compared	compare	VERB
ct-10123	178	18	to	to	ADP
ct-10123	178	19	culture	culture	NOUN
ct-10123	178	20	from	from	ADP
ct-10123	178	21	an	an	DET
ct-10123	178	22	endometrial	endometrial	ADJ
ct-10123	178	23	biopsy	biopsy	NOUN
ct-10123	178	24	as	as	ADP
ct-10123	178	25	the	the	DET
ct-10123	178	26	gold	gold	NOUN
ct-10123	178	27	standard	standard	NOUN
ct-10123	178	28	,	,	PUNCT
ct-10123	178	29	and	and	CCONJ
ct-10123	178	30	culture	culture	NOUN
ct-10123	178	31	from	from	ADP
ct-10123	178	32	either	either	CCONJ
ct-10123	178	33	a	a	DET
ct-10123	178	34	swab	swab	NOUN
ct-10123	178	35	or	or	CCONJ
ct-10123	178	36	a	a	DET
ct-10123	178	37	biopsy	biopsy	NOUN
ct-10123	178	38	compared	compare	VERB
ct-10123	178	39	to	to	ADP
ct-10123	178	40	inflammatory	inflammatory	ADJ
ct-10123	178	41	cells	cell	NOUN
ct-10123	178	42	seen	see	VERB
ct-10123	178	43	in	in	ADP
ct-10123	178	44	the	the	DET
ct-10123	178	45	biopsy	biopsy	NOUN
ct-10123	178	46	as	as	ADP
ct-10123	178	47	the	the	DET
ct-10123	178	48	gold	gold	PROPN
ct-10123	178	49	standard.27	standard.27	PROPN
ct-10123	178	50	swab	swab	PROPN
ct-10123	178	51	with	with	ADP
ct-10123	178	52	culture	culture	NOUN
ct-10123	178	53	from	from	ADP
ct-10123	178	54	biopsy	biopsy	NOUN
ct-10123	178	55	as	as	ADP
ct-10123	178	56	gold	gold	NOUN
ct-10123	178	57	standard	standard	NOUN
ct-10123	178	58	:	:	PUNCT
ct-10123	178	59	sensitivity	sensitivity	NOUN
ct-10123	178	60	specificity	specificity	NOUN
ct-10123	178	61	positive	positive	ADJ
ct-10123	178	62	predictive	predictive	ADJ
ct-10123	178	63	value	value	NOUN
ct-10123	178	64	negative	negative	ADJ
ct-10123	178	65	predictive	predictive	ADJ
ct-10123	178	66	value	value	NOUN
ct-10123	178	67	swab	swab	NOUN
ct-10123	178	68	culture	culture	NOUN
ct-10123	178	69	0.44	0.44	NUM
ct-10123	178	70	0.98	0.98	NUM
ct-10123	178	71	0.95	0.95	NUM
ct-10123	178	72	0.74	0.74	NUM
ct-10123	178	73	tests	test	NOUN
ct-10123	178	74	with	with	ADP
ct-10123	178	75	inflammatory	inflammatory	ADJ
ct-10123	178	76	cells	cell	NOUN
ct-10123	178	77	in	in	ADP
ct-10123	178	78	the	the	DET
ct-10123	178	79	biopsy	biopsy	NOUN
ct-10123	178	80	as	as	ADP
ct-10123	178	81	the	the	DET
ct-10123	178	82	gold	gold	NOUN
ct-10123	178	83	standard3	standard3	NOUN
ct-10123	178	84	:	:	PUNCT
ct-10123	178	85	in	in	ADP
ct-10123	178	86	an	an	DET
ct-10123	178	87	assessment	assessment	NOUN
ct-10123	178	88	of	of	ADP
ct-10123	178	89	subclinical	subclinical	ADJ
ct-10123	178	90	endometritis	endometritis	NOUN
ct-10123	178	91	as	as	SCONJ
ct-10123	178	92	defined	define	VERB
ct-10123	178	93	by	by	ADP
ct-10123	178	94	polymorphonuclear	polymorphonuclear	NOUN
ct-10123	178	95	cells	cell	NOUN
ct-10123	178	96	(	(	PUNCT
ct-10123	178	97	pmns	pmn	NOUN
ct-10123	178	98	)	)	PUNCT
ct-10123	178	99	present	present	ADJ
ct-10123	178	100	during	during	ADP
ct-10123	178	101	diestrus	diestrus	NOUN
ct-10123	178	102	in	in	ADP
ct-10123	178	103	the	the	DET
ct-10123	178	104	stratum	stratum	NOUN
ct-10123	178	105	compactum	compactum	NOUN
ct-10123	178	106	of	of	ADP
ct-10123	178	107	the	the	DET
ct-10123	178	108	endometrial	endometrial	ADJ
ct-10123	178	109	biopsy	biopsy	NOUN
ct-10123	178	110	in	in	ADP
ct-10123	178	111	the	the	DET
ct-10123	178	112	absence	absence	NOUN
ct-10123	178	113	of	of	ADP
ct-10123	178	114	intrauterine	intrauterine	ADJ
ct-10123	178	115	fluid	fluid	NOUN
ct-10123	178	116	,	,	PUNCT
ct-10123	178	117	another	another	DET
ct-10123	178	118	study	study	NOUN
ct-10123	178	119	compared	compare	VERB
ct-10123	178	120	the	the	DET
ct-10123	178	121	value	value	NOUN
ct-10123	178	122	of	of	ADP
ct-10123	178	123	a	a	DET
ct-10123	178	124	uterine	uterine	ADJ
ct-10123	178	125	swab	swab	NOUN
ct-10123	178	126	,	,	PUNCT
ct-10123	178	127	a	a	DET
ct-10123	178	128	cytology	cytology	NOUN
ct-10123	178	129	brush	brush	NOUN
ct-10123	178	130	,	,	PUNCT
ct-10123	178	131	and	and	CCONJ
ct-10123	178	132	an	an	DET
ct-10123	178	133	endometrial	endometrial	ADJ
ct-10123	178	134	biopsy	biopsy	NOUN
ct-10123	178	135	for	for	ADP
ct-10123	178	136	cytological	cytological	ADJ
ct-10123	178	137	and	and	CCONJ
ct-10123	178	138	bacteriological	bacteriological	ADJ
ct-10123	178	139	diagnosis	diagnosis	NOUN
ct-10123	178	140	of	of	ADP
ct-10123	178	141	endometritis	endometritis	NOUN
ct-10123	178	142	,	,	PUNCT
ct-10123	178	143	with	with	ADP
ct-10123	178	144	the	the	DET
ct-10123	178	145	following	follow	VERB
ct-10123	178	146	results:28	results:28	PUNCT
ct-10123	178	147	sensitivity	sensitivity	NOUN
ct-10123	178	148	specificity	specificity	NOUN
ct-10123	178	149	cytology	cytology	NOUN
ct-10123	178	150	bacteriology	bacteriology	NOUN
ct-10123	178	151	cytology	cytology	PROPN
ct-10123	178	152	bacteriology	bacteriology	NOUN
ct-10123	178	153	swab	swab	PROPN
ct-10123	178	154	0.00	0.00	NUM
ct-10123	178	155	0.33	0.33	NUM
ct-10123	178	156	0.93	0.93	NUM
ct-10123	178	157	0.83	0.83	NUM
ct-10123	178	158	brush	brush	NOUN
ct-10123	178	159	0.17	0.17	NUM
ct-10123	178	160	0.25	0.25	NUM
ct-10123	178	161	0.83	0.83	NUM
ct-10123	178	162	0.80	0.80	NUM
ct-10123	178	163	biopsy	biopsy	NOUN
ct-10123	178	164	0.25	0.25	NUM
ct-10123	178	165	0.25	0.25	NUM
ct-10123	178	166	0.85	0.85	NUM
ct-10123	178	167	0.95	0.95	NUM
ct-10123	178	168	brush	brush	NOUN
ct-10123	178	169	:	:	PUNCT
ct-10123	178	170	cytology+bacteriology	cytology+bacteriology	NOUN
ct-10123	178	171	0.42	0.42	NUM
ct-10123	178	172	0.70	0.70	NUM
ct-10123	179	1	these	these	DET
ct-10123	179	2	studies	study	NOUN
ct-10123	179	3	suggest	suggest	VERB
ct-10123	179	4	that	that	SCONJ
ct-10123	179	5	a	a	DET
ct-10123	179	6	uterine	uterine	ADJ
ct-10123	179	7	swab	swab	NOUN
ct-10123	179	8	for	for	ADP
ct-10123	179	9	microbial	microbial	ADJ
ct-10123	179	10	culture	culture	NOUN
ct-10123	179	11	used	use	VERB
ct-10123	179	12	alone	alone	ADV
ct-10123	179	13	is	be	AUX
ct-10123	179	14	insufficient	insufficient	ADJ
ct-10123	179	15	for	for	ADP
ct-10123	179	16	diagnosis	diagnosis	NOUN
ct-10123	179	17	of	of	ADP
ct-10123	179	18	endometritis	endometritis	NOUN
ct-10123	179	19	and	and	CCONJ
ct-10123	179	20	that	that	SCONJ
ct-10123	179	21	diagnostic	diagnostic	ADJ
ct-10123	179	22	ability	ability	NOUN
ct-10123	179	23	is	be	AUX
ct-10123	179	24	improved	improve	VERB
ct-10123	179	25	with	with	ADP
ct-10123	179	26	addition	addition	NOUN
ct-10123	179	27	of	of	ADP
ct-10123	179	28	at	at	ADV
ct-10123	179	29	least	least	ADJ
ct-10123	179	30	endometrial	endometrial	ADJ
ct-10123	179	31	cytology	cytology	NOUN
ct-10123	179	32	.	.	PUNCT
ct-10123	180	1	thus	thus	ADV
ct-10123	180	2	,	,	PUNCT
ct-10123	180	3	if	if	SCONJ
ct-10123	180	4	bacterial	bacterial	ADJ
ct-10123	180	5	infection	infection	NOUN
ct-10123	180	6	is	be	AUX
ct-10123	180	7	suspected	suspect	VERB
ct-10123	180	8	as	as	ADP
ct-10123	180	9	an	an	DET
ct-10123	180	10	underlying	underlying	ADJ
ct-10123	180	11	cause	cause	NOUN
ct-10123	180	12	of	of	ADP
ct-10123	180	13	the	the	DET
ct-10123	180	14	inflammation	inflammation	NOUN
ct-10123	180	15	,	,	PUNCT
ct-10123	180	16	antimicrobial	antimicrobial	ADJ
ct-10123	180	17	treatment	treatment	NOUN
ct-10123	180	18	may	may	AUX
ct-10123	180	19	be	be	AUX
ct-10123	180	20	empirical	empirical	ADJ
ct-10123	180	21	.	.	PUNCT
ct-10123	181	1	sensitivity	sensitivity	NOUN
ct-10123	181	2	specificity	specificity	NOUN
ct-10123	181	3	positive	positive	ADJ
ct-10123	181	4	predictive	predictive	ADJ
ct-10123	181	5	value	value	NOUN
ct-10123	181	6	negative	negative	ADJ
ct-10123	181	7	predictive	predictive	ADJ
ct-10123	181	8	value	value	NOUN
ct-10123	181	9	swab	swab	NOUN
ct-10123	181	10	culture	culture	NOUN
ct-10123	181	11	0.34	0.34	NUM
ct-10123	181	12	1.00	1.00	NUM
ct-10123	181	13	1.00	1.00	NUM
ct-10123	181	14	0.44	0.44	NUM
ct-10123	181	15	cytology	cytology	NOUN
ct-10123	181	16	0.77	0.77	NUM
ct-10123	181	17	1.00	1.00	NUM
ct-10123	181	18	1.00	1.00	NUM
ct-10123	181	19	0.62	0.62	NUM
ct-10123	181	20	biopsy	biopsy	NOUN
ct-10123	181	21	culture	culture	NOUN
ct-10123	181	22	0.82	0.82	NUM
ct-10123	181	23	0.92	0.92	NUM
ct-10123	181	24	0.97	0.97	NUM
ct-10123	181	25	0.67	0.67	NUM
ct-10123	181	26	510clinical	510clinical	ADJ
ct-10123	181	27	theriogenology	theriogenology	NOUN
ct-10123	181	28	•	•	NOUN
ct-10123	181	29	volume	volume	NOUN
ct-10123	181	30	5	5	NUM
ct-10123	181	31	,	,	PUNCT
ct-10123	181	32	number	number	NOUN
ct-10123	181	33	4	4	NUM
ct-10123	181	34	•	•	NOUN
ct-10123	181	35	december	december	PROPN
ct-10123	181	36	2013	2013	NUM
ct-10123	181	37	bacterial	bacterial	ADJ
ct-10123	181	38	growth	growth	NOUN
ct-10123	181	39	states	state	NOUN
ct-10123	181	40	it	it	PRON
ct-10123	181	41	has	have	AUX
ct-10123	181	42	been	be	AUX
ct-10123	181	43	suggested	suggest	VERB
ct-10123	181	44	that	that	SCONJ
ct-10123	181	45	bacteria	bacteria	NOUN
ct-10123	181	46	are	be	AUX
ct-10123	181	47	able	able	ADJ
ct-10123	181	48	to	to	PART
ct-10123	181	49	survive	survive	VERB
ct-10123	181	50	for	for	ADP
ct-10123	181	51	long	long	ADJ
ct-10123	181	52	periods	period	NOUN
ct-10123	181	53	in	in	ADP
ct-10123	181	54	a	a	DET
ct-10123	181	55	“	"	PUNCT
ct-10123	181	56	dormant	dormant	NOUN
ct-10123	181	57	”	"	PUNCT
ct-10123	181	58	or	or	CCONJ
ct-10123	181	59	“	"	PUNCT
ct-10123	181	60	viable	viable	ADJ
ct-10123	181	61	but	but	CCONJ
ct-10123	181	62	non	non	ADJ
ct-10123	181	63	-	-	ADJ
ct-10123	181	64	culturable	culturable	ADJ
ct-10123	181	65	(	(	PUNCT
ct-10123	181	66	vbnc	vbnc	NOUN
ct-10123	181	67	)	)	PUNCT
ct-10123	181	68	”	"	PUNCT
ct-10123	181	69	state	state	NOUN
ct-10123	181	70	during	during	ADP
ct-10123	181	71	which	which	DET
ct-10123	181	72	time	time	NOUN
ct-10123	181	73	neither	neither	PRON
ct-10123	181	74	plating	plate	VERB
ct-10123	181	75	onto	onto	ADP
ct-10123	181	76	solid	solid	ADJ
ct-10123	181	77	media	medium	NOUN
ct-10123	181	78	nor	nor	CCONJ
ct-10123	181	79	inoculation	inoculation	NOUN
ct-10123	181	80	into	into	ADP
ct-10123	181	81	liquid	liquid	ADJ
ct-10123	181	82	media	medium	NOUN
ct-10123	181	83	lead	lead	NOUN
ct-10123	181	84	to	to	ADP
ct-10123	181	85	growth	growth	NOUN
ct-10123	181	86	of	of	ADP
ct-10123	181	87	cells	cell	NOUN
ct-10123	181	88	.	.	PUNCT
ct-10123	182	1	furthermore	furthermore	ADV
ct-10123	182	2	,	,	PUNCT
ct-10123	182	3	bacteria	bacteria	NOUN
ct-10123	182	4	in	in	ADP
ct-10123	182	5	dormant	dormant	ADJ
ct-10123	182	6	states	state	NOUN
ct-10123	182	7	are	be	AUX
ct-10123	182	8	resistant	resistant	ADJ
ct-10123	182	9	to	to	ADP
ct-10123	182	10	antimicrobial	antimicrobial	ADJ
ct-10123	182	11	therapy	therapy	NOUN
ct-10123	182	12	.	.	PUNCT
ct-10123	183	1	testing	test	VERB
ct-10123	183	2	for	for	ADP
ct-10123	183	3	the	the	DET
ct-10123	183	4	presence	presence	NOUN
ct-10123	183	5	of	of	ADP
ct-10123	183	6	these	these	DET
ct-10123	183	7	bacteria	bacteria	NOUN
ct-10123	183	8	requires	require	VERB
ct-10123	183	9	fluorescence	fluorescence	NOUN
ct-10123	183	10	microscopy	microscopy	NOUN
ct-10123	183	11	and	and	CCONJ
ct-10123	183	12	fluorescence	fluorescence	NOUN
ct-10123	183	13	labeled	label	VERB
ct-10123	183	14	antibodies	antibody	NOUN
ct-10123	183	15	,	,	PUNCT
ct-10123	183	16	propidium	propidium	NOUN
ct-10123	183	17	iodide	iodide	NOUN
ct-10123	183	18	in	in	ADP
ct-10123	183	19	conjunction	conjunction	NOUN
ct-10123	183	20	with	with	ADP
ct-10123	183	21	molecular	molecular	ADJ
ct-10123	183	22	probes	probe	NOUN
ct-10123	183	23	,	,	PUNCT
ct-10123	183	24	or	or	CCONJ
ct-10123	183	25	amplification	amplification	NOUN
ct-10123	183	26	of	of	ADP
ct-10123	183	27	bacterial	bacterial	ADJ
ct-10123	183	28	mrna	mrna	NOUN
ct-10123	183	29	using	use	VERB
ct-10123	183	30	rt	rt	PROPN
ct-10123	183	31	-	-	PUNCT
ct-10123	183	32	pcr	pcr	NOUN
ct-10123	183	33	techniques	technique	NOUN
ct-10123	183	34	.	.	PUNCT
ct-10123	184	1	some	some	DET
ct-10123	184	2	species	specie	NOUN
ct-10123	184	3	of	of	ADP
ct-10123	184	4	bacteria	bacteria	NOUN
ct-10123	184	5	retain	retain	VERB
ct-10123	184	6	their	their	PRON
ct-10123	184	7	pathogenic	pathogenic	ADJ
ct-10123	184	8	potential	potential	NOUN
ct-10123	184	9	during	during	ADP
ct-10123	184	10	dormancy	dormancy	NOUN
ct-10123	184	11	.	.	PUNCT
ct-10123	185	1	a	a	DET
ct-10123	185	2	human	human	ADJ
ct-10123	185	3	example	example	NOUN
ct-10123	185	4	of	of	ADP
ct-10123	185	5	the	the	DET
ct-10123	185	6	medical	medical	ADJ
ct-10123	185	7	importance	importance	NOUN
ct-10123	185	8	of	of	ADP
ct-10123	185	9	non	non	ADJ
ct-10123	185	10	-	-	ADJ
ct-10123	185	11	growth	growth	ADJ
ct-10123	185	12	states	state	NOUN
ct-10123	185	13	is	be	AUX
ct-10123	185	14	mycobacterium	mycobacterium	NOUN
ct-10123	185	15	tuberculosis.29	tuberculosis.29	PROPN
ct-10123	185	16	-	-	PUNCT
ct-10123	185	17	31	31	NUM
ct-10123	185	18	research	research	NOUN
ct-10123	185	19	is	be	AUX
ct-10123	185	20	actively	actively	ADV
ct-10123	185	21	targeting	target	VERB
ct-10123	185	22	signals	signal	NOUN
ct-10123	185	23	for	for	SCONJ
ct-10123	185	24	bacteria	bacteria	NOUN
ct-10123	185	25	to	to	PART
ct-10123	185	26	resume	resume	VERB
ct-10123	185	27	growth	growth	NOUN
ct-10123	185	28	.	.	PUNCT
ct-10123	186	1	an	an	DET
ct-10123	186	2	example	example	NOUN
ct-10123	186	3	of	of	ADP
ct-10123	186	4	such	such	DET
ct-10123	186	5	a	a	DET
ct-10123	186	6	signal	signal	NOUN
ct-10123	186	7	is	be	AUX
ct-10123	186	8	the	the	DET
ct-10123	186	9	resuscitation	resuscitation	NOUN
ct-10123	186	10	-	-	PUNCT
ct-10123	186	11	promoting	promote	VERB
ct-10123	186	12	factor	factor	NOUN
ct-10123	186	13	(	(	PUNCT
ct-10123	186	14	rpf	rpf	NOUN
ct-10123	186	15	)	)	PUNCT
ct-10123	186	16	,	,	PUNCT
ct-10123	186	17	an	an	DET
ct-10123	186	18	enzyme	enzyme	NOUN
ct-10123	186	19	that	that	PRON
ct-10123	186	20	has	have	AUX
ct-10123	186	21	been	be	AUX
ct-10123	186	22	shown	show	VERB
ct-10123	186	23	to	to	PART
ct-10123	186	24	increase	increase	VERB
ct-10123	186	25	the	the	DET
ct-10123	186	26	culturability	culturability	NOUN
ct-10123	186	27	of	of	ADP
ct-10123	186	28	dormant	dormant	ADJ
ct-10123	186	29	bacteria	bacteria	NOUN
ct-10123	186	30	.	.	PUNCT
ct-10123	187	1	a	a	DET
ct-10123	187	2	mechanism	mechanism	NOUN
ct-10123	187	3	by	by	ADP
ct-10123	187	4	which	which	PRON
ct-10123	187	5	this	this	DET
ct-10123	187	6	enzyme	enzyme	NOUN
ct-10123	187	7	functions	function	NOUN
ct-10123	187	8	in	in	ADP
ct-10123	187	9	conjunction	conjunction	NOUN
ct-10123	187	10	with	with	ADP
ct-10123	187	11	other	other	ADJ
ct-10123	187	12	bacterial	bacterial	ADJ
ct-10123	187	13	proteins	protein	NOUN
ct-10123	187	14	is	be	AUX
ct-10123	187	15	under	under	ADP
ct-10123	187	16	investigation.32	investigation.32	NOUN
ct-10123	187	17	in	in	ADP
ct-10123	187	18	a	a	DET
ct-10123	187	19	study	study	NOUN
ct-10123	187	20	to	to	PART
ct-10123	187	21	evaluate	evaluate	VERB
ct-10123	187	22	for	for	ADP
ct-10123	187	23	a	a	DET
ct-10123	187	24	similar	similar	ADJ
ct-10123	187	25	bacterial	bacterial	ADJ
ct-10123	187	26	dormancy	dormancy	NOUN
ct-10123	187	27	state	state	NOUN
ct-10123	187	28	in	in	ADP
ct-10123	187	29	the	the	DET
ct-10123	187	30	equine	equine	NOUN
ct-10123	187	31	endometrium	endometrium	NOUN
ct-10123	187	32	,	,	PUNCT
ct-10123	187	33	petersen	petersen	PROPN
ct-10123	187	34	et	et	PROPN
ct-10123	187	35	al	al	PROPN
ct-10123	187	36	used	use	VERB
ct-10123	187	37	fluorescence	fluorescence	NOUN
ct-10123	187	38	in	in	ADP
ct-10123	187	39	situ	situ	ADJ
ct-10123	187	40	hybridization	hybridization	NOUN
ct-10123	187	41	(	(	PUNCT
ct-10123	187	42	fish	fish	NOUN
ct-10123	187	43	)	)	PUNCT
ct-10123	187	44	to	to	PART
ct-10123	187	45	evaluate	evaluate	VERB
ct-10123	187	46	s.	s.	PROPN
ct-10123	187	47	zooepidemicus	zooepidemicus	PROPN
ct-10123	187	48	endometritis	endometritis	PROPN
ct-10123	187	49	in	in	ADP
ct-10123	187	50	mares	mare	NOUN
ct-10123	187	51	treated	treat	VERB
ct-10123	187	52	with	with	ADP
ct-10123	187	53	systemic	systemic	ADJ
ct-10123	187	54	antibiotics	antibiotic	NOUN
ct-10123	187	55	.	.	PUNCT
ct-10123	188	1	despite	despite	SCONJ
ct-10123	188	2	systemic	systemic	ADJ
ct-10123	188	3	antibiotic	antibiotic	ADJ
ct-10123	188	4	treatment	treatment	NOUN
ct-10123	188	5	,	,	PUNCT
ct-10123	188	6	streptococci	streptococci	NOUN
ct-10123	188	7	could	could	AUX
ct-10123	188	8	still	still	ADV
ct-10123	188	9	be	be	AUX
ct-10123	188	10	visualized	visualize	VERB
ct-10123	188	11	deep	deep	ADV
ct-10123	188	12	within	within	ADP
ct-10123	188	13	the	the	DET
ct-10123	188	14	endometrium.33	endometrium.33	PROPN
ct-10123	188	15	research	research	NOUN
ct-10123	188	16	into	into	ADP
ct-10123	188	17	the	the	DET
ct-10123	188	18	effect	effect	NOUN
ct-10123	188	19	of	of	ADP
ct-10123	188	20	a	a	DET
ct-10123	188	21	proprietary	proprietary	ADJ
ct-10123	188	22	“	"	PUNCT
ct-10123	188	23	activation	activation	NOUN
ct-10123	188	24	”	"	PUNCT
ct-10123	188	25	signal	signal	NOUN
ct-10123	188	26	for	for	ADP
ct-10123	188	27	resumption	resumption	NOUN
ct-10123	188	28	of	of	ADP
ct-10123	188	29	bacterial	bacterial	ADJ
ct-10123	188	30	growth	growth	NOUN
ct-10123	188	31	is	be	AUX
ct-10123	188	32	ongoing.34	ongoing.34	ADP
ct-10123	188	33	post	post	ADJ
ct-10123	188	34	-	-	ADJ
ct-10123	188	35	mating	mating	ADJ
ct-10123	188	36	induced	induce	VERB
ct-10123	188	37	endometritis	endometritis	NOUN
ct-10123	188	38	treatment	treatment	NOUN
ct-10123	188	39	of	of	ADP
ct-10123	188	40	post	post	ADJ
ct-10123	188	41	-	-	ADJ
ct-10123	188	42	mating	mating	ADJ
ct-10123	188	43	induced	induce	VERB
ct-10123	188	44	endometritis	endometritis	NOUN
ct-10123	188	45	in	in	ADP
ct-10123	188	46	the	the	DET
ct-10123	188	47	form	form	NOUN
ct-10123	188	48	of	of	ADP
ct-10123	188	49	routine	routine	ADJ
ct-10123	188	50	antimicrobial	antimicrobial	ADJ
ct-10123	188	51	infusion	infusion	NOUN
ct-10123	188	52	postbreeding	postbreeding	NOUN
ct-10123	188	53	is	be	AUX
ct-10123	188	54	common	common	ADJ
ct-10123	188	55	in	in	ADP
ct-10123	188	56	the	the	DET
ct-10123	188	57	thoroughbred	thoroughbred	ADJ
ct-10123	188	58	breeding	breeding	NOUN
ct-10123	188	59	industry	industry	NOUN
ct-10123	188	60	.	.	PUNCT
ct-10123	189	1	as	as	ADP
ct-10123	189	2	in	in	ADP
ct-10123	189	3	any	any	DET
ct-10123	189	4	healthy	healthy	ADJ
ct-10123	189	5	debate	debate	NOUN
ct-10123	189	6	,	,	PUNCT
ct-10123	189	7	there	there	PRON
ct-10123	189	8	are	be	VERB
ct-10123	189	9	at	at	ADV
ct-10123	189	10	least	least	ADJ
ct-10123	189	11	two	two	NUM
ct-10123	189	12	sides	side	NOUN
ct-10123	189	13	to	to	ADP
ct-10123	189	14	the	the	DET
ct-10123	189	15	argument	argument	NOUN
ct-10123	189	16	.	.	PUNCT
ct-10123	190	1	on	on	ADP
ct-10123	190	2	one	one	NUM
ct-10123	190	3	hand	hand	NOUN
ct-10123	190	4	,	,	PUNCT
ct-10123	190	5	there	there	PRON
ct-10123	190	6	is	be	VERB
ct-10123	190	7	limited	limit	VERB
ct-10123	190	8	published	publish	VERB
ct-10123	190	9	,	,	PUNCT
ct-10123	190	10	statistically	statistically	ADV
ct-10123	190	11	significant	significant	ADJ
ct-10123	190	12	evidence	evidence	NOUN
ct-10123	190	13	supporting	support	VERB
ct-10123	190	14	this	this	DET
ct-10123	190	15	practice.35	practice.35	NOUN
ct-10123	190	16	copious	copious	ADJ
ct-10123	190	17	use	use	NOUN
ct-10123	190	18	of	of	ADP
ct-10123	190	19	antimicrobials	antimicrobial	NOUN
ct-10123	190	20	is	be	AUX
ct-10123	190	21	also	also	ADV
ct-10123	190	22	scrutinized	scrutinize	VERB
ct-10123	190	23	for	for	ADP
ct-10123	190	24	potential	potential	ADJ
ct-10123	190	25	antimicrobial	antimicrobial	ADJ
ct-10123	190	26	resistance	resistance	NOUN
ct-10123	190	27	development	development	NOUN
ct-10123	190	28	.	.	PUNCT
ct-10123	191	1	on	on	ADP
ct-10123	191	2	the	the	DET
ct-10123	191	3	other	other	ADJ
ct-10123	191	4	hand	hand	NOUN
ct-10123	191	5	,	,	PUNCT
ct-10123	191	6	a	a	DET
ct-10123	191	7	study	study	NOUN
ct-10123	191	8	evaluating	evaluate	VERB
ct-10123	191	9	thoroughbred	thoroughbred	ADJ
ct-10123	191	10	reproductive	reproductive	ADJ
ct-10123	191	11	efficiency	efficiency	NOUN
ct-10123	191	12	and	and	CCONJ
ct-10123	191	13	financial	financial	ADJ
ct-10123	191	14	value	value	NOUN
ct-10123	191	15	found	find	VERB
ct-10123	191	16	that	that	SCONJ
ct-10123	191	17	mares	mare	NOUN
ct-10123	191	18	that	that	PRON
ct-10123	191	19	were	be	AUX
ct-10123	191	20	barren	barren	ADJ
ct-10123	191	21	twice	twice	ADV
ct-10123	191	22	over	over	ADP
ct-10123	191	23	a	a	DET
ct-10123	191	24	seven	seven	NUM
ct-10123	191	25	-	-	PUNCT
ct-10123	191	26	year	year	NOUN
ct-10123	191	27	investment	investment	NOUN
ct-10123	191	28	were	be	AUX
ct-10123	191	29	not	not	PART
ct-10123	191	30	profitable	profitable	ADJ
ct-10123	191	31	.	.	PUNCT
ct-10123	192	1	this	this	PRON
ct-10123	192	2	taken	take	VERB
ct-10123	192	3	together	together	ADV
ct-10123	192	4	with	with	ADP
ct-10123	192	5	drift	drift	NOUN
ct-10123	192	6	(	(	PUNCT
ct-10123	192	7	in	in	ADP
ct-10123	192	8	the	the	DET
ct-10123	192	9	same	same	ADJ
ct-10123	192	10	study	study	NOUN
ct-10123	192	11	,	,	PUNCT
ct-10123	192	12	drift	drift	NOUN
ct-10123	192	13	was	be	AUX
ct-10123	192	14	13.4	13.4	NUM
ct-10123	192	15	+	+	PROPN
ct-10123	192	16	/23.2	/23.2	NOUN
ct-10123	192	17	days	day	NOUN
ct-10123	192	18	)	)	PUNCT
ct-10123	192	19	demonstrates	demonstrate	VERB
ct-10123	192	20	that	that	SCONJ
ct-10123	192	21	the	the	DET
ct-10123	192	22	average	average	ADJ
ct-10123	192	23	mare	mare	NOUN
ct-10123	192	24	needs	need	VERB
ct-10123	192	25	to	to	PART
ct-10123	192	26	become	become	VERB
ct-10123	192	27	pregnant	pregnant	ADJ
ct-10123	192	28	within	within	ADP
ct-10123	192	29	one	one	NUM
ct-10123	192	30	to	to	ADP
ct-10123	192	31	two	two	NUM
ct-10123	192	32	estrous	estrous	ADJ
ct-10123	192	33	cycles	cycle	NOUN
ct-10123	192	34	every	every	DET
ct-10123	192	35	year.36	year.36	PROPN
ct-10123	192	36	this	this	PRON
ct-10123	192	37	may	may	AUX
ct-10123	192	38	drive	drive	VERB
ct-10123	192	39	the	the	DET
ct-10123	192	40	broad	broad	ADJ
ct-10123	192	41	treatment	treatment	NOUN
ct-10123	192	42	for	for	ADP
ct-10123	192	43	even	even	ADV
ct-10123	192	44	potential	potential	ADJ
ct-10123	192	45	post	post	ADJ
ct-10123	192	46	-	-	ADJ
ct-10123	192	47	breeding	breeding	ADJ
ct-10123	192	48	infectious	infectious	ADJ
ct-10123	192	49	endometritis	endometritis	NOUN
ct-10123	192	50	.	.	PUNCT
ct-10123	193	1	in	in	ADP
ct-10123	193	2	a	a	DET
ct-10123	193	3	recent	recent	ADJ
ct-10123	193	4	study	study	NOUN
ct-10123	193	5	of	of	ADP
ct-10123	193	6	s.	s.	PROPN
ct-10123	193	7	zooepidemicus	zooepidemicus	PROPN
ct-10123	193	8	from	from	ADP
ct-10123	193	9	horses	horse	NOUN
ct-10123	193	10	conducted	conduct	VERB
ct-10123	193	11	by	by	ADP
ct-10123	193	12	the	the	DET
ct-10123	193	13	university	university	PROPN
ct-10123	193	14	of	of	ADP
ct-10123	193	15	kentucky	kentucky	PROPN
ct-10123	193	16	veterinary	veterinary	PROPN
ct-10123	193	17	diagnostic	diagnostic	ADJ
ct-10123	193	18	laboratory	laboratory	NOUN
ct-10123	193	19	,	,	PUNCT
ct-10123	193	20	resistance	resistance	NOUN
ct-10123	193	21	of	of	ADP
ct-10123	193	22	s.	s.	PROPN
ct-10123	193	23	zooepidemicus	zooepidemicus	PROPN
ct-10123	193	24	has	have	AUX
ct-10123	193	25	not	not	PART
ct-10123	193	26	developed.37	developed.37	VERB
ct-10123	193	27	placentitis	placentitis	PROPN
ct-10123	193	28	thirty	thirty	NUM
ct-10123	193	29	-	-	PUNCT
ct-10123	193	30	four	four	NUM
ct-10123	193	31	percent	percent	NOUN
ct-10123	193	32	of	of	ADP
ct-10123	193	33	equine	equine	NOUN
ct-10123	193	34	abortions	abortion	NOUN
ct-10123	193	35	or	or	CCONJ
ct-10123	193	36	stillbirths	stillbirth	NOUN
ct-10123	193	37	were	be	AUX
ct-10123	193	38	associated	associate	VERB
ct-10123	193	39	with	with	ADP
ct-10123	193	40	feto	feto	VERB
ct-10123	193	41	-	-	PUNCT
ct-10123	193	42	placental	placental	ADJ
ct-10123	193	43	infection	infection	NOUN
ct-10123	193	44	.	.	PUNCT
ct-10123	194	1	of	of	ADP
ct-10123	194	2	these	these	PRON
ct-10123	194	3	,	,	PUNCT
ct-10123	194	4	17.8	17.8	NUM
ct-10123	194	5	%	%	NOUN
ct-10123	194	6	had	have	AUX
ct-10123	194	7	an	an	DET
ct-10123	194	8	identified	identify	VERB
ct-10123	194	9	bacterial	bacterial	ADJ
ct-10123	194	10	etiology.38	etiology.38	NOUN
ct-10123	194	11	antimicrobials	antimicrobial	NOUN
ct-10123	194	12	are	be	AUX
ct-10123	194	13	a	a	DET
ct-10123	194	14	critical	critical	ADJ
ct-10123	194	15	component	component	NOUN
ct-10123	194	16	of	of	ADP
ct-10123	194	17	bacterial	bacterial	ADJ
ct-10123	194	18	placentitis	placentitis	PROPN
ct-10123	194	19	treatment	treatment	NOUN
ct-10123	194	20	.	.	PUNCT
ct-10123	195	1	antimicrobials	antimicrobial	NOUN
ct-10123	195	2	that	that	PRON
ct-10123	195	3	have	have	VERB
ct-10123	195	4	evidence	evidence	NOUN
ct-10123	195	5	of	of	ADP
ct-10123	195	6	reaching	reach	VERB
ct-10123	195	7	allantoic	allantoic	NOUN
ct-10123	195	8	fluid	fluid	NOUN
ct-10123	195	9	include	include	VERB
ct-10123	195	10	penicillin	penicillin	PROPN
ct-10123	195	11	g	g	PROPN
ct-10123	195	12	(	(	PUNCT
ct-10123	195	13	22,000	22,000	NUM
ct-10123	195	14	units	unit	NOUN
ct-10123	195	15	/	/	SYM
ct-10123	195	16	kg	kg	PROPN
ct-10123	196	1	i	i	PRON
ct-10123	196	2	m	m	AUX
ct-10123	196	3	bid	bid	ADJ
ct-10123	196	4	)	)	PUNCT
ct-10123	196	5	,	,	PUNCT
ct-10123	196	6	gentamicin	gentamicin	NOUN
ct-10123	196	7	(	(	PUNCT
ct-10123	196	8	6.6	6.6	NUM
ct-10123	196	9	mg	mg	NOUN
ct-10123	196	10	/	/	SYM
ct-10123	196	11	kg	kg	PROPN
ct-10123	196	12	iv	iv	NUM
ct-10123	196	13	sid	sid	PROPN
ct-10123	196	14	)	)	PUNCT
ct-10123	196	15	and	and	CCONJ
ct-10123	196	16	trimethoprim	trimethoprim	ADJ
ct-10123	196	17	sulfamethoxazole	sulfamethoxazole	NOUN
ct-10123	196	18	(	(	PUNCT
ct-10123	196	19	15	15	NUM
ct-10123	196	20	-	-	SYM
ct-10123	196	21	30	30	NUM
ct-10123	196	22	mg	mg	PROPN
ct-10123	196	23	/	/	SYM
ct-10123	196	24	kg	kg	PROPN
ct-10123	196	25	po	po	NOUN
ct-10123	196	26	bid).39,40	bid).39,40	VERB
ct-10123	196	27	other	other	ADJ
ct-10123	196	28	antimicrobials	antimicrobial	NOUN
ct-10123	196	29	are	be	AUX
ct-10123	196	30	anecdotally	anecdotally	ADV
ct-10123	196	31	used	use	VERB
ct-10123	196	32	with	with	ADP
ct-10123	196	33	effect	effect	NOUN
ct-10123	196	34	.	.	PUNCT
ct-10123	197	1	in	in	ADP
ct-10123	197	2	an	an	DET
ct-10123	197	3	experimental	experimental	ADJ
ct-10123	197	4	ascending	ascend	VERB
ct-10123	197	5	placentitis	placentitis	PROPN
ct-10123	197	6	model	model	NOUN
ct-10123	197	7	with	with	ADP
ct-10123	197	8	beta	beta	NOUN
ct-10123	197	9	-	-	PUNCT
ct-10123	197	10	streptococcus	streptococcus	NOUN
ct-10123	197	11	,	,	PUNCT
ct-10123	197	12	the	the	DET
ct-10123	197	13	introduced	introduce	VERB
ct-10123	197	14	organism	organism	NOUN
ct-10123	197	15	was	be	AUX
ct-10123	197	16	be	be	AUX
ct-10123	197	17	cultured	cultured	ADJ
ct-10123	197	18	from	from	ADP
ct-10123	197	19	the	the	DET
ct-10123	197	20	uterus	uterus	NOUN
ct-10123	197	21	post	post	NOUN
ct-10123	197	22	-	-	ADJ
ct-10123	197	23	foaling	foaling	NOUN
ct-10123	197	24	in	in	ADP
ct-10123	197	25	both	both	PRON
ct-10123	197	26	treated	treat	VERB
ct-10123	197	27	and	and	CCONJ
ct-10123	197	28	untreated	untreated	ADJ
ct-10123	197	29	controls	control	NOUN
ct-10123	197	30	.	.	PUNCT
ct-10123	198	1	the	the	DET
ct-10123	198	2	treated	treat	VERB
ct-10123	198	3	ponies	pony	NOUN
ct-10123	198	4	received	receive	VERB
ct-10123	198	5	antimicrobials	antimicrobial	NOUN
ct-10123	198	6	(	(	PUNCT
ct-10123	198	7	trimethoprim	trimethoprim	NOUN
ct-10123	198	8	sulfamethoxazole	sulfamethoxazole	NOUN
ct-10123	198	9	30	30	NUM
ct-10123	198	10	mg	mg	NUM
ct-10123	198	11	/	/	SYM
ct-10123	198	12	kg	kg	PROPN
ct-10123	198	13	po	po	NOUN
ct-10123	198	14	bid	bid	NOUN
ct-10123	198	15	)	)	PUNCT
ct-10123	198	16	continuously	continuously	ADV
ct-10123	198	17	until	until	ADP
ct-10123	198	18	parturition.41	parturition.41	NOUN
ct-10123	198	19	this	this	DET
ct-10123	198	20	information	information	NOUN
ct-10123	198	21	suggests	suggest	VERB
ct-10123	198	22	that	that	SCONJ
ct-10123	198	23	antimicrobial	antimicrobial	ADJ
ct-10123	198	24	therapy	therapy	NOUN
ct-10123	198	25	in	in	ADP
ct-10123	198	26	pregnant	pregnant	ADJ
ct-10123	198	27	mares	mare	NOUN
ct-10123	198	28	with	with	ADP
ct-10123	198	29	placentitis	placentitis	PROPN
ct-10123	198	30	may	may	AUX
ct-10123	198	31	need	need	VERB
ct-10123	198	32	to	to	PART
ct-10123	198	33	be	be	AUX
ct-10123	198	34	prolonged	prolong	VERB
ct-10123	198	35	and	and	CCONJ
ct-10123	198	36	weighed	weigh	VERB
ct-10123	198	37	against	against	ADP
ct-10123	198	38	side	side	NOUN
ct-10123	198	39	effects	effect	NOUN
ct-10123	198	40	of	of	ADP
ct-10123	198	41	long	long	ADJ
ct-10123	198	42	-	-	PUNCT
ct-10123	198	43	term	term	NOUN
ct-10123	198	44	antimicrobial	antimicrobial	ADJ
ct-10123	198	45	therapy	therapy	NOUN
ct-10123	198	46	.	.	PUNCT
ct-10123	199	1	references	reference	NOUN
ct-10123	199	2	1	1	NUM
ct-10123	199	3	.	.	PUNCT
ct-10123	200	1	causey	causey	PROPN
ct-10123	200	2	rc	rc	PROPN
ct-10123	200	3	,	,	PUNCT
ct-10123	200	4	weber	weber	PROPN
ct-10123	200	5	ja	ja	PROPN
ct-10123	200	6	,	,	PUNCT
ct-10123	200	7	emmans	emman	NOUN
ct-10123	200	8	ee	ee	PROPN
ct-10123	200	9	,	,	PUNCT
ct-10123	200	10	et	et	PROPN
ct-10123	200	11	al	al	PROPN
ct-10123	200	12	:	:	PUNCT
ct-10123	200	13	the	the	DET
ct-10123	200	14	equine	equine	ADJ
ct-10123	200	15	immune	immune	ADJ
ct-10123	200	16	response	response	NOUN
ct-10123	200	17	to	to	PART
ct-10123	200	18	streptococcus	streptococcus	VERB
ct-10123	200	19	equi	equi	NOUN
ct-10123	200	20	subspecies	subspecie	NOUN
ct-10123	200	21	zooepidemicus	zooepidemicus	VERB
ct-10123	200	22	during	during	ADP
ct-10123	200	23	uterine	uterine	ADJ
ct-10123	200	24	infection	infection	NOUN
ct-10123	200	25	.	.	PUNCT
ct-10123	201	1	vet	vet	NOUN
ct-10123	201	2	j	j	PROPN
ct-10123	201	3	2006;172:248	2006;172:248	NUM
ct-10123	201	4	-	-	SYM
ct-10123	201	5	257	257	NUM
ct-10123	201	6	.	.	NOUN
ct-10123	202	1	2	2	NUM
ct-10123	202	2	.	.	X
ct-10123	202	3	giguere	giguere	NOUN
ct-10123	202	4	s	s	NOUN
ct-10123	202	5	,	,	PUNCT
ct-10123	202	6	prescott	prescott	PROPN
ct-10123	202	7	jf	jf	PROPN
ct-10123	202	8	,	,	PUNCT
ct-10123	202	9	baggot	baggot	VERB
ct-10123	202	10	jd	jd	PROPN
ct-10123	202	11	,	,	PUNCT
ct-10123	202	12	et	et	PROPN
ct-10123	202	13	al	al	PROPN
ct-10123	202	14	,	,	PUNCT
ct-10123	202	15	editors	editor	NOUN
ct-10123	202	16	:	:	PUNCT
ct-10123	202	17	antimicrobial	antimicrobial	ADJ
ct-10123	202	18	therapy	therapy	NOUN
ct-10123	202	19	in	in	ADP
ct-10123	202	20	veterinary	veterinary	ADJ
ct-10123	202	21	medicine	medicine	NOUN
ct-10123	202	22	.	.	PUNCT
ct-10123	203	1	4th	4th	ADJ
ct-10123	203	2	ed	ed	NOUN
ct-10123	203	3	.	.	PUNCT
ct-10123	204	1	ames	ames	PROPN
ct-10123	204	2	(	(	PUNCT
ct-10123	204	3	ia	ia	PROPN
ct-10123	204	4	):	):	PUNCT
ct-10123	204	5	blackwell	blackwell	PROPN
ct-10123	204	6	publishing	publishing	NOUN
ct-10123	204	7	;	;	PUNCT
ct-10123	204	8	2006	2006	NUM
ct-10123	204	9	.	.	PUNCT
ct-10123	205	1	3	3	X
ct-10123	205	2	.	.	X
ct-10123	205	3	love	love	PROPN
ct-10123	205	4	cc	cc	PROPN
ct-10123	205	5	,	,	PUNCT
ct-10123	205	6	strzemienski	strzemienski	PROPN
ct-10123	205	7	pj	pj	PROPN
ct-10123	205	8	,	,	PUNCT
ct-10123	205	9	kenney	kenney	PROPN
ct-10123	205	10	rm	rm	PROPN
ct-10123	205	11	:	:	PUNCT
ct-10123	205	12	endometrial	endometrial	ADJ
ct-10123	205	13	concentrations	concentration	NOUN
ct-10123	205	14	of	of	ADP
ct-10123	205	15	ampicillin	ampicillin	NOUN
ct-10123	205	16	in	in	ADP
ct-10123	205	17	mares	mare	NOUN
ct-10123	205	18	after	after	ADP
ct-10123	205	19	intrauterine	intrauterine	ADJ
ct-10123	205	20	infusion	infusion	NOUN
ct-10123	205	21	of	of	ADP
ct-10123	205	22	the	the	DET
ct-10123	205	23	drug	drug	NOUN
ct-10123	205	24	.	.	PUNCT
ct-10123	206	1	am	be	AUX
ct-10123	206	2	j	j	PROPN
ct-10123	206	3	vet	vet	NOUN
ct-10123	206	4	res	re	NOUN
ct-10123	206	5	1990;51:197	1990;51:197	PROPN
ct-10123	206	6	-	-	SYM
ct-10123	206	7	199	199	NUM
ct-10123	206	8	.	.	PUNCT
ct-10123	207	1	511	511	NUM
ct-10123	207	2	clinical	clinical	ADJ
ct-10123	207	3	theriogenology	theriogenology	NOUN
ct-10123	207	4	•	•	NOUN
ct-10123	207	5	volume	volume	NOUN
ct-10123	207	6	5	5	NUM
ct-10123	207	7	,	,	PUNCT
ct-10123	207	8	number	number	NOUN
ct-10123	207	9	4	4	NUM
ct-10123	207	10	•	•	NOUN
ct-10123	207	11	december	december	PROPN
ct-10123	207	12	2013	2013	NUM
ct-10123	207	13	4	4	NUM
ct-10123	207	14	.	.	PUNCT
ct-10123	208	1	van	van	PROPN
ct-10123	208	2	camp	camp	PROPN
ct-10123	208	3	sd	sd	PROPN
ct-10123	208	4	,	,	PUNCT
ct-10123	208	5	papich	papich	NOUN
ct-10123	208	6	mg	mg	PROPN
ct-10123	208	7	,	,	PUNCT
ct-10123	208	8	whitacre	whitacre	PROPN
ct-10123	208	9	md	md	PROPN
ct-10123	208	10	:	:	PUNCT
ct-10123	208	11	administration	administration	NOUN
ct-10123	208	12	of	of	ADP
ct-10123	208	13	ticarcillin	ticarcillin	PROPN
ct-10123	208	14	in	in	ADP
ct-10123	208	15	combination	combination	NOUN
ct-10123	208	16	with	with	ADP
ct-10123	208	17	clavulanic	clavulanic	ADJ
ct-10123	208	18	acid	acid	NOUN
ct-10123	208	19	intravenously	intravenously	ADV
ct-10123	208	20	and	and	CCONJ
ct-10123	208	21	intrauterinely	intrauterinely	ADV
ct-10123	208	22	to	to	PART
ct-10123	208	23	clinically	clinically	ADV
ct-10123	208	24	normal	normal	ADJ
ct-10123	208	25	oestrous	oestrous	ADJ
ct-10123	208	26	mares	mare	NOUN
ct-10123	208	27	.	.	PUNCT
ct-10123	209	1	j	j	PROPN
ct-10123	209	2	vet	vet	NOUN
ct-10123	209	3	pharmacol	pharmacol	PROPN
ct-10123	209	4	ther	ther	ADV
ct-10123	209	5	2000;23:373	2000;23:373	NOUN
ct-10123	209	6	-	-	PUNCT
ct-10123	209	7	378	378	NUM
ct-10123	209	8	.	.	NOUN
ct-10123	210	1	5	5	NUM
ct-10123	210	2	.	.	NUM
ct-10123	210	3	murchie	murchie	PROPN
ct-10123	210	4	t	t	PROPN
ct-10123	210	5	,	,	PUNCT
ct-10123	210	6	macpherson	macpherson	PROPN
ct-10123	210	7	ml	ml	PROPN
ct-10123	210	8	,	,	PUNCT
ct-10123	210	9	leblanc	leblanc	PROPN
ct-10123	210	10	m	m	PROPN
ct-10123	210	11	,	,	PUNCT
ct-10123	210	12	et	et	PROPN
ct-10123	210	13	al	al	PROPN
ct-10123	210	14	:	:	PUNCT
ct-10123	210	15	a	a	DET
ct-10123	210	16	microdialysis	microdialysis	NOUN
ct-10123	210	17	model	model	NOUN
ct-10123	210	18	to	to	PART
ct-10123	210	19	detect	detect	VERB
ct-10123	210	20	drugs	drug	NOUN
ct-10123	210	21	in	in	ADP
ct-10123	210	22	the	the	DET
ct-10123	210	23	allantoic	allantoic	NOUN
ct-10123	210	24	fluid	fluid	NOUN
ct-10123	210	25	of	of	ADP
ct-10123	210	26	pregnant	pregnant	ADJ
ct-10123	210	27	pony	pony	NOUN
ct-10123	210	28	mares	mare	NOUN
ct-10123	210	29	.	.	PUNCT
ct-10123	211	1	proc	proc	PROPN
ct-10123	211	2	annu	annu	PROPN
ct-10123	211	3	conv	conv	PROPN
ct-10123	211	4	am	am	PROPN
ct-10123	211	5	assoc	assoc	PROPN
ct-10123	211	6	equine	equine	PROPN
ct-10123	211	7	pract	pract	NOUN
ct-10123	211	8	;	;	PUNCT
ct-10123	211	9	2003	2003	NUM
ct-10123	211	10	.	.	PUNCT
ct-10123	212	1	p.	p.	NOUN
ct-10123	212	2	118	118	NUM
ct-10123	212	3	-	-	SYM
ct-10123	212	4	121	121	NUM
ct-10123	212	5	.	.	PUNCT
ct-10123	212	6	6	6	NUM
ct-10123	212	7	.	.	X
ct-10123	212	8	olivieri	olivieri	PROPN
ct-10123	212	9	bt	bt	PROPN
ct-10123	212	10	,	,	PUNCT
ct-10123	212	11	love	love	PROPN
ct-10123	212	12	bc	bc	PROPN
ct-10123	212	13	,	,	PUNCT
ct-10123	212	14	rezabek	rezabek	VERB
ct-10123	212	15	gb	gb	PROPN
ct-10123	212	16	,	,	PUNCT
ct-10123	212	17	et	et	PROPN
ct-10123	212	18	al	al	PROPN
ct-10123	212	19	:	:	PUNCT
ct-10123	212	20	effect	effect	NOUN
ct-10123	212	21	of	of	ADP
ct-10123	212	22	antibiotic	antibiotic	NOUN
ct-10123	212	23	-	-	PUNCT
ct-10123	212	24	containing	contain	VERB
ct-10123	212	25	extenders	extender	NOUN
ct-10123	212	26	on	on	ADP
ct-10123	212	27	taylorella	taylorella	NOUN
ct-10123	212	28	equigenitalis	equigenitalis	PROPN
ct-10123	212	29	contaminated	contaminate	VERB
ct-10123	212	30	semen	semen	NOUN
ct-10123	212	31	.	.	PUNCT
ct-10123	213	1	j	j	PROPN
ct-10123	213	2	equine	equine	PROPN
ct-10123	213	3	vet	vet	NOUN
ct-10123	213	4	sci	sci	PROPN
ct-10123	213	5	2011;31:655	2011;31:655	PROPN
ct-10123	213	6	-	-	PUNCT
ct-10123	213	7	660	660	NUM
ct-10123	213	8	.	.	PUNCT
ct-10123	214	1	7	7	X
ct-10123	214	2	.	.	X
ct-10123	214	3	dean	dean	PROPN
ct-10123	214	4	cj	cj	PROPN
ct-10123	214	5	,	,	PUNCT
ct-10123	214	6	hobgood	hobgood	PROPN
ct-10123	214	7	am	am	PROPN
ct-10123	214	8	,	,	PUNCT
ct-10123	214	9	blodgett	blodgett	PROPN
ct-10123	214	10	gp	gp	PROPN
ct-10123	214	11	,	,	PUNCT
ct-10123	214	12	et	et	PROPN
ct-10123	214	13	al	al	PROPN
ct-10123	214	14	:	:	PUNCT
ct-10123	214	15	the	the	DET
ct-10123	214	16	addition	addition	NOUN
ct-10123	214	17	of	of	ADP
ct-10123	214	18	ticarcillin	ticarcillin	NOUN
ct-10123	214	19	-	-	PUNCT
ct-10123	214	20	clavulanic	clavulanic	NOUN
ct-10123	214	21	acid	acid	NOUN
ct-10123	214	22	to	to	AUX
ct-10123	214	23	inra	inra	NOUN
ct-10123	214	24	96	96	NUM
ct-10123	214	25	extender	extender	NOUN
ct-10123	214	26	for	for	ADP
ct-10123	214	27	stallion	stallion	NOUN
ct-10123	214	28	semen	seman	NOUN
ct-10123	214	29	cooling	cool	VERB
ct-10123	214	30	.	.	PUNCT
ct-10123	215	1	equine	equine	NOUN
ct-10123	215	2	vet	vet	NOUN
ct-10123	215	3	j	j	PROPN
ct-10123	215	4	2012;44:95	2012;44:95	NUM
ct-10123	215	5	-	-	SYM
ct-10123	215	6	99	99	NUM
ct-10123	215	7	.	.	NOUN
ct-10123	215	8	8	8	NUM
ct-10123	215	9	.	.	PUNCT
ct-10123	216	1	cervantes	cervantes	PROPN
ct-10123	216	2	cc	cc	PROPN
ct-10123	216	3	,	,	PUNCT
ct-10123	216	4	brown	brown	PROPN
ct-10123	216	5	mp	mp	PROPN
ct-10123	216	6	,	,	PUNCT
ct-10123	216	7	gronwall	gronwall	ADJ
ct-10123	216	8	r	r	NOUN
ct-10123	216	9	,	,	PUNCT
ct-10123	216	10	et	et	PROPN
ct-10123	216	11	al	al	PROPN
ct-10123	216	12	:	:	PUNCT
ct-10123	216	13	pharmacokinetics	pharmacokinetic	NOUN
ct-10123	216	14	and	and	CCONJ
ct-10123	216	15	concentrations	concentration	NOUN
ct-10123	216	16	of	of	ADP
ct-10123	216	17	ceftiofur	ceftiofur	NOUN
ct-10123	216	18	sodium	sodium	NOUN
ct-10123	216	19	in	in	ADP
ct-10123	216	20	body	body	NOUN
ct-10123	216	21	fluids	fluid	NOUN
ct-10123	216	22	and	and	CCONJ
ct-10123	216	23	endometrium	endometrium	NOUN
ct-10123	216	24	after	after	SCONJ
ct-10123	216	25	repeated	repeat	VERB
ct-10123	216	26	intramuscular	intramuscular	ADJ
ct-10123	216	27	injections	injection	NOUN
ct-10123	216	28	in	in	ADP
ct-10123	216	29	mares	mare	NOUN
ct-10123	216	30	.	.	PUNCT
ct-10123	217	1	am	be	AUX
ct-10123	217	2	j	j	PROPN
ct-10123	217	3	vet	vet	NOUN
ct-10123	217	4	res	re	NOUN
ct-10123	217	5	1993;54:573	1993;54:573	PROPN
ct-10123	217	6	-	-	SYM
ct-10123	217	7	575	575	NUM
ct-10123	217	8	.	.	PUNCT
ct-10123	218	1	9	9	NUM
ct-10123	218	2	.	.	X
ct-10123	218	3	witte	witte	PROPN
ct-10123	218	4	ts	ts	PROPN
ct-10123	218	5	,	,	PUNCT
ct-10123	218	6	bergwerff	bergwerff	ADJ
ct-10123	218	7	aa	aa	NOUN
ct-10123	218	8	,	,	PUNCT
ct-10123	218	9	scherpenisse	scherpenisse	VERB
ct-10123	218	10	p	p	X
ct-10123	218	11	,	,	PUNCT
ct-10123	218	12	et	et	PROPN
ct-10123	218	13	al	al	PROPN
ct-10123	218	14	.	.	PUNCT
ct-10123	219	1	ceftiofur	ceftiofur	VERB
ct-10123	219	2	derivates	derivate	NOUN
ct-10123	219	3	in	in	ADP
ct-10123	219	4	serum	serum	NOUN
ct-10123	219	5	and	and	CCONJ
ct-10123	219	6	endometrial	endometrial	ADJ
ct-10123	219	7	tissue	tissue	NOUN
ct-10123	219	8	after	after	ADP
ct-10123	219	9	intramuscular	intramuscular	ADJ
ct-10123	219	10	administration	administration	NOUN
ct-10123	219	11	in	in	ADP
ct-10123	219	12	healthy	healthy	ADJ
ct-10123	219	13	mares	mare	NOUN
ct-10123	219	14	.	.	PUNCT
ct-10123	220	1	theriogenology	theriogenology	NOUN
ct-10123	220	2	2010;74:466	2010;74:466	NUM
ct-10123	220	3	-	-	SYM
ct-10123	220	4	472	472	NUM
ct-10123	220	5	.	.	PUNCT
ct-10123	220	6	10	10	NUM
ct-10123	220	7	.	.	PUNCT
ct-10123	221	1	scofield	scofield	PROPN
ct-10123	221	2	d	d	PROPN
ct-10123	221	3	,	,	PUNCT
ct-10123	221	4	black	black	PROPN
ct-10123	221	5	j	j	PROPN
ct-10123	221	6	,	,	PUNCT
ct-10123	221	7	wittenburg	wittenburg	PROPN
ct-10123	221	8	l	l	PROPN
ct-10123	221	9	,	,	PUNCT
ct-10123	221	10	et	et	PROPN
ct-10123	221	11	al	al	PROPN
ct-10123	221	12	:	:	PUNCT
ct-10123	221	13	endometrial	endometrial	ADJ
ct-10123	221	14	tissue	tissue	NOUN
ct-10123	221	15	and	and	CCONJ
ct-10123	221	16	blood	blood	NOUN
ct-10123	221	17	plasma	plasma	NOUN
ct-10123	221	18	concentration	concentration	NOUN
ct-10123	221	19	of	of	ADP
ct-10123	221	20	ceftiofur	ceftiofur	NOUN
ct-10123	221	21	and	and	CCONJ
ct-10123	221	22	metabolites	metabolite	NOUN
ct-10123	221	23	after	after	ADP
ct-10123	221	24	intramuscular	intramuscular	ADJ
ct-10123	221	25	administration	administration	NOUN
ct-10123	221	26	of	of	ADP
ct-10123	221	27	ceftiofur	ceftiofur	NOUN
ct-10123	221	28	crystalline	crystalline	NOUN
ct-10123	221	29	-	-	PUNCT
ct-10123	221	30	free	free	ADJ
ct-10123	221	31	acid	acid	NOUN
ct-10123	221	32	to	to	ADP
ct-10123	221	33	mares	mare	NOUN
ct-10123	221	34	.	.	PUNCT
ct-10123	222	1	proc	proc	PROPN
ct-10123	222	2	annu	annu	PROPN
ct-10123	222	3	conv	conv	PROPN
ct-10123	222	4	am	am	PROPN
ct-10123	222	5	assoc	assoc	PROPN
ct-10123	222	6	equine	equine	PROPN
ct-10123	222	7	pract	pract	NOUN
ct-10123	222	8	;	;	PUNCT
ct-10123	222	9	2012	2012	NUM
ct-10123	222	10	.	.	PUNCT
ct-10123	223	1	p.	p.	NOUN
ct-10123	223	2	519	519	NUM
ct-10123	223	3	-	-	SYM
ct-10123	223	4	520	520	NUM
ct-10123	223	5	.	.	PUNCT
ct-10123	223	6	11	11	NUM
ct-10123	223	7	.	.	X
ct-10123	224	1	hatzel	hatzel	PROPN
ct-10123	224	2	jn	jn	PROPN
ct-10123	224	3	,	,	PUNCT
ct-10123	224	4	macpherson	macpherson	PROPN
ct-10123	224	5	ml	ml	PROPN
ct-10123	224	6	,	,	PUNCT
ct-10123	224	7	giguere	giguere	NOUN
ct-10123	224	8	s	s	X
ct-10123	224	9	,	,	PUNCT
ct-10123	224	10	et	et	PROPN
ct-10123	224	11	al	al	PROPN
ct-10123	224	12	:	:	PUNCT
ct-10123	224	13	administration	administration	NOUN
ct-10123	224	14	of	of	ADP
ct-10123	224	15	ceftiofur	ceftiofur	NOUN
ct-10123	224	16	crystalline	crystalline	NOUN
ct-10123	224	17	-	-	PUNCT
ct-10123	224	18	free	free	ADJ
ct-10123	224	19	acid	acid	NOUN
ct-10123	224	20	to	to	ADP
ct-10123	224	21	pony	pony	NOUN
ct-10123	224	22	mares	mare	NOUN
ct-10123	224	23	with	with	ADP
ct-10123	224	24	placentitis	placentitis	PROPN
ct-10123	224	25	.	.	PUNCT
ct-10123	225	1	proc	proc	PROPN
ct-10123	225	2	annu	annu	PROPN
ct-10123	225	3	conv	conv	PROPN
ct-10123	225	4	am	am	PROPN
ct-10123	225	5	assoc	assoc	PROPN
ct-10123	225	6	equine	equine	PROPN
ct-10123	225	7	pract	pract	NOUN
ct-10123	225	8	;	;	PUNCT
ct-10123	225	9	2012	2012	NUM
ct-10123	225	10	.	.	PUNCT
ct-10123	226	1	p.	p.	NOUN
ct-10123	226	2	521	521	NUM
ct-10123	226	3	-	-	SYM
ct-10123	226	4	522	522	NUM
ct-10123	226	5	.	.	PUNCT
ct-10123	226	6	12	12	NUM
ct-10123	226	7	.	.	PUNCT
ct-10123	227	1	ricketts	ricketts	PROPN
ct-10123	227	2	sw	sw	PROPN
ct-10123	227	3	:	:	PUNCT
ct-10123	227	4	treatment	treatment	NOUN
ct-10123	227	5	of	of	ADP
ct-10123	227	6	equine	equine	NOUN
ct-10123	227	7	endometritis	endometritis	NOUN
ct-10123	227	8	with	with	ADP
ct-10123	227	9	intrauterine	intrauterine	ADJ
ct-10123	227	10	irrigations	irrigation	NOUN
ct-10123	227	11	of	of	ADP
ct-10123	227	12	ceftiofur	ceftiofur	NOUN
ct-10123	227	13	sodium	sodium	NOUN
ct-10123	227	14	:	:	PUNCT
ct-10123	227	15	a	a	DET
ct-10123	227	16	comparison	comparison	NOUN
ct-10123	227	17	with	with	ADP
ct-10123	227	18	mares	mare	NOUN
ct-10123	227	19	treated	treat	VERB
ct-10123	227	20	in	in	ADP
ct-10123	227	21	a	a	DET
ct-10123	227	22	similar	similar	ADJ
ct-10123	227	23	manner	manner	NOUN
ct-10123	227	24	with	with	ADP
ct-10123	227	25	a	a	DET
ct-10123	227	26	mixture	mixture	NOUN
ct-10123	227	27	of	of	ADP
ct-10123	227	28	sodium	sodium	NOUN
ct-10123	227	29	benzylpenicillin	benzylpenicillin	NOUN
ct-10123	227	30	,	,	PUNCT
ct-10123	227	31	neomycin	neomycin	NOUN
ct-10123	227	32	sulphate	sulphate	NOUN
ct-10123	227	33	,	,	PUNCT
ct-10123	227	34	polymixin	polymixin	NOUN
ct-10123	227	35	b	b	NOUN
ct-10123	227	36	sulphate	sulphate	NOUN
ct-10123	227	37	and	and	CCONJ
ct-10123	227	38	furaltadone	furaltadone	NOUN
ct-10123	227	39	hydrochloride	hydrochloride	NOUN
ct-10123	227	40	.	.	PUNCT
ct-10123	228	1	pferdeheilkunde	pferdeheilkunde	PROPN
ct-10123	228	2	1997;13:486	1997;13:486	PROPN
ct-10123	228	3	-	-	SYM
ct-10123	228	4	489	489	NUM
ct-10123	228	5	.	.	PUNCT
ct-10123	229	1	13	13	NUM
ct-10123	229	2	.	.	PUNCT
ct-10123	230	1	eilts	eilt	NOUN
ct-10123	230	2	be	be	VERB
ct-10123	230	3	,	,	PUNCT
ct-10123	230	4	mccoy	mccoy	PROPN
ct-10123	230	5	dj	dj	PROPN
ct-10123	230	6	,	,	PUNCT
ct-10123	230	7	taylor	taylor	PROPN
ct-10123	230	8	h	h	PROPN
ct-10123	230	9	,	,	PUNCT
ct-10123	230	10	et	et	PROPN
ct-10123	230	11	al	al	PROPN
ct-10123	230	12	:	:	PUNCT
ct-10123	230	13	effect	effect	NOUN
ct-10123	230	14	of	of	ADP
ct-10123	230	15	repeated	repeat	VERB
ct-10123	230	16	intrauterine	intrauterine	ADJ
ct-10123	230	17	infusions	infusion	NOUN
ct-10123	230	18	of	of	ADP
ct-10123	230	19	gentamicin	gentamicin	NOUN
ct-10123	230	20	on	on	ADP
ct-10123	230	21	the	the	DET
ct-10123	230	22	equine	equine	NOUN
ct-10123	230	23	endometrium	endometrium	NOUN
ct-10123	230	24	.	.	PUNCT
ct-10123	231	1	theriogenology	theriogenology	NOUN
ct-10123	231	2	1988;29:1253	1988;29:1253	NUM
ct-10123	231	3	-	-	SYM
ct-10123	231	4	1259	1259	NUM
ct-10123	231	5	.	.	PUNCT
ct-10123	232	1	14	14	NUM
ct-10123	232	2	.	.	PUNCT
ct-10123	233	1	al	al	PROPN
ct-10123	233	2	bagdadi	bagdadi	PROPN
ct-10123	233	3	fk	fk	INTJ
ct-10123	233	4	,	,	PUNCT
ct-10123	233	5	eilts	eilt	NOUN
ct-10123	233	6	be	be	VERB
ct-10123	233	7	,	,	PUNCT
ct-10123	233	8	richardson	richardson	PROPN
ct-10123	233	9	gf	gf	PROPN
ct-10123	233	10	:	:	PUNCT
ct-10123	233	11	scanning	scan	VERB
ct-10123	233	12	electron	electron	NOUN
ct-10123	233	13	microscopy	microscopy	NOUN
ct-10123	233	14	of	of	ADP
ct-10123	233	15	the	the	DET
ct-10123	233	16	endometrium	endometrium	NOUN
ct-10123	233	17	of	of	ADP
ct-10123	233	18	mares	mare	NOUN
ct-10123	233	19	infused	infuse	VERB
ct-10123	233	20	with	with	ADP
ct-10123	233	21	gentamicin	gentamicin	NOUN
ct-10123	233	22	.	.	PUNCT
ct-10123	234	1	microsc	microsc	ADJ
ct-10123	234	2	microanal	microanal	ADJ
ct-10123	234	3	2004;10:280	2004;10:280	NUM
ct-10123	234	4	-	-	SYM
ct-10123	234	5	285	285	NUM
ct-10123	234	6	.	.	PUNCT
ct-10123	234	7	15	15	NUM
ct-10123	234	8	.	.	PUNCT
ct-10123	235	1	bryant	bryant	PROPN
ct-10123	235	2	je	je	PROPN
ct-10123	235	3	,	,	PUNCT
ct-10123	235	4	brown	brown	PROPN
ct-10123	235	5	mp	mp	PROPN
ct-10123	235	6	,	,	PUNCT
ct-10123	235	7	gronwall	gronwall	PROPN
ct-10123	235	8	rr	rr	PROPN
ct-10123	235	9	,	,	PUNCT
ct-10123	235	10	et	et	PROPN
ct-10123	235	11	al	al	PROPN
ct-10123	235	12	:	:	PUNCT
ct-10123	235	13	study	study	NOUN
ct-10123	235	14	of	of	ADP
ct-10123	235	15	intragastric	intragastric	ADJ
ct-10123	235	16	administration	administration	NOUN
ct-10123	235	17	of	of	ADP
ct-10123	235	18	doxycycline	doxycycline	NOUN
ct-10123	235	19	:	:	PUNCT
ct-10123	235	20	pharmacokinetics	pharmacokinetic	NOUN
ct-10123	235	21	including	include	VERB
ct-10123	235	22	body	body	NOUN
ct-10123	235	23	fluid	fluid	NOUN
ct-10123	235	24	,	,	PUNCT
ct-10123	235	25	endometrial	endometrial	ADJ
ct-10123	235	26	and	and	CCONJ
ct-10123	235	27	minimum	minimum	ADJ
ct-10123	235	28	inhibitory	inhibitory	ADJ
ct-10123	235	29	concentrations	concentration	NOUN
ct-10123	235	30	.	.	PUNCT
ct-10123	236	1	equine	equine	NOUN
ct-10123	236	2	vet	vet	NOUN
ct-10123	236	3	j	j	PROPN
ct-10123	236	4	2000;32:233	2000;32:233	NOUN
ct-10123	236	5	-	-	NOUN
ct-10123	236	6	238	238	NUM
ct-10123	236	7	.	.	PUNCT
ct-10123	236	8	16	16	NUM
ct-10123	236	9	.	.	PUNCT
ct-10123	237	1	ros	ros	PROPN
ct-10123	237	2	bd	bd	PROPN
ct-10123	237	3	,	,	PUNCT
ct-10123	237	4	willsallen	willsallen	PROPN
ct-10123	237	5	cc	cc	PROPN
ct-10123	237	6	,	,	PUNCT
ct-10123	237	7	norman	norman	PROPN
ct-10123	237	8	st	st	PROPN
ct-10123	237	9	:	:	PUNCT
ct-10123	237	10	the	the	DET
ct-10123	237	11	renaissance	renaissance	NOUN
ct-10123	237	12	of	of	ADP
ct-10123	237	13	oxytetracycline	oxytetracycline	NOUN
ct-10123	237	14	-	-	PUNCT
ct-10123	237	15	a	a	DET
ct-10123	237	16	treatment	treatment	NOUN
ct-10123	237	17	for	for	ADP
ct-10123	237	18	equine	equine	NOUN
ct-10123	237	19	endometritis	endometritis	NOUN
ct-10123	237	20	?	?	PUNCT
ct-10123	238	1	proc	proc	PROPN
ct-10123	238	2	aust	aust	PROPN
ct-10123	238	3	college	college	PROPN
ct-10123	238	4	vet	vet	PROPN
ct-10123	238	5	sci	sci	PROPN
ct-10123	238	6	annu	annu	PROPN
ct-10123	238	7	conf	conf	PROPN
ct-10123	238	8	2010	2010	NUM
ct-10123	238	9	.	.	PUNCT
ct-10123	239	1	p.70	p.70	X
ct-10123	239	2	.	.	NOUN
ct-10123	239	3	17	17	NUM
ct-10123	239	4	.	.	PUNCT
ct-10123	240	1	papich	papich	PROPN
ct-10123	240	2	mg	mg	PROPN
ct-10123	240	3	,	,	PUNCT
ct-10123	240	4	van	van	PROPN
ct-10123	240	5	camp	camp	PROPN
ct-10123	240	6	sd	sd	PROPN
ct-10123	240	7	,	,	PUNCT
ct-10123	240	8	cole	cole	PROPN
ct-10123	240	9	ja	ja	PROPN
ct-10123	240	10	,	,	PUNCT
ct-10123	240	11	et	et	PROPN
ct-10123	240	12	al	al	PROPN
ct-10123	240	13	:	:	PUNCT
ct-10123	240	14	pharmacokinetics	pharmacokinetic	NOUN
ct-10123	240	15	and	and	CCONJ
ct-10123	240	16	endometrial	endometrial	ADJ
ct-10123	240	17	tissue	tissue	NOUN
ct-10123	240	18	concentrations	concentration	NOUN
ct-10123	240	19	of	of	ADP
ct-10123	240	20	enrofloxacin	enrofloxacin	PROPN
ct-10123	240	21	and	and	CCONJ
ct-10123	240	22	the	the	DET
ct-10123	240	23	metabolite	metabolite	NOUN
ct-10123	240	24	ciprofloxacin	ciprofloxacin	NOUN
ct-10123	240	25	after	after	ADP
ct-10123	240	26	i.v	i.v	PROPN
ct-10123	240	27	.	.	PROPN
ct-10123	240	28	administration	administration	PROPN
ct-10123	240	29	of	of	ADP
ct-10123	240	30	enrofloxacin	enrofloxacin	PROPN
ct-10123	240	31	to	to	ADP
ct-10123	240	32	mares	mare	NOUN
ct-10123	240	33	.	.	PUNCT
ct-10123	241	1	j	j	PROPN
ct-10123	241	2	vet	vet	NOUN
ct-10123	241	3	pharmacol	pharmacol	PROPN
ct-10123	241	4	ther	ther	ADV
ct-10123	241	5	2002;25:343	2002;25:343	NUM
ct-10123	241	6	-	-	SYM
ct-10123	241	7	350	350	NUM
ct-10123	241	8	.	.	PUNCT
ct-10123	241	9	18	18	NUM
ct-10123	241	10	.	.	PUNCT
ct-10123	242	1	gonzalez	gonzalez	PROPN
ct-10123	242	2	c	c	PROPN
ct-10123	242	3	,	,	PUNCT
ct-10123	242	4	moreno	moreno	PROPN
ct-10123	242	5	l	l	PROPN
ct-10123	242	6	,	,	PUNCT
ct-10123	242	7	fumuso	fumuso	PROPN
ct-10123	242	8	e	e	PROPN
ct-10123	242	9	,	,	PUNCT
ct-10123	242	10	et	et	PROPN
ct-10123	242	11	al	al	PROPN
ct-10123	242	12	.	.	PROPN
ct-10123	242	13	enrofloxacin	enrofloxacin	PROPN
ct-10123	242	14	-	-	PUNCT
ct-10123	242	15	based	base	VERB
ct-10123	242	16	therapeutic	therapeutic	ADJ
ct-10123	242	17	strategy	strategy	NOUN
ct-10123	242	18	for	for	ADP
ct-10123	242	19	the	the	DET
ct-10123	242	20	prevention	prevention	NOUN
ct-10123	242	21	of	of	ADP
ct-10123	242	22	endometritis	endometritis	NOUN
ct-10123	242	23	in	in	ADP
ct-10123	242	24	susceptible	susceptible	ADJ
ct-10123	242	25	mares	mare	NOUN
ct-10123	242	26	.	.	PUNCT
ct-10123	243	1	j	j	PROPN
ct-10123	243	2	vet	vet	NOUN
ct-10123	243	3	pharmacol	pharmacol	PROPN
ct-10123	243	4	ther	ther	ADV
ct-10123	243	5	2010;33:287	2010;33:287	NOUN
ct-10123	243	6	-	-	PUNCT
ct-10123	243	7	294	294	NUM
ct-10123	243	8	.	.	PUNCT
ct-10123	244	1	19	19	NUM
ct-10123	244	2	.	.	PUNCT
ct-10123	245	1	troedsson	troedsson	PROPN
ct-10123	245	2	mh	mh	NOUN
ct-10123	245	3	:	:	PUNCT
ct-10123	245	4	treatment	treatment	NOUN
ct-10123	245	5	strategies	strategy	NOUN
ct-10123	245	6	in	in	ADP
ct-10123	245	7	mares	mare	NOUN
ct-10123	245	8	with	with	ADP
ct-10123	245	9	endometritis	endometritis	NOUN
ct-10123	245	10	:	:	PUNCT
ct-10123	245	11	proc	proc	PROPN
ct-10123	245	12	soc	soc	PROPN
ct-10123	245	13	therio	therio	PROPN
ct-10123	245	14	mare	mare	PROPN
ct-10123	245	15	reprod	reprod	PROPN
ct-10123	245	16	symp	symp	PROPN
ct-10123	245	17	1996	1996	NUM
ct-10123	245	18	.	.	PUNCT
ct-10123	246	1	p.	p.	NOUN
ct-10123	246	2	40	40	NUM
ct-10123	246	3	-	-	SYM
ct-10123	246	4	50	50	NUM
ct-10123	246	5	.	.	PUNCT
ct-10123	246	6	20	20	NUM
ct-10123	246	7	.	.	PUNCT
ct-10123	247	1	fumuso	fumuso	PROPN
ct-10123	247	2	e	e	PROPN
ct-10123	247	3	,	,	PUNCT
ct-10123	247	4	checura	checura	NOUN
ct-10123	247	5	c	c	PROPN
ct-10123	247	6	,	,	PUNCT
ct-10123	247	7	losinno	losinno	PROPN
ct-10123	247	8	l	l	PROPN
ct-10123	247	9	,	,	PUNCT
ct-10123	247	10	et	et	PROPN
ct-10123	247	11	al	al	PROPN
ct-10123	247	12	:	:	PUNCT
ct-10123	247	13	endometrial	endometrial	ADJ
ct-10123	247	14	tissue	tissue	NOUN
ct-10123	247	15	concentrations	concentration	NOUN
ct-10123	247	16	of	of	ADP
ct-10123	247	17	enrofloxacin	enrofloxacin	PROPN
ct-10123	247	18	after	after	ADP
ct-10123	247	19	intrauterine	intrauterine	ADJ
ct-10123	247	20	administration	administration	NOUN
ct-10123	247	21	to	to	ADP
ct-10123	247	22	mares	mare	NOUN
ct-10123	247	23	.	.	PUNCT
ct-10123	248	1	vet	vet	NOUN
ct-10123	248	2	res	re	NOUN
ct-10123	248	3	commun	commun	PROPN
ct-10123	248	4	2002;26:371	2002;26:371	PROPN
ct-10123	248	5	-	-	SYM
ct-10123	248	6	380	380	NUM
ct-10123	248	7	.	.	PUNCT
ct-10123	249	1	21	21	NUM
ct-10123	249	2	.	.	PUNCT
ct-10123	250	1	rodriguez	rodriguez	PROPN
ct-10123	250	2	js	js	PROPN
ct-10123	250	3	,	,	PUNCT
ct-10123	250	4	han	han	PROPN
ct-10123	250	5	s	s	PROPN
ct-10123	250	6	,	,	PUNCT
ct-10123	250	7	nielsen	nielsen	PROPN
ct-10123	250	8	s	s	PROPN
ct-10123	250	9	,	,	PUNCT
ct-10123	250	10	et	et	PROPN
ct-10123	250	11	al	al	PROPN
ct-10123	250	12	:	:	PUNCT
ct-10123	250	13	consequences	consequence	NOUN
ct-10123	250	14	of	of	ADP
ct-10123	250	15	intrauterine	intrauterine	ADJ
ct-10123	250	16	enrofloxacin	enrofloxacin	PROPN
ct-10123	250	17	infusion	infusion	NOUN
ct-10123	250	18	on	on	ADP
ct-10123	250	19	mare	mare	NOUN
ct-10123	250	20	endometrium	endometrium	NOUN
ct-10123	250	21	.	.	PUNCT
ct-10123	251	1	j	j	PROPN
ct-10123	251	2	equine	equine	PROPN
ct-10123	251	3	vet	vet	NOUN
ct-10123	251	4	sci	sci	PROPN
ct-10123	251	5	2012;32:106	2012;32:106	NUM
ct-10123	251	6	-	-	SYM
ct-10123	251	7	111	111	NUM
ct-10123	251	8	.	.	PUNCT
ct-10123	252	1	22	22	NUM
ct-10123	252	2	.	.	PUNCT
ct-10123	253	1	specht	specht	PROPN
ct-10123	253	2	te	te	PROPN
ct-10123	253	3	,	,	PUNCT
ct-10123	253	4	brown	brown	PROPN
ct-10123	253	5	mp	mp	PROPN
ct-10123	253	6	,	,	PUNCT
ct-10123	253	7	gronwall	gronwall	PROPN
ct-10123	253	8	rr	rr	PROPN
ct-10123	253	9	,	,	PUNCT
ct-10123	253	10	et	et	PROPN
ct-10123	253	11	al	al	PROPN
ct-10123	253	12	:	:	PUNCT
ct-10123	253	13	pharmacokinetics	pharmacokinetic	NOUN
ct-10123	253	14	of	of	ADP
ct-10123	253	15	metronidazole	metronidazole	NOUN
ct-10123	253	16	and	and	CCONJ
ct-10123	253	17	its	its	PRON
ct-10123	253	18	concentration	concentration	NOUN
ct-10123	253	19	in	in	ADP
ct-10123	253	20	body	body	NOUN
ct-10123	253	21	fluids	fluid	NOUN
ct-10123	253	22	and	and	CCONJ
ct-10123	253	23	endometrial	endometrial	ADJ
ct-10123	253	24	tissues	tissue	NOUN
ct-10123	253	25	of	of	ADP
ct-10123	253	26	mares	mare	NOUN
ct-10123	253	27	.	.	PUNCT
ct-10123	254	1	am	be	AUX
ct-10123	254	2	j	j	PROPN
ct-10123	254	3	vet	vet	NOUN
ct-10123	254	4	res	re	NOUN
ct-10123	254	5	1992;53:1807	1992;53:1807	NUM
ct-10123	254	6	-	-	SYM
ct-10123	254	7	1812	1812	NUM
ct-10123	254	8	.	.	PUNCT
ct-10123	255	1	23	23	NUM
ct-10123	255	2	.	.	X
ct-10123	255	3	beltaire	beltaire	PROPN
ct-10123	255	4	ka	ka	PROPN
ct-10123	255	5	,	,	PUNCT
ct-10123	255	6	cheong	cheong	PROPN
ct-10123	255	7	sh	sh	PROPN
ct-10123	255	8	,	,	PUNCT
ct-10123	255	9	coutinho	coutinho	PROPN
ct-10123	255	10	da	da	PROPN
ct-10123	255	11	silva	silva	PROPN
ct-10123	255	12	ma	ma	PROPN
ct-10123	255	13	:	:	PUNCT
ct-10123	255	14	retrospective	retrospective	ADJ
ct-10123	255	15	study	study	NOUN
ct-10123	255	16	on	on	ADP
ct-10123	255	17	equine	equine	NOUN
ct-10123	255	18	uterine	uterine	ADJ
ct-10123	255	19	fungal	fungal	ADJ
ct-10123	255	20	isolates	isolate	NOUN
ct-10123	255	21	and	and	CCONJ
ct-10123	255	22	antifungal	antifungal	ADJ
ct-10123	255	23	susceptibility	susceptibility	NOUN
ct-10123	255	24	patterns	pattern	NOUN
ct-10123	255	25	(	(	PUNCT
ct-10123	255	26	1999	1999	NUM
ct-10123	255	27	-	-	SYM
ct-10123	255	28	2011	2011	NUM
ct-10123	255	29	)	)	PUNCT
ct-10123	255	30	.	.	PUNCT
ct-10123	256	1	equine	equine	PROPN
ct-10123	256	2	vet	vet	PROPN
ct-10123	256	3	j	j	PROPN
ct-10123	256	4	2012;44:84	2012;44:84	PROPN
ct-10123	256	5	-	-	SYM
ct-10123	256	6	87	87	NUM
ct-10123	256	7	.	.	PUNCT
ct-10123	257	1	24	24	NUM
ct-10123	257	2	.	.	PUNCT
ct-10123	258	1	olsen	olsen	PROPN
ct-10123	258	2	lm	lm	PROPN
ct-10123	258	3	,	,	PUNCT
ct-10123	258	4	al	al	PROPN
ct-10123	258	5	-	-	PUNCT
ct-10123	258	6	bagdadi	bagdadi	PROPN
ct-10123	258	7	fk	fk	PROPN
ct-10123	258	8	,	,	PUNCT
ct-10123	258	9	richardson	richardson	PROPN
ct-10123	258	10	gf	gf	PROPN
ct-10123	258	11	,	,	PUNCT
ct-10123	258	12	et	et	PROPN
ct-10123	258	13	al	al	PROPN
ct-10123	258	14	:	:	PUNCT
ct-10123	258	15	a	a	DET
ct-10123	258	16	histological	histological	ADJ
ct-10123	258	17	study	study	NOUN
ct-10123	258	18	of	of	ADP
ct-10123	258	19	the	the	DET
ct-10123	258	20	effect	effect	NOUN
ct-10123	258	21	of	of	ADP
ct-10123	258	22	saline	saline	NOUN
ct-10123	258	23	and	and	CCONJ
ct-10123	258	24	povidone	povidone	NOUN
ct-10123	258	25	-	-	PUNCT
ct-10123	258	26	iodine	iodine	NOUN
ct-10123	258	27	infusions	infusion	NOUN
ct-10123	258	28	on	on	ADP
ct-10123	258	29	the	the	DET
ct-10123	258	30	equine	equine	NOUN
ct-10123	258	31	endometrium	endometrium	NOUN
ct-10123	258	32	.	.	PUNCT
ct-10123	259	1	theriogenology	theriogenology	NOUN
ct-10123	259	2	1992;37:1311	1992;37:1311	NUM
ct-10123	259	3	-	-	PUNCT
ct-10123	259	4	1325	1325	NUM
ct-10123	259	5	.	.	PUNCT
ct-10123	260	1	25	25	NUM
ct-10123	260	2	.	.	NUM
ct-10123	260	3	fuursted	fuurste	VERB
ct-10123	260	4	k	k	PROPN
ct-10123	260	5	,	,	PUNCT
ct-10123	260	6	hjort	hjort	NOUN
ct-10123	260	7	a	a	PRON
ct-10123	260	8	,	,	PUNCT
ct-10123	260	9	knudsen	knudsen	PROPN
ct-10123	260	10	l	l	PROPN
ct-10123	260	11	:	:	PUNCT
ct-10123	260	12	evaluation	evaluation	NOUN
ct-10123	260	13	of	of	ADP
ct-10123	260	14	bactericidal	bactericidal	ADJ
ct-10123	260	15	activity	activity	NOUN
ct-10123	260	16	and	and	CCONJ
ct-10123	260	17	lag	lag	NOUN
ct-10123	260	18	of	of	ADP
ct-10123	260	19	regrowth	regrowth	NOUN
ct-10123	260	20	(	(	PUNCT
ct-10123	260	21	postantibiotic	postantibiotic	ADJ
ct-10123	260	22	effect	effect	NOUN
ct-10123	260	23	)	)	PUNCT
ct-10123	260	24	of	of	ADP
ct-10123	260	25	five	five	NUM
ct-10123	260	26	antiseptics	antiseptic	NOUN
ct-10123	260	27	on	on	ADP
ct-10123	260	28	nine	nine	NUM
ct-10123	260	29	bacterial	bacterial	ADJ
ct-10123	260	30	pathogens	pathogen	NOUN
ct-10123	260	31	.	.	PUNCT
ct-10123	261	1	j	j	PROPN
ct-10123	261	2	antimicrob	antimicrob	PROPN
ct-10123	261	3	chemother	chemother	PROPN
ct-10123	261	4	1997;40:221	1997;40:221	PROPN
ct-10123	261	5	-	-	PUNCT
ct-10123	261	6	226	226	NUM
ct-10123	261	7	.	.	PUNCT
ct-10123	261	8	26	26	NUM
ct-10123	261	9	.	.	PUNCT
ct-10123	261	10	ritchie	ritchie	PROPN
ct-10123	261	11	bw	bw	PROPN
ct-10123	261	12	,	,	PUNCT
ct-10123	261	13	wooley	wooley	PROPN
ct-10123	261	14	re	re	PROPN
ct-10123	261	15	,	,	PUNCT
ct-10123	261	16	kemp	kemp	PROPN
ct-10123	261	17	dt	dt	PROPN
ct-10123	261	18	:	:	PUNCT
ct-10123	261	19	use	use	NOUN
ct-10123	261	20	of	of	ADP
ct-10123	261	21	potentiated	potentiate	VERB
ct-10123	261	22	antibiotics	antibiotic	NOUN
ct-10123	261	23	in	in	ADP
ct-10123	261	24	wound	wound	NOUN
ct-10123	261	25	management	management	NOUN
ct-10123	261	26	.	.	PUNCT
ct-10123	262	1	vet	vet	NOUN
ct-10123	262	2	clin	clin	PROPN
ct-10123	262	3	north	north	PROPN
ct-10123	262	4	am	be	AUX
ct-10123	262	5	exotic	exotic	ADJ
ct-10123	262	6	anim	anim	NOUN
ct-10123	262	7	pract	pract	NOUN
ct-10123	262	8	2004;7:169	2004;7:169	PROPN
ct-10123	262	9	-	-	SYM
ct-10123	262	10	189	189	NUM
ct-10123	262	11	.	.	PUNCT
ct-10123	262	12	27	27	NUM
ct-10123	262	13	.	.	PUNCT
ct-10123	263	1	nielsen	nielsen	PROPN
ct-10123	263	2	jm	jm	PROPN
ct-10123	263	3	:	:	PUNCT
ct-10123	263	4	endometritis	endometritis	VERB
ct-10123	263	5	in	in	ADP
ct-10123	263	6	the	the	DET
ct-10123	263	7	mare	mare	NOUN
ct-10123	263	8	:	:	PUNCT
ct-10123	263	9	a	a	DET
ct-10123	263	10	diagnostic	diagnostic	ADJ
ct-10123	263	11	study	study	NOUN
ct-10123	263	12	comparing	compare	VERB
ct-10123	263	13	cultures	culture	NOUN
ct-10123	263	14	from	from	ADP
ct-10123	263	15	swab	swab	NOUN
ct-10123	263	16	and	and	CCONJ
ct-10123	263	17	biopsy	biopsy	NOUN
ct-10123	263	18	.	.	PUNCT
ct-10123	264	1	theriogenology	theriogenology	NOUN
ct-10123	264	2	2005;64(3):510	2005;64(3):510	PROPN
ct-10123	264	3	-	-	SYM
ct-10123	264	4	8	8	NUM
ct-10123	264	5	.	.	PUNCT
ct-10123	264	6	28	28	NUM
ct-10123	264	7	.	.	PUNCT
ct-10123	265	1	overbeck	overbeck	PROPN
ct-10123	265	2	w	w	PROPN
ct-10123	265	3	,	,	PUNCT
ct-10123	265	4	witte	witte	PROPN
ct-10123	265	5	ts	ts	PROPN
ct-10123	265	6	,	,	PUNCT
ct-10123	265	7	heuwieser	heuwieser	PROPN
ct-10123	265	8	w	w	PROPN
ct-10123	265	9	:	:	PUNCT
ct-10123	265	10	comparison	comparison	NOUN
ct-10123	265	11	of	of	ADP
ct-10123	265	12	three	three	NUM
ct-10123	265	13	diagnostic	diagnostic	ADJ
ct-10123	265	14	methods	method	NOUN
ct-10123	265	15	to	to	PART
ct-10123	265	16	identify	identify	VERB
ct-10123	265	17	subclinical	subclinical	ADJ
ct-10123	265	18	endometritis	endometritis	NOUN
ct-10123	265	19	in	in	ADP
ct-10123	265	20	mares	mare	NOUN
ct-10123	265	21	.	.	PUNCT
ct-10123	266	1	theriogenology	theriogenology	NOUN
ct-10123	266	2	2011;75:1311	2011;75:1311	NUM
ct-10123	266	3	-	-	SYM
ct-10123	266	4	1318	1318	NUM
ct-10123	266	5	.	.	PUNCT
ct-10123	267	1	29	29	NUM
ct-10123	267	2	.	.	PUNCT
ct-10123	268	1	curras	curras	PROPN
ct-10123	268	2	m	m	PROPN
ct-10123	268	3	,	,	PUNCT
ct-10123	268	4	magarinos	magarinos	PROPN
ct-10123	268	5	b	b	PROPN
ct-10123	268	6	,	,	PUNCT
ct-10123	268	7	toranzo	toranzo	PROPN
ct-10123	268	8	ae	ae	PROPN
ct-10123	268	9	,	,	PUNCT
ct-10123	268	10	et	et	PROPN
ct-10123	268	11	al	al	PROPN
ct-10123	268	12	:	:	PUNCT
ct-10123	268	13	dormancy	dormancy	NOUN
ct-10123	268	14	as	as	ADP
ct-10123	268	15	a	a	DET
ct-10123	268	16	survival	survival	NOUN
ct-10123	268	17	strategy	strategy	NOUN
ct-10123	268	18	of	of	ADP
ct-10123	268	19	the	the	DET
ct-10123	268	20	fish	fish	NOUN
ct-10123	268	21	pathogen	pathogen	NOUN
ct-10123	268	22	streptococcus	streptococcus	NOUN
ct-10123	268	23	parauberis	parauberis	NOUN
ct-10123	268	24	in	in	ADP
ct-10123	268	25	the	the	DET
ct-10123	268	26	marine	marine	PROPN
ct-10123	268	27	environment	environment	NOUN
ct-10123	268	28	.	.	PUNCT
ct-10123	269	1	dis	dis	PROPN
ct-10123	269	2	aquat	aquat	VERB
ct-10123	269	3	organ	organ	NOUN
ct-10123	269	4	2002;52:129	2002;52:129	NUM
ct-10123	269	5	-	-	PUNCT
ct-10123	269	6	136	136	NUM
ct-10123	269	7	.	.	PUNCT
ct-10123	270	1	30	30	NUM
ct-10123	270	2	.	.	PUNCT
ct-10123	271	1	oliver	oliver	PROPN
ct-10123	271	2	jd	jd	PROPN
ct-10123	271	3	:	:	PUNCT
ct-10123	271	4	recent	recent	ADJ
ct-10123	271	5	findings	finding	NOUN
ct-10123	271	6	on	on	ADP
ct-10123	271	7	the	the	DET
ct-10123	271	8	viable	viable	ADJ
ct-10123	271	9	but	but	CCONJ
ct-10123	271	10	nonculturable	nonculturable	ADJ
ct-10123	271	11	state	state	NOUN
ct-10123	271	12	in	in	ADP
ct-10123	271	13	pathogenic	pathogenic	ADJ
ct-10123	271	14	bacteria	bacteria	NOUN
ct-10123	271	15	.	.	PUNCT
ct-10123	272	1	fems	fems	PROPN
ct-10123	272	2	microbiol	microbiol	PROPN
ct-10123	272	3	rev	rev	VERB
ct-10123	272	4	2010;34:415	2010;34:415	PROPN
ct-10123	272	5	-	-	SYM
ct-10123	272	6	425	425	NUM
ct-10123	272	7	.	.	PUNCT
ct-10123	273	1	31	31	NUM
ct-10123	273	2	.	.	PUNCT
ct-10123	274	1	keep	keep	VERB
ct-10123	274	2	nh	nh	PROPN
ct-10123	274	3	,	,	PUNCT
ct-10123	274	4	ward	ward	PROPN
ct-10123	274	5	jm	jm	PROPN
ct-10123	274	6	,	,	PUNCT
ct-10123	274	7	cohen	cohen	PROPN
ct-10123	274	8	-	-	PUNCT
ct-10123	274	9	gonsaud	gonsaud	PROPN
ct-10123	274	10	m	m	PROPN
ct-10123	274	11	,	,	PUNCT
ct-10123	274	12	et	et	PROPN
ct-10123	274	13	al	al	PROPN
ct-10123	274	14	:	:	PUNCT
ct-10123	274	15	wake	wake	VERB
ct-10123	274	16	up	up	ADP
ct-10123	274	17	!	!	PUNCT
ct-10123	275	1	peptidoglycan	peptidoglycan	ADJ
ct-10123	275	2	lysis	lysis	NOUN
ct-10123	275	3	and	and	CCONJ
ct-10123	275	4	bacterial	bacterial	ADJ
ct-10123	275	5	non	non	ADJ
ct-10123	275	6	-	-	ADJ
ct-10123	275	7	growth	growth	ADJ
ct-10123	275	8	states	state	NOUN
ct-10123	275	9	.	.	PUNCT
ct-10123	276	1	trends	trend	NOUN
ct-10123	276	2	microbiol	microbiol	VERB
ct-10123	276	3	2006;14:271	2006;14:271	NOUN
ct-10123	276	4	-	-	SYM
ct-10123	276	5	276	276	NUM
ct-10123	276	6	.	.	PUNCT
ct-10123	277	1	32	32	NUM
ct-10123	277	2	.	.	PUNCT
ct-10123	278	1	kana	kana	PROPN
ct-10123	278	2	bd	bd	PROPN
ct-10123	278	3	,	,	PUNCT
ct-10123	278	4	mizrahi	mizrahi	PROPN
ct-10123	278	5	v	v	PROPN
ct-10123	278	6	:	:	PUNCT
ct-10123	278	7	resuscitation	resuscitation	NOUN
ct-10123	278	8	-	-	PUNCT
ct-10123	278	9	promoting	promote	VERB
ct-10123	278	10	factors	factor	NOUN
ct-10123	278	11	as	as	ADP
ct-10123	278	12	lytic	lytic	ADJ
ct-10123	278	13	enzymes	enzyme	NOUN
ct-10123	278	14	for	for	ADP
ct-10123	278	15	bacterial	bacterial	ADJ
ct-10123	278	16	growth	growth	NOUN
ct-10123	278	17	and	and	CCONJ
ct-10123	278	18	signaling	signal	VERB
ct-10123	278	19	.	.	PUNCT
ct-10123	279	1	fems	fems	PROPN
ct-10123	279	2	immunol	immunol	PROPN
ct-10123	279	3	med	med	PROPN
ct-10123	279	4	microbiol	microbiol	NOUN
ct-10123	279	5	2010;58:39	2010;58:39	PROPN
ct-10123	279	6	-	-	PUNCT
ct-10123	279	7	50	50	NUM
ct-10123	279	8	.	.	PUNCT
ct-10123	279	9	33	33	NUM
ct-10123	279	10	.	.	PUNCT
ct-10123	280	1	petersen	petersen	PROPN
ct-10123	280	2	mr	mr	PROPN
ct-10123	280	3	,	,	PUNCT
ct-10123	280	4	lehn	lehn	PROPN
ct-10123	280	5	-	-	PUNCT
ct-10123	280	6	jensen	jensen	PROPN
ct-10123	280	7	h	h	PROPN
ct-10123	280	8	,	,	PUNCT
ct-10123	280	9	bojesen	bojesen	PROPN
ct-10123	280	10	am	be	AUX
ct-10123	280	11	:	:	PUNCT
ct-10123	280	12	use	use	NOUN
ct-10123	280	13	of	of	ADP
ct-10123	280	14	fluorescent	fluorescent	NOUN
ct-10123	280	15	in	in	ADP
ct-10123	280	16	situ	situ	ADJ
ct-10123	280	17	hybridization	hybridization	NOUN
ct-10123	280	18	(	(	PUNCT
ct-10123	280	19	fish	fish	NOUN
ct-10123	280	20	)	)	PUNCT
ct-10123	280	21	to	to	PART
ct-10123	280	22	identify	identify	VERB
ct-10123	280	23	endometritis	endometritis	NOUN
ct-10123	280	24	pathogens	pathogen	NOUN
ct-10123	280	25	in	in	ADP
ct-10123	280	26	the	the	DET
ct-10123	280	27	mare	mare	NOUN
ct-10123	280	28	(	(	PUNCT
ct-10123	280	29	abstract	abstract	ADJ
ct-10123	280	30	)	)	PUNCT
ct-10123	280	31	.	.	PUNCT
ct-10123	281	1	j	j	PROPN
ct-10123	281	2	anim	anim	NOUN
ct-10123	281	3	sci	sci	PROPN
ct-10123	281	4	2010;88[e	2010;88[e	PROPN
ct-10123	281	5	-	-	PUNCT
ct-10123	281	6	suppl]:1097	suppl]:1097	PROPN
ct-10123	281	7	.	.	PUNCT
ct-10123	282	1	512clinical	512clinical	ADJ
ct-10123	282	2	theriogenology	theriogenology	NOUN
ct-10123	282	3	•	•	NOUN
ct-10123	282	4	volume	volume	NOUN
ct-10123	282	5	5	5	NUM
ct-10123	282	6	,	,	PUNCT
ct-10123	282	7	number	number	NOUN
ct-10123	282	8	4	4	NUM
ct-10123	282	9	•	•	NOUN
ct-10123	282	10	december	december	PROPN
ct-10123	282	11	2013	2013	NUM
ct-10123	282	12	34	34	NUM
ct-10123	282	13	.	.	PUNCT
ct-10123	283	1	petersen	petersen	PROPN
ct-10123	283	2	mr	mr	PROPN
ct-10123	283	3	,	,	PUNCT
ct-10123	283	4	lu	lu	PROPN
ct-10123	283	5	kg	kg	PROPN
ct-10123	283	6	,	,	PUNCT
ct-10123	283	7	christoffersen	christoffersen	VERB
ct-10123	283	8	m	m	PRON
ct-10123	283	9	,	,	PUNCT
ct-10123	283	10	et	et	PROPN
ct-10123	283	11	al	al	PROPN
ct-10123	283	12	:	:	PUNCT
ct-10123	283	13	chronic	chronic	ADJ
ct-10123	283	14	streptococcus	streptococcus	NOUN
ct-10123	283	15	equi	equi	NOUN
ct-10123	283	16	subspecies	subspecie	NOUN
ct-10123	283	17	zooepidemicus	zooepidemicus	PROPN
ct-10123	283	18	endometritis	endometritis	PROPN
ct-10123	283	19	in	in	ADP
ct-10123	283	20	the	the	DET
ct-10123	283	21	mare	mare	NOUN
ct-10123	283	22	-	-	PUNCT
ct-10123	283	23	induction	induction	NOUN
ct-10123	283	24	of	of	ADP
ct-10123	283	25	active	active	ADJ
ct-10123	283	26	growth	growth	NOUN
ct-10123	283	27	and	and	CCONJ
ct-10123	283	28	treatment	treatment	NOUN
ct-10123	283	29	improves	improve	VERB
ct-10123	283	30	diagnosis	diagnosis	NOUN
ct-10123	283	31	and	and	CCONJ
ct-10123	283	32	fertility	fertility	NOUN
ct-10123	283	33	in	in	ADP
ct-10123	283	34	the	the	DET
ct-10123	283	35	subfertile	subfertile	ADJ
ct-10123	283	36	thoroughbred	thoroughbred	ADJ
ct-10123	283	37	mare	mare	NOUN
ct-10123	283	38	.	.	PUNCT
ct-10123	284	1	proc	proc	PROPN
ct-10123	284	2	havemeyer	havemeyer	NOUN
ct-10123	284	3	workshop	workshop	NOUN
ct-10123	284	4	strangles	strangle	NOUN
ct-10123	284	5	and	and	CCONJ
ct-10123	284	6	other	other	ADJ
ct-10123	284	7	streptococcal	streptococcal	ADJ
ct-10123	284	8	diseases	disease	NOUN
ct-10123	284	9	2012	2012	NUM
ct-10123	284	10	.	.	PUNCT
ct-10123	285	1	35	35	NUM
ct-10123	285	2	.	.	X
ct-10123	285	3	brinsko	brinsko	PROPN
ct-10123	285	4	sp	sp	NOUN
ct-10123	285	5	:	:	PUNCT
ct-10123	285	6	common	common	ADJ
ct-10123	285	7	procedures	procedure	NOUN
ct-10123	285	8	in	in	ADP
ct-10123	285	9	broodmare	broodmare	ADJ
ct-10123	285	10	practice	practice	NOUN
ct-10123	285	11	:	:	PUNCT
ct-10123	285	12	what	what	PRON
ct-10123	285	13	is	be	AUX
ct-10123	285	14	the	the	DET
ct-10123	285	15	evidence	evidence	NOUN
ct-10123	285	16	?	?	PUNCT
ct-10123	286	1	vet	vet	NOUN
ct-10123	286	2	clin	clin	PROPN
ct-10123	286	3	north	north	PROPN
ct-10123	286	4	am	be	AUX
ct-10123	286	5	equine	equine	NOUN
ct-10123	286	6	pract	pract	NOUN
ct-10123	286	7	2007;23:385	2007;23:385	PROPN
ct-10123	286	8	-	-	SYM
ct-10123	286	9	402	402	NUM
ct-10123	286	10	.	.	PUNCT
ct-10123	287	1	36	36	NUM
ct-10123	287	2	.	.	PUNCT
ct-10123	288	1	bosh	bosh	PROPN
ct-10123	288	2	ka	ka	PROPN
ct-10123	288	3	,	,	PUNCT
ct-10123	288	4	powell	powell	PROPN
ct-10123	288	5	d	d	PROPN
ct-10123	288	6	,	,	PUNCT
ct-10123	288	7	neibergs	neibergs	NOUN
ct-10123	288	8	js	js	PROPN
ct-10123	288	9	,	,	PUNCT
ct-10123	288	10	et	et	PROPN
ct-10123	288	11	al	al	PROPN
ct-10123	288	12	:	:	PUNCT
ct-10123	288	13	impact	impact	NOUN
ct-10123	288	14	of	of	ADP
ct-10123	288	15	reproductive	reproductive	ADJ
ct-10123	288	16	efficiency	efficiency	NOUN
ct-10123	288	17	over	over	ADP
ct-10123	288	18	time	time	NOUN
ct-10123	288	19	and	and	CCONJ
ct-10123	288	20	mare	mare	NOUN
ct-10123	288	21	financial	financial	ADJ
ct-10123	288	22	value	value	NOUN
ct-10123	288	23	on	on	ADP
ct-10123	288	24	economic	economic	ADJ
ct-10123	288	25	returns	return	NOUN
ct-10123	288	26	among	among	ADP
ct-10123	288	27	thoroughbred	thoroughbred	ADJ
ct-10123	288	28	mares	mare	NOUN
ct-10123	288	29	in	in	ADP
ct-10123	288	30	central	central	ADJ
ct-10123	288	31	kentucky	kentucky	PROPN
ct-10123	288	32	.	.	PUNCT
ct-10123	289	1	equine	equine	PROPN
ct-10123	289	2	vet	vet	PROPN
ct-10123	289	3	j	j	PROPN
ct-10123	289	4	2009;41:889	2009;41:889	PROPN
ct-10123	289	5	-	-	SYM
ct-10123	289	6	894	894	NUM
ct-10123	289	7	.	.	PUNCT
ct-10123	289	8	37	37	NUM
ct-10123	289	9	.	.	PUNCT
ct-10123	290	1	erol	erol	PROPN
ct-10123	290	2	e	e	NOUN
ct-10123	290	3	,	,	PUNCT
ct-10123	290	4	locke	locke	PROPN
ct-10123	290	5	sj	sj	PROPN
ct-10123	290	6	,	,	PUNCT
ct-10123	290	7	donahoe	donahoe	PROPN
ct-10123	290	8	jk	jk	PROPN
ct-10123	290	9	,	,	PUNCT
ct-10123	290	10	et	et	PROPN
ct-10123	290	11	al	al	PROPN
ct-10123	290	12	:	:	PUNCT
ct-10123	290	13	beta	beta	ADJ
ct-10123	290	14	-	-	PUNCT
ct-10123	290	15	hemolytic	hemolytic	ADJ
ct-10123	290	16	streptococcus	streptococcus	NOUN
ct-10123	290	17	spp	spp	NOUN
ct-10123	290	18	.	.	PUNCT
ct-10123	290	19	from	from	ADP
ct-10123	290	20	horses	horse	NOUN
ct-10123	290	21	:	:	PUNCT
ct-10123	290	22	a	a	DET
ct-10123	290	23	retrospective	retrospective	ADJ
ct-10123	290	24	study	study	NOUN
ct-10123	290	25	(	(	PUNCT
ct-10123	290	26	20002010	20002010	NUM
ct-10123	290	27	)	)	PUNCT
ct-10123	290	28	.	.	PUNCT
ct-10123	291	1	j	j	PROPN
ct-10123	291	2	vet	vet	PROPN
ct-10123	291	3	diagn	diagn	PROPN
ct-10123	291	4	invest	invest	VERB
ct-10123	291	5	2012;24:142	2012;24:142	NUM
ct-10123	291	6	-	-	SYM
ct-10123	291	7	147	147	NUM
ct-10123	291	8	.	.	PUNCT
ct-10123	292	1	38	38	NUM
ct-10123	292	2	.	.	PUNCT
ct-10123	293	1	giles	giles	PROPN
ct-10123	293	2	rc	rc	PROPN
ct-10123	293	3	,	,	PUNCT
ct-10123	293	4	donahue	donahue	PROPN
ct-10123	293	5	jm	jm	PROPN
ct-10123	293	6	,	,	PUNCT
ct-10123	293	7	hong	hong	PROPN
ct-10123	293	8	cb	cb	PROPN
ct-10123	293	9	,	,	PUNCT
ct-10123	293	10	et	et	PROPN
ct-10123	293	11	al	al	PROPN
ct-10123	293	12	:	:	PUNCT
ct-10123	293	13	causes	cause	NOUN
ct-10123	293	14	of	of	ADP
ct-10123	293	15	abortion	abortion	NOUN
ct-10123	293	16	,	,	PUNCT
ct-10123	293	17	stillbirth	stillbirth	NOUN
ct-10123	293	18	,	,	PUNCT
ct-10123	293	19	and	and	CCONJ
ct-10123	293	20	perinatal	perinatal	ADJ
ct-10123	293	21	death	death	NOUN
ct-10123	293	22	in	in	ADP
ct-10123	293	23	horses	horse	NOUN
ct-10123	293	24	:	:	PUNCT
ct-10123	293	25	3,527	3,527	NUM
ct-10123	293	26	cases	case	NOUN
ct-10123	293	27	(	(	PUNCT
ct-10123	293	28	19861991	19861991	NUM
ct-10123	293	29	)	)	PUNCT
ct-10123	293	30	.	.	PUNCT
ct-10123	294	1	j	j	PROPN
ct-10123	294	2	am	be	AUX
ct-10123	294	3	vet	vet	NOUN
ct-10123	294	4	med	med	ADJ
ct-10123	294	5	assoc	assoc	PROPN
ct-10123	294	6	1993;203:1170	1993;203:1170	PROPN
ct-10123	294	7	-	-	SYM
ct-10123	294	8	1175	1175	NUM
ct-10123	294	9	.	.	PUNCT
ct-10123	295	1	39	39	NUM
ct-10123	295	2	.	.	PUNCT
ct-10123	296	1	murchie	murchie	VERB
ct-10123	296	2	ta	ta	PROPN
ct-10123	296	3	,	,	PUNCT
ct-10123	296	4	macpherson	macpherson	PROPN
ct-10123	296	5	ml	ml	PROPN
ct-10123	296	6	,	,	PUNCT
ct-10123	296	7	leblanc	leblanc	PROPN
ct-10123	296	8	mm	mm	PROPN
ct-10123	296	9	,	,	PUNCT
ct-10123	296	10	et	et	PROPN
ct-10123	296	11	al	al	PROPN
ct-10123	296	12	:	:	PUNCT
ct-10123	296	13	continuous	continuous	ADJ
ct-10123	296	14	monitoring	monitoring	NOUN
ct-10123	296	15	of	of	ADP
ct-10123	296	16	penicillin	penicillin	NOUN
ct-10123	296	17	g	g	PROPN
ct-10123	296	18	and	and	CCONJ
ct-10123	296	19	gentamicin	gentamicin	VERB
ct-10123	296	20	in	in	ADP
ct-10123	296	21	allantoic	allantoic	NOUN
ct-10123	296	22	fluid	fluid	NOUN
ct-10123	296	23	of	of	ADP
ct-10123	296	24	pregnant	pregnant	ADJ
ct-10123	296	25	pony	pony	NOUN
ct-10123	296	26	mares	mare	NOUN
ct-10123	296	27	by	by	ADP
ct-10123	296	28	in	in	ADP
ct-10123	296	29	vivo	vivo	ADJ
ct-10123	296	30	microdialysis	microdialysis	NOUN
ct-10123	296	31	.	.	PUNCT
ct-10123	297	1	equine	equine	NOUN
ct-10123	297	2	vet	vet	NOUN
ct-10123	297	3	j	j	PROPN
ct-10123	297	4	2006;38:520	2006;38:520	PROPN
ct-10123	297	5	-	-	SYM
ct-10123	297	6	525	525	NUM
ct-10123	297	7	.	.	PUNCT
ct-10123	297	8	40	40	NUM
ct-10123	297	9	.	.	PUNCT
ct-10123	298	1	macpherson	macpherson	PROPN
ct-10123	298	2	ml	ml	NOUN
ct-10123	298	3	:	:	PUNCT
ct-10123	298	4	treatment	treatment	NOUN
ct-10123	298	5	strategies	strategy	NOUN
ct-10123	298	6	for	for	ADP
ct-10123	298	7	mares	mare	NOUN
ct-10123	298	8	with	with	ADP
ct-10123	298	9	placentitis	placentitis	PROPN
ct-10123	298	10	.	.	PUNCT
ct-10123	299	1	theriogenology	theriogenology	NOUN
ct-10123	299	2	2005;64:528	2005;64:528	NUM
ct-10123	299	3	-	-	PUNCT
ct-10123	299	4	534	534	NUM
ct-10123	299	5	.	.	PUNCT
ct-10123	299	6	41	41	NUM
ct-10123	299	7	.	.	PUNCT
ct-10123	300	1	bailey	bailey	PROPN
ct-10123	300	2	cs	cs	PROPN
ct-10123	300	3	,	,	PUNCT
ct-10123	300	4	macpherson	macpherson	PROPN
ct-10123	300	5	ml	ml	PROPN
ct-10123	300	6	,	,	PUNCT
ct-10123	300	7	pozor	pozor	PROPN
ct-10123	300	8	ma	ma	PROPN
ct-10123	300	9	,	,	PUNCT
ct-10123	300	10	et	et	PROPN
ct-10123	300	11	al	al	PROPN
ct-10123	300	12	.	.	PROPN
ct-10123	300	13	treatment	treatment	NOUN
ct-10123	300	14	efficacy	efficacy	NOUN
ct-10123	300	15	of	of	ADP
ct-10123	300	16	trimethoprim	trimethoprim	ADJ
ct-10123	300	17	sulfamethoxazole	sulfamethoxazole	NOUN
ct-10123	300	18	,	,	PUNCT
ct-10123	300	19	pentoxifylline	pentoxifylline	NOUN
ct-10123	300	20	and	and	CCONJ
ct-10123	300	21	altrenogest	altrenogest	NOUN
ct-10123	300	22	in	in	ADP
ct-10123	300	23	experimentally	experimentally	ADV
ct-10123	300	24	induced	induce	VERB
ct-10123	300	25	equine	equine	NOUN
ct-10123	300	26	placentitis	placentitis	PROPN
ct-10123	300	27	.	.	PUNCT
ct-10123	301	1	theriogenology	theriogenology	NOUN
ct-10123	301	2	2010;74:402	2010;74:402	PROPN
ct-10123	301	3	-	-	SYM
ct-10123	301	4	412	412	NUM
ct-10123	301	5	.	.	PUNCT
ct-10123	302	1	513	513	NUM
ct-10123	302	2	clinical	clinical	ADJ
ct-10123	302	3	theriogenology	theriogenology	NOUN
ct-10123	302	4	•	•	NOUN
ct-10123	302	5	volume	volume	NOUN
ct-10123	302	6	5	5	NUM
ct-10123	302	7	,	,	PUNCT
ct-10123	302	8	number	number	NOUN
ct-10123	302	9	4	4	NUM
ct-10123	302	10	•	•	NOUN
ct-10123	302	11	december	december	PROPN
ct-10123	302	12	2013	2013	NUM
ct-10123	302	13	table	table	NOUN
ct-10123	302	14	1	1	NUM
ct-10123	302	15	.	.	PUNCT
ct-10123	302	16	antimicrobial	antimicrobial	ADJ
ct-10123	302	17	routes	route	NOUN
ct-10123	302	18	and	and	CCONJ
ct-10123	302	19	doses	dose	NOUN
ct-10123	302	20	antimicrobial	antimicrobial	ADJ
ct-10123	302	21	systemic	systemic	ADJ
ct-10123	302	22	dose	dose	NOUN
ct-10123	302	23	intrauterine	intrauterine	NOUN
ct-10123	302	24	dose	dose	NOUN
ct-10123	302	25	procaine	procaine	PROPN
ct-10123	302	26	penicillin	penicillin	PROPN
ct-10123	302	27	g	g	PROPN
ct-10123	302	28	22,000	22,000	NUM
ct-10123	302	29	iu	iu	NOUN
ct-10123	302	30	/	/	SYM
ct-10123	302	31	kg	kg	PROPN
ct-10123	302	32	5	5	NUM
ct-10123	302	33	million	million	NUM
ct-10123	302	34	iu	iu	ADP
ct-10123	302	35	potassium	potassium	NOUN
ct-10123	302	36	penicillin	penicillin	NOUN
ct-10123	302	37	22,000	22,000	NUM
ct-10123	302	38	iu	iu	NOUN
ct-10123	302	39	/	/	SYM
ct-10123	302	40	kg	kg	PROPN
ct-10123	302	41	5	5	NUM
ct-10123	302	42	million	million	NUM
ct-10123	302	43	iu	iu	ADP
ct-10123	302	44	ampicillin	ampicillin	PROPN
ct-10123	302	45	20	20	NUM
ct-10123	302	46	-	-	SYM
ct-10123	302	47	40	40	NUM
ct-10123	302	48	mg	mg	NUM
ct-10123	302	49	/	/	SYM
ct-10123	302	50	kg	kg	NOUN
ct-10123	302	51	iv	iv	NOUN
ct-10123	302	52	tidqid	tidqid	NOUN
ct-10123	302	53	3	3	NUM
ct-10123	302	54	g	g	PROPN
ct-10123	302	55	ticarcillin	ticarcillin	NOUN
ct-10123	302	56	and	and	CCONJ
ct-10123	302	57	clavulanic	clavulanic	ADJ
ct-10123	302	58	acid	acid	NOUN
ct-10123	302	59	50	50	NUM
ct-10123	302	60	-	-	SYM
ct-10123	302	61	60	60	NUM
ct-10123	302	62	mg	mg	NUM
ct-10123	302	63	/	/	SYM
ct-10123	302	64	kg	kg	NOUN
ct-10123	302	65	iv	iv	PROPN
ct-10123	302	66	tidqid	tidqid	NOUN
ct-10123	302	67	3.1	3.1	NUM
ct-10123	302	68	-	-	SYM
ct-10123	302	69	6.2	6.2	NUM
ct-10123	302	70	g	g	NOUN
ct-10123	302	71	0.5	0.5	NUM
ct-10123	302	72	to	to	PART
ct-10123	302	73	1.5	1.5	NUM
ct-10123	302	74	mg	mg	NOUN
ct-10123	302	75	/	/	SYM
ct-10123	302	76	ml	ml	X
ct-10123	302	77	in	in	ADP
ct-10123	302	78	inra96	inra96	ADJ
ct-10123	302	79	ceftiofur	ceftiofur	NOUN
ct-10123	302	80	sodium	sodium	NOUN
ct-10123	302	81	2.2	2.2	NUM
ct-10123	302	82	mg	mg	NOUN
ct-10123	302	83	/	/	SYM
ct-10123	302	84	kg	kg	PROPN
ct-10123	302	85	iv	iv	PROPN
ct-10123	302	86	/	/	SYM
ct-10123	302	87	im	im	NOUN
ct-10123	302	88	sidbid	sidbid	VERB
ct-10123	302	89	1	1	NUM
ct-10123	302	90	g	g	NOUN
ct-10123	302	91	marketed	market	VERB
ct-10123	302	92	as	as	ADP
ct-10123	302	93	naxcel	naxcel	NOUN
ct-10123	302	94	in	in	ADP
ct-10123	302	95	us	we	PRON
ct-10123	302	96	ceftiofur	ceftiofur	NOUN
ct-10123	302	97	crystalline	crystalline	NOUN
ct-10123	302	98	free	free	ADJ
ct-10123	302	99	acid	acid	PROPN
ct-10123	302	100	6.6	6.6	NUM
ct-10123	302	101	mg	mg	NOUN
ct-10123	302	102	/	/	SYM
ct-10123	302	103	kg	kg	PROPN
ct-10123	303	1	i	i	NOUN
ct-10123	303	2	m	m	VERB
ct-10123	303	3	2	2	NUM
ct-10123	303	4	doses	dose	NOUN
ct-10123	303	5	4	4	NUM
ct-10123	303	6	days	day	NOUN
ct-10123	303	7	apart	apart	ADV
ct-10123	303	8	marketed	market	VERB
ct-10123	303	9	as	as	ADP
ct-10123	303	10	excede	excede	NOUN
ct-10123	303	11	in	in	ADP
ct-10123	303	12	us	we	PRON
ct-10123	303	13	ceftiofur	ceftiofur	NOUN
ct-10123	303	14	hydrochloride	hydrochloride	NOUN
ct-10123	303	15	1	1	NUM
ct-10123	303	16	g	g	NOUN
ct-10123	303	17	marketed	market	VERB
ct-10123	303	18	as	as	ADP
ct-10123	303	19	excenel	excenel	NOUN
ct-10123	303	20	in	in	ADP
ct-10123	303	21	us	us	PROPN
ct-10123	303	22	polymyxin	polymyxin	PROPN
ct-10123	303	23	b	b	PROPN
ct-10123	303	24	6000	6000	NUM
ct-10123	303	25	u	u	NOUN
ct-10123	303	26	/	/	SYM
ct-10123	303	27	kg	kg	PROPN
ct-10123	303	28	iv	iv	NOUN
ct-10123	303	29	bidtid	bidtid	NOUN
ct-10123	303	30	(	(	PUNCT
ct-10123	303	31	antiendotoxic	antiendotoxic	ADJ
ct-10123	303	32	)	)	PUNCT
ct-10123	303	33	1	1	NUM
ct-10123	303	34	million	million	NUM
ct-10123	303	35	u	u	NOUN
ct-10123	303	36	amikacin	amikacin	PROPN
ct-10123	303	37	10	10	NUM
ct-10123	303	38	-	-	SYM
ct-10123	303	39	15	15	NUM
ct-10123	303	40	mg	mg	PROPN
ct-10123	303	41	/	/	SYM
ct-10123	303	42	kg	kg	PROPN
ct-10123	303	43	iv	iv	NUM
ct-10123	303	44	sid	sid	PROPN
ct-10123	303	45	(	(	PUNCT
ct-10123	303	46	adults	adult	NOUN
ct-10123	303	47	)	)	PUNCT
ct-10123	303	48	2	2	NUM
ct-10123	303	49	g	g	NOUN
ct-10123	303	50	gentamicin	gentamicin	VERB
ct-10123	303	51	6.6	6.6	NUM
ct-10123	303	52	mg	mg	NOUN
ct-10123	303	53	/	/	SYM
ct-10123	303	54	kg	kg	NOUN
ct-10123	303	55	iv	iv	NUM
ct-10123	303	56	sid	sid	PROPN
ct-10123	303	57	500	500	NUM
ct-10123	303	58	-	-	SYM
ct-10123	303	59	2000	2000	NUM
ct-10123	303	60	mg	mg	NOUN
ct-10123	303	61	buffered	buffer	VERB
ct-10123	303	62	or	or	CCONJ
ct-10123	303	63	diluted	dilute	VERB
ct-10123	303	64	oxytetracycline	oxytetracycline	NOUN
ct-10123	303	65	6.6	6.6	NUM
ct-10123	303	66	-	-	SYM
ct-10123	303	67	10	10	NUM
ct-10123	303	68	mg	mg	NUM
ct-10123	303	69	/	/	SYM
ct-10123	303	70	kg	kg	PROPN
ct-10123	303	71	sidbid	sidbid	VERB
ct-10123	303	72	slow	slow	ADJ
ct-10123	303	73	dilute	dilute	NOUN
ct-10123	303	74	iv	iv	NUM
ct-10123	303	75	(	(	PUNCT
ct-10123	303	76	6	6	NUM
ct-10123	303	77	g	g	NOUN
ct-10123	303	78	)	)	PUNCT
ct-10123	303	79	*	*	PUNCT
ct-10123	304	1	*	*	PUNCT
ct-10123	304	2	pending	pende	VERB
ct-10123	304	3	further	further	ADJ
ct-10123	304	4	study	study	NOUN
ct-10123	304	5	doxycycline	doxycycline	NOUN
ct-10123	304	6	10	10	NUM
ct-10123	304	7	mg	mg	PROPN
ct-10123	304	8	/	/	SYM
ct-10123	304	9	kg	kg	PROPN
ct-10123	304	10	po	po	NOUN
ct-10123	304	11	bid	bid	VERB
ct-10123	304	12	enrofloxacin	enrofloxacin	PROPN
ct-10123	304	13	6	6	NUM
ct-10123	304	14	mg	mg	NOUN
ct-10123	304	15	/	/	SYM
ct-10123	304	16	kg	kg	NOUN
ct-10123	304	17	iv	iv	NUM
ct-10123	304	18	sid	sid	PROPN
ct-10123	304	19	ciprofloxacin	ciprofloxacin	PROPN
ct-10123	304	20	2.5	2.5	NUM
ct-10123	304	21	g	g	NOUN
ct-10123	304	22	po	po	PROPN
ct-10123	304	23	sid	sid	PROPN
ct-10123	304	24	with	with	ADP
ct-10123	304	25	1	1	NUM
ct-10123	304	26	g	g	PROPN
ct-10123	304	27	probenecid	probenecid	PROPN
ct-10123	304	28	po	po	PROPN
ct-10123	304	29	sid	sid	PROPN
ct-10123	304	30	amphotericin	amphotericin	ADP
ct-10123	304	31	b	b	PROPN
ct-10123	304	32	0.3	0.3	NUM
ct-10123	304	33	-	-	SYM
ct-10123	304	34	0.5	0.5	NUM
ct-10123	304	35	mg	mg	PROPN
ct-10123	304	36	/	/	SYM
ct-10123	304	37	kg	kg	NOUN
ct-10123	304	38	iv	iv	NUM
ct-10123	304	39	eod	eod	NOUN
ct-10123	304	40	100	100	NUM
ct-10123	304	41	-	-	SYM
ct-10123	304	42	200	200	NUM
ct-10123	304	43	mg	mg	PROPN
ct-10123	304	44	nystatin	nystatin	PROPN
ct-10123	304	45	0.5	0.5	NUM
ct-10123	304	46	-	-	SYM
ct-10123	304	47	2.5	2.5	NUM
ct-10123	304	48	million	million	NUM
ct-10123	304	49	u	u	NOUN
ct-10123	304	50	ketoconazole	ketoconazole	NOUN
ct-10123	304	51	10	10	NUM
ct-10123	304	52	mg	mg	PROPN
ct-10123	304	53	/	/	SYM
ct-10123	304	54	kg	kg	PROPN
ct-10123	304	55	in	in	ADP
ct-10123	304	56	0.2n	0.2n	PROPN
ct-10123	304	57	hcl	hcl	PROPN
ct-10123	304	58	ngtube	ngtube	PROPN
ct-10123	304	59	bid	bid	VERB
ct-10123	304	60	clotrimazole	clotrimazole	NOUN
ct-10123	304	61	500	500	NUM
ct-10123	304	62	-	-	SYM
ct-10123	304	63	700	700	NUM
ct-10123	304	64	mg	mg	PROPN
ct-10123	304	65	miconazole	miconazole	NOUN
ct-10123	304	66	400	400	NUM
ct-10123	304	67	-	-	SYM
ct-10123	304	68	700	700	NUM
ct-10123	304	69	mg	mg	PROPN
ct-10123	304	70	itraconazole	itraconazole	NOUN
ct-10123	304	71	6	6	NUM
ct-10123	304	72	mg	mg	NOUN
ct-10123	304	73	/	/	SYM
ct-10123	304	74	kg	kg	PROPN
ct-10123	304	75	po	po	PROPN
ct-10123	304	76	sid	sid	PROPN
ct-10123	304	77	fluconazole	fluconazole	PROPN
ct-10123	304	78	5	5	NUM
ct-10123	304	79	mg	mg	NUM
ct-10123	304	80	/	/	SYM
ct-10123	304	81	kg	kg	PROPN
ct-10123	304	82	po	po	PROPN
ct-10123	304	83	sid	sid	PROPN
ct-10123	304	84	100	100	NUM
ct-10123	304	85	mg	mg	PROPN
ct-10123	304	86	514clinical	514clinical	PROPN
ct-10123	304	87	theriogenology	theriogenology	NOUN
ct-10123	304	88	•	•	NOUN
ct-10123	304	89	volume	volume	NOUN
ct-10123	304	90	5	5	NUM
ct-10123	304	91	,	,	PUNCT
ct-10123	304	92	number	number	NOUN
ct-10123	304	93	4	4	NUM
ct-10123	304	94	•	•	NOUN
ct-10123	304	95	december	december	PROPN
ct-10123	304	96	2013	2013	NUM
ct-10123	304	97	t	t	PROPN
ct-10123	304	98	ab	ab	PROPN
ct-10123	304	99	le	le	X
ct-10123	304	100	2	2	NUM
ct-10123	304	101	.	.	PUNCT
ct-10123	305	1	s	s	PART
ct-10123	305	2	en	en	ADP
ct-10123	305	3	si	si	X
ct-10123	305	4	ti	ti	PROPN
ct-10123	305	5	vi	vi	NOUN
ct-10123	306	1	ty	ty	INTJ
ct-10123	307	1	o	o	NOUN
ct-10123	307	2	f	f	X
ct-10123	307	3	ut	ut	PROPN
ct-10123	307	4	er	er	INTJ
ct-10123	307	5	in	in	ADP
ct-10123	307	6	e	e	PROPN
ct-10123	307	7	or	or	CCONJ
ct-10123	307	8	ga	ga	PROPN
ct-10123	307	9	ni	ni	PROPN
ct-10123	307	10	sm	sm	PROPN
ct-10123	307	11	s	s	PROPN
ct-10123	307	12	is	be	AUX
ct-10123	307	13	ol	ol	ADJ
ct-10123	307	14	at	at	ADP
ct-10123	307	15	ed	ed	PROPN
ct-10123	307	16	a	a	DET
ct-10123	307	17	t	t	PROPN
ct-10123	307	18	h	h	NOUN
ct-10123	307	19	ag	ag	PROPN
ct-10123	307	20	ya	ya	PROPN
ct-10123	307	21	rd	rd	PROPN
ct-10123	307	22	l	l	PROPN
ct-10123	307	23	ab	ab	PROPN
ct-10123	307	24	or	or	CCONJ
ct-10123	307	25	to	to	PART
ct-10123	307	26	ry	ry	VERB
ct-10123	307	27	in	in	ADP
ct-10123	307	28	2	2	NUM
ct-10123	307	29	01	01	NUM
ct-10123	307	30	2	2	NUM
ct-10123	307	31	.	.	PUNCT
ct-10123	308	1	r	r	NOUN
ct-10123	308	2	es	es	NOUN
ct-10123	308	3	ul	ul	INTJ
ct-10123	308	4	ts	ts	ADP
ct-10123	308	5	a	a	DET
ct-10123	308	6	re	re	ADJ
ct-10123	308	7	b	b	NOUN
ct-10123	308	8	as	as	ADP
ct-10123	308	9	ed	ed	PROPN
ct-10123	308	10	o	o	PROPN
ct-10123	308	11	n	n	NUM
ct-10123	308	12	cu	cu	NOUN
ct-10123	308	13	lt	lt	INTJ
ct-10123	308	14	ur	ur	INTJ
ct-10123	308	15	es	es	X
ct-10123	308	16	c	c	PROPN
ct-10123	308	17	ol	ol	PROPN
ct-10123	308	18	le	le	PROPN
ct-10123	308	19	ct	ct	PROPN
ct-10123	309	1	ed	ed	PROPN
ct-10123	309	2	b	b	PROPN
ct-10123	309	3	y	y	PROPN
ct-10123	309	4	h	h	PROPN
ct-10123	309	5	ag	ag	PROPN
ct-10123	309	6	ya	ya	PROPN
ct-10123	309	7	rd	rd	PROPN
ct-10123	309	8	v	v	INTJ
ct-10123	309	9	et	et	NOUN
ct-10123	309	10	er	er	INTJ
ct-10123	309	11	in	in	ADP
ct-10123	309	12	ar	ar	PROPN
ct-10123	309	13	ia	ia	PROPN
ct-10123	309	14	ns	ns	NUM
ct-10123	309	15	in	in	ADP
ct-10123	309	16	c	c	PROPN
ct-10123	309	17	en	en	X
ct-10123	309	18	tr	tr	PROPN
ct-10123	309	19	al	al	PROPN
ct-10123	309	20	k	k	PROPN
ct-10123	309	21	en	en	PROPN
ct-10123	309	22	tu	tu	PROPN
ct-10123	309	23	ck	ck	PROPN
ct-10123	309	24	y.	y.	PROPN
ct-10123	309	25	t	t	PROPN
ct-10123	309	26	ot	ot	INTJ
ct-10123	309	27	al	al	PROPN
ct-10123	309	28	n	n	PROPN
ct-10123	309	29	um	um	INTJ
ct-10123	309	30	be	be	AUX
ct-10123	309	31	r	r	NOUN
ct-10123	309	32	of	of	ADP
ct-10123	309	33	e	e	PROPN
ct-10123	309	34	nd	nd	ADV
ct-10123	309	35	om	om	PROPN
ct-10123	309	36	et	et	PROPN
ct-10123	309	37	ri	ri	PROPN
ct-10123	310	1	al	al	PROPN
ct-10123	310	2	c	c	PROPN
ct-10123	310	3	ul	ul	INTJ
ct-10123	310	4	tu	tu	X
ct-10123	310	5	re	re	PART
ct-10123	310	6	s=	s=	PROPN
ct-10123	310	7	60	60	NUM
ct-10123	310	8	62	62	NUM
ct-10123	310	9	.	.	PUNCT
ct-10123	311	1	*	*	PUNCT
ct-10123	311	2	a	a	PRON
ct-10123	311	3	nt	not	PART
ct-10123	311	4	ib	ib	X
ct-10123	311	5	io	io	X
ct-10123	311	6	ti	ti	PROPN
ct-10123	311	7	c	c	NOUN
ct-10123	311	8	no	no	DET
ct-10123	311	9	t	t	NOUN
ct-10123	311	10	r	r	NOUN
ct-10123	311	11	ec	ec	PROPN
ct-10123	312	1	om	om	PROPN
ct-10123	312	2	m	m	VERB
ct-10123	312	3	en	en	X
ct-10123	312	4	de	de	PROPN
ct-10123	312	5	d	d	PROPN
ct-10123	312	6	fo	fo	INTJ
ct-10123	312	7	r	r	NOUN
ct-10123	312	8	us	we	PRON
ct-10123	313	1	e	e	X
ct-10123	313	2	w	w	NOUN
ct-10123	313	3	it	it	PRON
ct-10123	313	4	h	h	NOUN
ct-10123	313	5	th	th	INTJ
ct-10123	313	6	is	be	AUX
ct-10123	313	7	o	o	PROPN
ct-10123	313	8	rg	rg	NOUN
ct-10123	313	9	an	an	PRON
ct-10123	313	10	is	be	AUX
ct-10123	313	11	m	m	PRON
ct-10123	313	12	p	p	NOUN
ct-10123	313	13	er	er	INTJ
ct-10123	313	14	c	c	PROPN
ct-10123	313	15	li	li	PROPN
ct-10123	313	16	ni	ni	PROPN
ct-10123	313	17	ca	ca	PROPN
ct-10123	313	18	l	l	PROPN
ct-10123	313	19	l	l	NOUN
ct-10123	313	20	ab	ab	NOUN
ct-10123	313	21	or	or	CCONJ
ct-10123	313	22	at	at	ADP
ct-10123	313	23	or	or	CCONJ
ct-10123	313	24	y	y	PROPN
ct-10123	313	25	s	s	PROPN
ct-10123	314	1	ta	ta	AUX
ct-10123	314	2	nd	nd	PART
ct-10123	314	3	ar	ar	VERB
ct-10123	314	4	ds	ds	VERB
ct-10123	315	1	i	i	PRON
ct-10123	315	2	ns	ns	VERB
ct-10123	315	3	ti	ti	PROPN
ct-10123	315	4	tu	tu	X
ct-10123	315	5	te	te	PROPN
ct-10123	315	6	(	(	PUNCT
ct-10123	315	7	c	c	PROPN
ct-10123	315	8	l	l	NOUN
ct-10123	315	9	s	s	X
ct-10123	315	10	i	i	NOUN
ct-10123	315	11	)	)	PUNCT
ct-10123	315	12	g	g	PROPN
ct-10123	315	13	ui	ui	PROPN
ct-10123	315	14	de	de	PROPN
ct-10123	315	15	li	li	PROPN
ct-10123	315	16	ne	ne	PROPN
ct-10123	315	17	s.	s.	PROPN
ct-10123	316	1	p	p	PROPN
ct-10123	316	2	en	en	PROPN
ct-10123	316	3	ic	ic	PROPN
ct-10123	316	4	il	il	PROPN
ct-10123	316	5	li	li	PROPN
ct-10123	316	6	n	n	PROPN
ct-10123	316	7	su	su	PROPN
ct-10123	316	8	sc	sc	PROPN
ct-10123	316	9	ep	ep	PROPN
ct-10123	316	10	ti	ti	PROPN
ct-10123	316	11	bl	bl	PROPN
ct-10123	316	12	e	e	NOUN
ct-10123	316	13	be	be	AUX
ct-10123	316	14	ta	ta	ADP
ct-10123	316	15	s	s	PROPN
ct-10123	316	16	tr	tr	VERB
ct-10123	316	17	ep	ep	PROPN
ct-10123	316	18	to	to	PART
ct-10123	316	19	co	co	VERB
ct-10123	316	20	cc	cc	VERB
ct-10123	316	21	us	us	PROPN
ct-10123	316	22	s	s	PROPN
ct-10123	316	23	pe	pe	INTJ
ct-10123	316	24	ci	ci	PROPN
ct-10123	316	25	es	es	ADP
ct-10123	316	26	c	c	PROPN
ct-10123	316	27	an	an	DET
ct-10123	316	28	b	b	PROPN
ct-10123	316	29	e	e	X
ct-10123	316	30	co	co	NOUN
ct-10123	316	31	ns	ns	VERB
ct-10123	317	1	i	i	PROPN
ct-10123	318	1	d	d	PROPN
ct-10123	319	1	er	er	INTJ
ct-10123	319	2	ed	ed	NOUN
ct-10123	319	3	s	s	PROPN
ct-10123	319	4	us	us	PROPN
ct-10123	319	5	ce	ce	PROPN
ct-10123	319	6	pt	pt	PROPN
ct-10123	319	7	ib	ib	X
ct-10123	319	8	le	le	X
ct-10123	319	9	to	to	ADP
ct-10123	319	10	a	a	DET
ct-10123	319	11	m	m	NOUN
ct-10123	319	12	pi	pi	NOUN
ct-10123	319	13	ci	ci	PROPN
ct-10123	319	14	ll	ll	AUX
ct-10123	319	15	in	in	ADV
ct-10123	319	16	,	,	PUNCT
ct-10123	319	17	ce	ce	PROPN
ct-10123	319	18	fa	fa	PROPN
ct-10123	319	19	zo	zo	PROPN
ct-10123	319	20	li	li	PROPN
ct-10123	320	1	n	n	PROPN
ct-10123	320	2	an	an	PROPN
ct-10123	320	3	d	d	X
ct-10123	321	1	i	i	PRON
ct-10123	321	2	m	m	VERB
ct-10123	321	3	ip	ip	VERB
ct-10123	321	4	en	en	ADP
ct-10123	321	5	em	em	PRON
ct-10123	321	6	p	p	X
ct-10123	321	7	er	er	INTJ
ct-10123	321	8	c	c	NOUN
ct-10123	321	9	l	l	NOUN
ct-10123	322	1	s	s	VERB
ct-10123	322	2	i	i	PRON
ct-10123	322	3	g	g	PROPN
ct-10123	322	4	ui	ui	PROPN
ct-10123	322	5	de	de	PROPN
ct-10123	322	6	li	li	PROPN
ct-10123	322	7	ne	ne	PROPN
ct-10123	322	8	s.	s.	PROPN
ct-10123	323	1	o	o	PROPN
ct-10123	323	2	f	f	X
ct-10123	323	3	th	th	X
ct-10123	323	4	e	e	PROPN
ct-10123	323	5	60	60	NUM
ct-10123	323	6	62	62	NUM
ct-10123	324	1	c	c	NOUN
ct-10123	324	2	ul	ul	INTJ
ct-10123	324	3	tu	tu	X
ct-10123	324	4	re	re	X
ct-10123	324	5	s	s	PROPN
ct-10123	324	6	,	,	PUNCT
ct-10123	324	7	3	3	NUM
ct-10123	324	8	0	0	NUM
ct-10123	324	9	ye	ye	PRON
ct-10123	324	10	as	as	ADP
ct-10123	324	11	t	t	PROPN
ct-10123	324	12	s	s	PROPN
ct-10123	324	13	pe	pe	INTJ
ct-10123	324	14	ci	ci	PROPN
ct-10123	324	15	es	es	ADP
ct-10123	324	16	a	a	DET
ct-10123	324	17	nd	nd	NOUN
ct-10123	324	18	1	1	NUM
ct-10123	324	19	7	7	NUM
ct-10123	324	20	fu	fu	NOUN
ct-10123	324	21	ng	ng	PROPN
ct-10123	324	22	al	al	PROPN
ct-10123	324	23	s	s	PROPN
ct-10123	324	24	pe	pe	INTJ
ct-10123	324	25	ci	ci	PROPN
ct-10123	324	26	es	es	PROPN
ct-10123	324	27	w	w	PROPN
ct-10123	324	28	er	er	INTJ
ct-10123	324	29	e	e	X
ct-10123	324	30	i	i	PROPN
ct-10123	324	31	d	d	PROPN
ct-10123	324	32	en	en	X
ct-10123	324	33	ti	ti	PROPN
ct-10123	324	34	fi	fi	NOUN
ct-10123	324	35	ed	ed	NOUN
ct-10123	324	36	.	.	PUNCT
ct-10123	325	1	515	515	NUM
ct-10123	325	2	clinical	clinical	ADJ
ct-10123	325	3	theriogenology	theriogenology	NOUN
ct-10123	325	4	•	•	NOUN
ct-10123	325	5	volume	volume	NOUN
ct-10123	325	6	5	5	NUM
ct-10123	325	7	,	,	PUNCT
ct-10123	325	8	number	number	NOUN
ct-10123	325	9	4	4	NUM
ct-10123	325	10	•	•	NOUN
ct-10123	325	11	december	december	PROPN
ct-10123	325	12	2013	2013	NUM
ct-10123	325	13	516clinical	516clinical	PROPN
ct-10123	325	14	theriogenology	theriogenology	NOUN
ct-10123	325	15	•	•	NOUN
ct-10123	325	16	volume	volume	NOUN
ct-10123	325	17	5	5	NUM
ct-10123	325	18	,	,	PUNCT
ct-10123	325	19	number	number	NOUN
ct-10123	325	20	4	4	NUM
ct-10123	325	21	•	•	NOUN
ct-10123	325	22	december	december	PROPN
ct-10123	325	23	2013	2013	NUM
ct-10123	325	24	omniblank	omniblank	NOUN
ct-10123	325	25	:	:	PUNCT